CN102711645A - Systems, apparatuses, and methods for treating tissue and controlling stenosis - Google Patents

Systems, apparatuses, and methods for treating tissue and controlling stenosis Download PDF

Info

Publication number
CN102711645A
CN102711645A CN2010800606276A CN201080060627A CN102711645A CN 102711645 A CN102711645 A CN 102711645A CN 2010800606276 A CN2010800606276 A CN 2010800606276A CN 201080060627 A CN201080060627 A CN 201080060627A CN 102711645 A CN102711645 A CN 102711645A
Authority
CN
China
Prior art keywords
damage
air flue
electrode
energy
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2010800606276A
Other languages
Chinese (zh)
Other versions
CN102711645B (en
Inventor
马丁·L·梅瑟
马克·蒂姆
汉森·S·吉福德三世
史蒂文·C·迪米尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nouarra Co
Original Assignee
Innovative Pulmonary Solutions Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innovative Pulmonary Solutions Inc filed Critical Innovative Pulmonary Solutions Inc
Priority to CN201611095404.9A priority Critical patent/CN106618731B/en
Publication of CN102711645A publication Critical patent/CN102711645A/en
Application granted granted Critical
Publication of CN102711645B publication Critical patent/CN102711645B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B18/1477Needle-like probes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B18/1492Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00005Cooling or heating of the probe or tissue immediately surrounding the probe
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00005Cooling or heating of the probe or tissue immediately surrounding the probe
    • A61B2018/00011Cooling or heating of the probe or tissue immediately surrounding the probe with fluids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/0016Energy applicators arranged in a two- or three dimensional array
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00184Moving parts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00214Expandable means emitting energy, e.g. by elements carried thereon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00214Expandable means emitting energy, e.g. by elements carried thereon
    • A61B2018/0022Balloons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00214Expandable means emitting energy, e.g. by elements carried thereon
    • A61B2018/00267Expandable means emitting energy, e.g. by elements carried thereon having a basket shaped structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00434Neural system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00541Lung or bronchi
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B2018/1405Electrodes having a specific shape
    • A61B2018/1435Spiral
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B2018/1467Probes or electrodes therefor using more than two electrodes on a single probe
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B2018/1475Electrodes retractable in or deployable from a housing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00Ultrasound therapy
    • A61N2007/0004Applications of ultrasound therapy
    • A61N2007/0021Neural system treatment
    • A61N2007/003Destruction of nerve tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00Ultrasound therapy
    • A61N7/02Localised ultrasound hyperthermia
    • A61N7/022Localised ultrasound hyperthermia intracavitary

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Plasma & Fusion (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Otolaryngology (AREA)
  • Physics & Mathematics (AREA)
  • Cardiology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Surgical Instruments (AREA)

Abstract

Systems, delivery devices, and methods to treat to ablate, damage, or otherwise affect tissue. The treatment systems are capable of delivering a coolable ablation assembly that ablates targeted tissue without damaging non-targeted tissue. The coolable ablation assembly damages nerve tissue to temporarily or permanently decrease nervous system input. The system, delivery devices, and methods can damage tissue and manage scarring and stenosis.

Description

Be used to handle tissue and control narrow system, apparatus and method
Quoting of related application
The rights and interests that No. the 61/260th, 349, the U.S. Provisional Patent Application that the application requires to submit on November 11st, 2009 according to 35 U.S.C. § 119 (e).Incorporate this piece provisional application into this paper in full by reference.
Background
Technical field
The present invention relates generally to the system, the apparatus and method that are used to handle tissue, more specifically, the present invention relates to be used to cause required reaction and control narrow system, apparatus and method simultaneously.
Description of related art
Pneumonopathy possibly cause many problems that lung functions is caused adverse effect.Pneumonopathy such as asthma and chronic obstructive pulmonary disease (" COPD ") may cause the gas-flow resistance of pulmonary to increase.The mortality rate that causes by pneumonopathy, all be considerable with healthy relevant cost and population size with adverse effect.These diseases often cause adverse effect to quality of life.Symptom is diversified, but generally includes cough, dyspnea and asthma.For example, in COPD,, may observe dyspnea when carrying out to a certain degree aggravating activities when (as running, jog, hurry up etc.).Along with advancing of disease, carry out such as the walking non-aggravating activities the time also may observe dyspnea.As time goes on, the symptom of COPD may take place during more and more littler activity, exist up to these symptoms always, thereby seriously limit the ability that the people accomplishes normal activity.
The common characteristics of pneumonopathy are airway obstruction, it stops up with the air flue chamber, airway walls thickens, in the airway walls or the change of structure on every side or above combination relevant.Airway obstruction can significantly reduce the gas exchange amount of pulmonary, thereby causes dyspnea.The obstruction in air flue chamber can be caused by too much intracavity mucus or edema fluid do or both.Airway walls thickens and can be caused by airway smooth muscle excess shrinkage, airway smooth muscle hypertrophy, mucous gland hypertrophy, inflammation, edema or above combination.The variation of air flue surrounding structure (the for example destruction of lung tissue itself) can cause the radially forfeiture of traction of airway walls and airway constriction subsequently.
The characteristic of asthma can be shunk for airway smooth muscle, smooth muscle is loose, mucus produces too much, the inflammation and the swelling of mucous gland hypertrophy and/or air flue.These are stimulus object (for example cold air, smog, anaphylactogen or other chemical substance), the systemic hormone (chemical substance of blood of local inflammation cytokine (by being arranged in the chemical substance that airway walls or near immunocyte discharge in the part), suction unusually; Like antiinflammatory hydrocortisone and analeptic epinephrine), the complicated interactional result of local nerve system input (be completely contained in the neurocyte in the airway walls, its local reflex that can produce smooth muscle cell and mucous gland stimulates) and central nervous system's input (being transmitted to the nervous system signal of smooth muscle cell and mucous gland from brain through vagus nerve).These conditions tend to cause provisional widely change in organization and initial reversibility airflow obstruction, and these finally possibly cause permanent change in organization and permanent airflow obstruction, and this makes the asthmatic patient dyspnea.Asthma may further include through the hyperergy airway smooth muscle that can significantly increase gas-flow resistance shrinks acute attack or the attack that the air flue cause further narrows down.SOA comprises repeatedly dyspnea (for example, breathe hard or out of breath), asthma, the uncomfortable in chest and cough of outbreak.
Emphysema are types of COPD, it is characterized by around pulmonary's air flue or the change of contiguous lung tissue.Emphysema can relate to the destruction of lung tissue (for example alveolar tissue, such as alveolar sac), and this causes the minimizing of gas exchange and lung tissue radially reducing of traction that airway walls is applied on every side.The destruction of alveolar tissue stays the emphysema lung areas with excessive space, its lack alveolar wall and alveolar blood capillary and so when gas exchange inefficiency.Air " stranded " is in these bigger spaces.The air of this " stranded " may cause the excessive expansion of lung, and in the scope of breast, has limited the interior stream of rich oxygen containing air and than the normal function of health tissues.This has caused significant dyspnea, and possibly cause hypoxia level and high carbon dioxide level in the blood.Even in healthy individuals, such lung tissue destruction is also taken place as the part of usual aging process.Unfortunately, be exposed to chemical substance or other material (like tobacco smoke) can significantly be accelerated tissue injury or destructive speed.Airway obstruction can further increase dyspnea.Radially weakening of traction possibly cause airway walls to become " relaxing ", makes that the air flue wall part subsides or subsides fully when exhaling.This air flue during owing to exhale subsides and airway obstruction, and emphysema are individual possibly breathe out air outside the lung.
Chronic bronchitis is a type of COPD, it is characterized by that airway smooth muscle shrinks, smooth muscle is loose, mucus produces too much, mucous gland hypertrophy and airway walls inflammation.Similar with asthma, these are local inflammation cytokine, the complicated results of interaction that sucks stimulus object, systemic hormone, local nerve system and central nervous system unusually.With respiratory obstruction is that reversible asthma is different to a great extent, and the airway obstruction of chronic bronchitis mainly is chronic and nonvolatil.Owing to breathe hard, asthma, the uncomfortable in chest and chronic sympton that produces mucous cough, for chronic bronchitis patient, breathing is difficult usually.
Different techniques can be used for assessing the order of severity and the progress of pneumonopathy.For example, pulmonary function test (pft), motor capacity and quality of life questionnaire by individual through being commonly used to estimate.Pulmonary function test (pft) relates to the objective and repeatable measurement of basic physiological lung parameter, like total air flow, lung volume and gas exchange.The index that is used to assess the pulmonary function test (pft) of obstructive pulmonary disease comprises ratio, total lung capacity, TLC (TLC), airway resistance and the arterial blood gas test of 1 second forced expiratory volume (FEV1), forced vital capacity (FVC), FEV1 and FVC.FEV1 is a patient pulmonary when being full of air fully, the volume of air that forced expiration was breathed out in first second.FEV1 also is the average discharge that takes place in FE first second.This parameter can be used for assessment and determines whether to exist any airway obstruction and influence thereof.FVC is a patient pulmonary when being full of air fully, the total volume of air that forced expiration can be breathed out.The ratio of all gas that the gas comprises that can breathe out in first second when FEV1/FVC is forced expiration can be breathed out.After giving at least a bronchodilator, FEV1/FVC ratio is less than the existence of 0.7 definition COPD.TLC is the total amount of gas in the lung when pulmonary is full of fully, and TLC may increase when in obstructive pulmonary patient's lung, bottling up air.Airway resistance is defined as barometric gradient and the ratio of the air velocity between alveolar and the mouth between alveolar and the mouth.The resistance of equally, given air flue is defined as through the barometric gradient of this given air flue and the ratio of the air-flow of this air flue of process.The amount of the oxygen in the ABG thermometrically blood and the amount of carbon dioxide, and be that assessment pulmonary and respiratory system are brought oxygen into blood and carbon dioxide taken out of the most direct method of external ability from blood from air.
The motor capacity test is that the patient carries out the objective of active ability and repeatably detection.Six minutes walk test (6MWT) be a kind of motor capacity test, wherein patient's walking as much as possible on smooth surface in 6 minutes.Another kind of motor capacity test relates to the largest motion ability of measuring patient.For example, the amount of doctor's power that can measuring patient on cycle ergometer, can produce.The patient can breathe 30% oxygen and live load can increase 5-10 watt in per 3 minutes.
Quality of life the questionnaire assess holistic health and happiness.It is a kind of quality of life questionnaire that the St.George's breathes questionnaire, and it comprises 75 problems, and it is designed for measures the influence of obstructive pulmonary disease to total health status, daily life and perception happiness.The therapeutic effect of pneumonopathy can use pulmonary function test (pft), motor capacity test and/or questionnaire to assess.Can be based on the results modification therapeutic scheme of these tests and/or questionnaire.
Anaplastic treatment relates to through melting in the lung airway walls of numerous bronchial trees and destroys smooth muscle tension force such as bronchus heat, eliminates smooth muscle and nerve in pulmonary's airway walls thus.The air flue of treatment can not be well in response to the stimulus object, systemic hormone and the part that suck and central nervous system's input.Unfortunately, the smooth muscle tension force of airway walls possibly can have a negative impact to pulmonary function with neural this destruction thus.For instance, the suction stimulus object such as smog or other toxicant can stimulate irritant receptor of lung usually and produce cough and air flue smooth muscle contraction.Eliminate nerve in the airway walls and removed partial function of nervous system and import, thereby eliminated lung is discharged toxicant through strong cough ability with nervus centralis.Eliminate airway smooth muscle tension force and possibly eliminate the ability that air flue tightens, thereby allow deeper to infiltrate through in the lung such as the harmful substance of toxicant.
Asthma and COPD are serious diseases, and its patient is more and more.Present treatment technology comprises prescription drugs, and both not exclusively success can not have no side effect.In addition, many patients do not observe its drug prescription dosage.Therefore, the treatment that can improve gas-flow resistance and not need patient's compliance need be provided.
Brief description
At least some embodiments relate to device in the tube chamber, and said device can be removed hollow organ's innervation, can prevent, minimize or limit simultaneously narrow possibility.Can treat the target area of organ, and can not cause the undesirable narrow of appreciable impact organ dysfunction.In certain embodiments, device melts the independent purpose zone that is spaced apart from each other in the tube chamber.Even take place narrowly, also can avoid extending the continuous narrow ring of 360 degree.If said organ is an air flue, can forms damage, and can not cause gas-flow resistance that any increase that perceives takes place.
In some embodiments, be used to treat individual system and comprise that size is set at the elongate member that can move along the air flue chamber.Said assembly can weaken the signal that is transmitted by nervous tissue (the for example nervous tissue of nerve trunk), can the inner surface of air flue irreversibly not destroyed to any significant degree simultaneously.In certain embodiments, one or more electrode output RF energies are handled rear portion 90 degree of air flue circumference to 180 degree, thereby remove the innervation of lung.When destroying destination organization, cooling system (for example, cooling duct) can control electrode and/or the temperature of airway tissue.
In some versions, tissue injury can be enough to cause cicatrization, reduces, limit or eliminate basically because narrowing down of perceiving of scar tissue, the air flue chamber generation that causes such as narrow but can place electrode.The spacing distance of damage can be enough to prevent that the tissue between the contiguous damage from thickening.Disclosed at least some embodiments of this paper can melt basically airway walls whole circumference and not can with the plane of air flue axis in form successive ablation tissue ring.
In some embodiments, method comprises the nervous tissue that destroys first main bronchus, is passed to the almost whole far-end bronchial trees that are connected with said first main bronchus to prevent the nervous system signal basically.Most of in the bronchial tree of the said first main bronchus far-end or all can't receive the nervous system signal.In certain embodiments, nervous tissue is between the lung that trachea and bronchus branch extends through.Said method also comprises the nervous tissue that destroys second main bronchus, is passed to the almost whole far-end bronchial trees that are connected with said second main bronchus to prevent the nervous system signal basically.In certain embodiments, along the rear portion air flue less than 180 ° or in the required part delivery of energy of air flue circumference.This has limited the amount of the tissue that is exposed to emitted energy.
In some embodiments, innervation is removed and is related to the damage that generation can influence outside adventitial tissue layer, and wherein nerve trunk is arranged in said outside adventitial tissue layer on anatomical structure.In the innervation of lung is removed, melt the nerve trunk that runs through right side and left side main bronchus outside and can cut off the airway smooth muscle that is lining in the lung airway and the product mucus body of gland and vagal contact that are positioned at air flue effectively.When this thing happens, airway smooth muscle was lax, and mucus produces and reduces.These variations can reduce the airway obstruction under the morbid state (such as COPD and asthma).The airway obstruction that reduces makes breathing easier, and this can improve individual quality of life and health status.
The air flue arm is in be lower than second temperature of said first temperature can heat damage nervous tissue through the temperature of nervous tissue being brought up to first temperature (for example, melting temperature).In some embodiments, a part that is positioned at the radially inner airway walls of nervous tissue can be in first temperature, to prevent that this part airway walls is caused permanent damage.Said first temperature can be enough high, and can cause permanent damage to nervous tissue.In some embodiments, nervous tissue is a part that is arranged in the nerve trunk of the outside connective tissue of airway walls.It is functional that smooth muscle in the airway walls and nervous tissue can keep, so that smooth muscle tension force maintains aspiration level.Air flue can shrink/expand in response to stimulating (stimulation that for example, is caused by the stimulus object, local nerve system or the systemic hormone that suck).In other embodiments, nervous tissue is nervous ramification or the part of nerve fiber in the airway walls.In other embodiments, simultaneously or destroy the nervous tissue of nerve trunk and the nervous tissue of nervous ramification/fiber in succession.But various types of starting elements (for example ablation) can be used for exporting energy.
Some embodiments are utilized the advantage of big airways anatomical structure.Vagal air flue nerve trunk is usually located at the latter half of main bronchus air flue.Main airway (being trachea, right side and left side main bronchus) Background Region does not have cartilage.The cartilaginous ring of these air flues is not a whole circumference, and only has soft tissue along their rear portion.In addition, can realize damaging away from the nervous tissue of air flue nerve trunk through producing damage less than 360 degree of (for example, significantly less than) air flue circumference to being positioned at the air flue latter half.For example, 180 degree of processing air flue circumference, 150 degree or 130 degree maybe be just enough for the innervation of effective removal air flue.Because damage has remarkable arc length less than 360 degree, therefore can significantly reduce or prevent airway constriction.
Electrode can have complicated shape (comprising arc, polygon) or have any other shape or structure.Electrode can be V-arrangement, U-shaped, L shaped, T shape, W shape, straight, crooked or above combination.In some embodiments, electrode assemblie is zigzag configuration, curl shape structure, winding escalator or coil shape structure, corkscrew shape (corkscrew) structure, helical configuration, Z-shaped structure, above combination etc.Corkscrew shape electrode assemblie can have the electrode that can independently control, and said electrode forms the discontinuous or successive damage that is substantially corkscrew shape.
Another embodiment comprises and can or all produce the successive electrode assemblie that is substantially corkscrew weakened and emaciated body wound along the part of air flue circumference.For same circumferential area, it is less that the cicatrix with small surface area produces the probability can form narrow tissue net.At least some embodiments can be handled narrow target area, to form corresponding narrow damage.The blade electrode assemblie can carry out such processing, thereby further reduces scar tissue.
Another embodiment depends on nerve, tremulous pulse and the vein that tends to companion's row in the human anatomy structure.Carrying out before the air flue innervation removes, can use the energy of ultrasonic or other type to confirm arteriae bronchiales or the venous position of walking near air flue nerve trunk place very.After confirming the position of blood vessel, with near the air flue zone of energy process blood vessel to melt the air flue nerve trunk.This technology minimizes or limits the volume of handled tissue, thereby reduces or eliminate narrow risk.
In some versions, conduit forms the damage of at least one place in the degree of depth of expectation.For example, can in a bronchus airway walls, form the damage of a place or many places corkscrew shape or spiral type, and can in another airway walls, form arc damage, thereby remove the innervation of bronchial tree different piece.Damage can or be positioned at the depths of airway walls along the inner surface of air flue, perhaps can be along the outer surface of air flue.
In some embodiments, the energy delivery apparatus comprises catheter shaft and the ablation member that is connected with said catheter shaft.Said ablation member comprises can be from collapsed mode energy emitter between cooling element that deployed condition moves and cartilage, and energy emitter comprises a plurality of electrodes that the longitudinal axis around said ablation member departs from a circumferential direction each other between said cartilage.Said electrode is configured to can be to a plurality of target areas of air flue delivery of energy, and said a plurality of target areas separate each other with respect to the longitudinal axis of said air flue.Said energy emitter and said cooling element are configured to cooperatively interact and damage to form between cartilage, and the surface texture of damage and said air flue separates and between the cartilaginous ring of said air flue between said cartilage.
In certain embodiments, delivery apparatus comprises ablation member in the tube chamber, and said ablation member comprises deployable device and a plurality of ablation and/or electrode.Said electrode is separated along the circumference of said deployable member, and can export energy to dispersive target area, thereby forms damage in said target area.At least a portion of first damage separates with second damage in the axial direction, and contiguous or overlapping with said second damage in a circumferential direction.
In certain embodiments, the individual method of treatment comprises with respect to air flue places ablation member, and exports energy from said ablation member to axially spaced air flue target area.When the long axis direction of said air flue is observed, the profile of said target area is overlapping.
In other embodiments, the individual method of treatment comprises the energy emitter that moves delivery apparatus along air flue.At least one electrode of said energy emitter is placed between the cartilaginous ring of said air flue., damage to being positioned at from said electrode to form between cartilaginous ring along the target area delivery of energy of the position that the major axis of said air flue axially separates.
The certain methods of handling tissue comprises ablation member is placed on the air flue intracavity, and utilizes at least one electrode of being placed near the said ablation member said air flue inner surface delivery of energy of organizing to said air flue.The energy of being sent destroys the target area that axially separates along said air flue, and the target area part of feasible qualification maximum cross section, said target area width is separated with the inner surface of said air flue.
In some embodiments, delivery apparatus comprises catheter shaft and the ablation member that is connected with said catheter shaft.Said ablation member comprises the deployable elements that can move to deployed condition from collapsed mode.When said deployable member was in deployed condition, energy emitter can be sent energy and produce damage, and said damage has the end that is axially offset to one another along the axial length of body structure.
Delivery apparatus can produce the continuous or discrete damage in a place or many places.Said damage can have different shapes, comprises arc, spirally (spiral shape), spiral type (helical shape), waveform, curl shape or above combination.In order to produce successive damage, ablation member can have the very near electrode of being separated by, to form successive substantially damage.Perhaps, said ablation member can have long electrode or energy emitter, and they have corresponding spirally, spiral type, curl shape etc.In other embodiments, electrode can separate enough distances, to form discontinuous damage.Can preference pattern, the size of interval and damage comes the processing target zone.
In certain embodiments, can form damage simultaneously along the diverse location of airway walls.In some versions, can form oblique damage at the offside of air flue.Whole damage can be between cartilaginous ring damages said ring avoiding.In other embodiments, damage can be passed trachea or cartilaginous ring.
Description of drawings
In the accompanying drawings, same reference number is represented similar element or assembly.
Fig. 1 has shown near lung, the lung and blood vessel and nerve in the lung.
Fig. 2 has shown according to an embodiment and has been placed on the intracavity processing system in the left principal bronchus.
Fig. 3 has shown the delivery apparatus that the access to plant from be placed on left principal bronchus stretches out.
Fig. 4 A is the air flue of bronchial tree and the sectional view of the ablation member of subsiding.
Fig. 4 B is the air flue of bronchial tree and the sectional view of unfolded ablation member.
Fig. 5 A is the sectional view that when the smooth muscle contraction of air flue and mucus are in the air flue chamber, is centered around the air flue around the ablation member of subsiding.
Fig. 5 B is the sectional view that is centered around unfolded ablation member air flue on every side.
Fig. 6 is the figure of tissue depth with respect to tissue temperature.
Fig. 7 is the side view of the ablation member in the air flue.
Fig. 8 is the isometric view with delivery apparatus of ablation member.
Fig. 9 is the sectional view of the elongate bars obtained of the line 9-9 along Fig. 8.
Figure 10 is the side view of ablation member.
Figure 11 is the longitdinal cross-section diagram of the ablation member of Figure 10.
Figure 12 is the partial cross section figure of therapy system, and wherein delivery apparatus stretches out from access to plant.
Figure 13 is the side view of ablation member.
Figure 14 is the sectional view that is centered around the air flue around the unfolded ablation member, and this sectional view is that the line 14-14 along Figure 13 obtains.
Figure 15 is the side view of ablation member.
Figure 16 is the side view that is used to produce the ablation member of oblique damage.
Figure 17 is the side view with ablation member of inner passage.
Figure 18 is the sectional view of the ablation member of Figure 17 of obtaining of 18-18 along the line.
Figure 19 is the side view with ablation member of outlet.
Figure 20 is the sectional view of the ablation member of Figure 19 of obtaining of 20-20 along the line.
Figure 21 is the side view with ablation member of V-arrangement electrod-array.
Figure 22 is the side view with ablation member of T shape electrode.
Figure 23 is the side view of multiple tooth ablation member.
Figure 24 is the side view with the right ablation member of electrode assemblie.
But Figure 25 is the side view with ablation member of cooling electrode assembly.
Figure 26 is the sectional view of the electrode assemblie that obtains of the line 26-26 along Figure 25.
Figure 27 A-31B has shown isothermal line and corresponding damage.
Figure 32 is the side view of helical form ablation member.
Figure 33 is the side view of another helical form ablation member.
Figure 34 is the isometric view with ablation member of isolated electrode.
Figure 35 is the isometric view that is placed on the ablation member of the Figure 34 in the air flue body cavity.
Figure 36 is the isometric view of the damage that forms of the ablation member by Figure 34.
Figure 37 is the isometric view of ablation member with electrode of coolant cools.
Figure 38 is the sectional view of the ablation member obtained of the line 38-38 along Figure 37.
Figure 39 A is the isometric view with ablation member of crooked energy emitter.
Figure 39 B is the isometric view by the blood vessel of the ablation member processing of Figure 39 A.
Figure 40 A is another isometric view of the ablation member of Figure 39 A.
Figure 40 B is the isometric view by the blood vessel of the ablation member processing of Figure 40 A.
Figure 41 is the isometric view of the ablation member of another embodiment.
Figure 42 is the isometric view that is in the ablation member of sending configuration.
Figure 43 is the isometric view that is in the ablation member of the Figure 42 that launches configuration.
Figure 43 A is the side view of the ablation member of Figure 43.
Figure 44 is the sectional view of distal section of the ablation member of Figure 43.
Describe in detail
Fig. 1 has showed the people's lung 10 with left lung 11 and right lung 12.Trachea 20 from nose with mouthful to extending below and being divided into left principal bronchus 21 and right principal bronchus 22.Left principal bronchus 21 is all distinguished branch with right principal bronchus 22 and is formed lobar bronchi, segmental bronchi and inferior segmental bronchus, and they have diameter that diminishes gradually and the length that shortens gradually along outside direction (being distal direction).30 of main pulmonary arteries pass through from the right ventricle of heart and in the place ahead of radix pulmonis 24.At radix pulmonis 24 places, tremulous pulse 30 branches into left and right pulmonary artery, and left and right pulmonary artery branch shape successively becomes ramose blood vessel network.These blood vessels can extend along the air flue of bronchial tree 27.Bronchial tree 27 comprises left principal bronchus 21, right principal bronchus 22, bronchioles and alveolar.Vagus nerve 41,42 extends and branch's formation nerve trunk 45 along trachea 20.
Left vagus nerve 41 passes cervical region with 42 of right vagus nerves from brain stem, and passes through chest downwards in the both sides of trachea 20.Vagus nerve 41,42 expands into nerve trunk 45, and nerve trunk 45 comprises the plexus pulmonalis of the front and rear that holds trachea 20, left principal bronchus 21 and right principal bronchus 22.Also the branch branch airway along bronchial tree 27 extends nerve trunk 45 in the branch branch airway outside of bronchial tree 27.Nerve trunk 45 is neural trunks, comprises that the hard sheath by connective tissue wraps in nerve fibre bundle together.
The major function of lung 10 is that airborne exchange of oxygen is gone into blood, and with the carbon dioxide exchange in the blood in air.When the oxygen containing air of richness was drawn into lung 10, gas exchange process began.The contraction of diaphram and intercostal chest muscle wall cooperatively interacts and reduces the pressure in the chest, makes rich oxygen containing air flow cross the air flue of lung 10.For example, air through port and nose, trachea 20, then through bronchial tree 27.Air finally is delivered to alveolar sac and carries out gas exchange process.
The blood of oxygen poor pumps through pulmonary artery 30 from right side of heart and also finally is delivered to the alveolar blood capillary.Be rich in the carbon dioxide refuse in the blood of this oxygen poor.Thin semipermeable membrane separates oxygen poor blood in the blood capillary and the rich oxygen containing air in the alveolar.These blood capillaries surround alveolar and in the middle of alveolar, extend.Diffuse into blood from airborne oxygen through film, and come the carbon dioxide of autoblood to diffuse in the air of alveolar through film.Then, new rich oxygen containing blood flows to heart from the branch vessel of alveolar blood capillary through the pulmonary vein system.Heart is delivered to whole body everywhere with the oxygen containing blood pump of richness.When diaphram and Intercostal muscle were lax, the air that has consumed oxygen in the lung was breathed out, and lung and thoracic wall return elastically normal relaxed condition.By this way, air can flow through branch's bronchioles, bronchus 21,22 and trachea 20, and final through port and nose discharge.
Fig. 2 has shown processing system 200, thereby it can handle the air-flow in adjustment expiration or air-breathing or expiration and the breathing process.Increase gas exchange in order to reduce gas-flow resistance, processing system 200 can be used for enlarging (for example, expansion) air flue.The nervous tissue (for example nervous tissue) that can influence in some versions, (in the inside of lung or outside) nerve trunk expands air flue.Nervous system uses the signal of telecommunication and chemical signal that the communication between brain and the lung 10 is provided.The activity of autonomic nervous tissue network sensation and adjusting respiratory system and vascular system.Nervous tissue comprise use chemical signal and the signal of telecommunication from a body part to feeling to another body part transmission and the fiber of movable information.For example, nervous tissue can be with the form transmitting sports information of nervous system input, such as the signal that causes muscle contraction or other reaction.Fiber can be made up of neuron.Nervous tissue can be held by connective tissue (being epineurium).Autonomic nervous system comprises the sympathetic nervous system parasympathetic nervous system of unifying.Sympathetic nervous system mainly participate in stress during " excitement " function.Parasympathetic nervous system is mainly participated in " plant " function during energy keeps.The sympathetic nervous system parasympathetic nervous system of unifying is simultaneously movable, and usually tract is produced mutual effect.The innervation of blood vessel comes from this two systems, and the innervation of air flue mainly is parasympathetic in itself, and between the lung of right vagus nerve 42 and left vagus nerve 41 and brain, transmits.
Can be in these nerve trunk 45 one or more on carry out the part that any amount of operation influences the lung relevant with these nerve trunk.Because some nervous tissue in the network of nerve trunk 45 (for example imports other nerve; The nerve that is connected with esophagus, get into the nerve of abdominal part etc. through chest), so thereby can targeting minimize, limit or eliminate basically other non-target nerve or structure are caused undesirable destruction in specific site.Some fiber of front and rear plexus pulmonalis imports little nerve trunk, and these little nerve trunk are extended along trachea 20 and branch's bronchus and bronchiolar outer surface when outwards walking into lung 10.Along branch's bronchus, these little nerve trunk are bifurcated and fiber sent into airway walls each other constantly.
Processing system 200 can influence specific nervous tissue, such as the vagus nerve tissue relevant with the objectives site.The vagus nerve tissue is included in efferent nerve fiber parallel in the nervous ramification and afferent nerve fiber.The nervus centrifugalis tissue transmits signal from brain to the air flue effector lymphocyte, and the air flue effector lymphocyte mainly is airway smooth muscle cells and product myxocyte.The nervus centripetalis tissue transmits signal from the air flue sensory receptors in response to stimulation, and extends to brain.The nervus centrifugalis tissue makes from trachea 20 and all receives innervation to the smooth muscle cell to terminal bronchiole, and the innervation of centripetal fiber mainly is confined to trachea 20 and bigger bronchus.The efferent vagus nerve tissue has the nervous activity of constant baseline to air flue, and this makes smooth muscle contraction and mucous secretion be in baseline values.Processing system 200 can influence and spread out of and/or the nervus centripetalis tissue, thus the inflammation and the tissue fluid content (for example, edema) of control airway smooth muscle (for example, making smooth muscle receive innervation), mucous secretion, neural mediation.The airway smooth muscle contraction relevant with pneumonopathy, Polyblennia, inflammation and airway walls edema usually cause high relatively gas-flow resistance, and this causes gas exchange to reduce and pulmonary function descends.
In some scheme, melt nervous tissue to weaken along the transmission of the signal of can causing of transmitting of vagus nerve 41,42 or muscle, mediate muscle contraction, mucus generation, inflammation, edema etc.Weaken and to include but not limited to obstruction, restriction, blocking-up and/or interrupt signal transmission.For example, weaken and to comprise the signal amplitude that reduces nerve signal or weaken transmission through nerve signal.Reduce or distad stop that the nervous system input of air flue can change airway smooth muscle tension force, generations of air flue mucus, airway inflammation etc., thereby control air flows into and outflow lung 10.Reduce or stop from air flue and lung to the local effect cell or to central nervous system's sensation input can also reduce that reflection bronchial stenosis, reflection mucus produce, the release of inflammatory mediator and in body lung or the organ nervous system that possibly cause the airway walls edema of other cell import.In some embodiments, can reduce the nervous system input, thereby correspondingly reduce airway smooth muscle tension force.In some embodiments, air flue mucus produces the amount that is reduced can be enough to cause cough and/or the substantive decline of gas-flow resistance.In some embodiments, the amount that airway inflammation reduced can be enough to make gas-flow resistance and reduce the ongoing inflammatory damage of airway walls is substantive.Signal weakening can make smooth muscle loosening, prevents, limits or eliminate basically the mucus generation of producing myxocyte and reduce inflammation.Under this mode, can change healthy air flue and/or ill air flue to regulate pulmonary function.After the processing, can utilize various types of questionnaires or test to assess individual reaction to handling.If desired or hope, can carry out other operates and reduces the cough frequency, reduces dyspnea, reduces asthma etc.
The main bronchus 21,22 (i.e. 1 grade of air flue (airway generation 1)) that can handle Fig. 1 and 2 influences the distal portions of bronchial tree 27.In some embodiments, at processing left side, positions and right side main bronchus 21,22 along left side and right side radix pulmonis 24 and left lung 11 and right lung 12 outsides.Treatment site can be positioned at vagus nerve branch and trachea and main bronchus 21,22 distally of remittance place and the nearside of lung 11,12 mutually.The single processing procedure that relates to two kinds of treatment application can be used to handle the most of or whole bronchial tree 27 of bronchial tree 27.The overwhelming majority that extends into the bronchial tree in the lung 11,12 can be affected, thereby high-caliber curative effect is provided.Because the arteriae bronchiales of main bronchus 21,22 have big relatively diameter and high heat absorption capacity, handle the undesirable destruction that produces so can protect these arteriae bronchiales to exempt from.
Fig. 3 has shown the delivery apparatus of conduit system 204 forms, and wherein conduit system 204 extends through access to plant 206.Conduit system 204 can be handled the air flue of main bronchus 21,22, and the air flue in main bronchus 21,22 distally.Ablation member 208 can be placed on outside the pulmonary, in right side or left side main bronchus, lobe of the lung bronchioles or the middle bronchus.Middle bronchus is formed by the part of right side main bronchus and is middle period bronchioles and the bronchiolar origin of inferior lobe.Ablation member 208 can also be placed in the more high-grade air flue distal part that (for example,>2 grades air flue) influences bronchial tree 27.
Can guide catheter system 204 carry out various operation through zigzag air flue, for example, the innervation of the cut-off parts lobe of the lung, the whole lobe of the lung, a plurality of lobe of the lung or a lung or two lungs.In some embodiments, handle lobar bronchi to cut off the innervation of the lobe of the lung.For example, but targeting in along one or more treatment site of lobar bronchi to cut off the innervation of the whole lobe of the lung that is connected with this lobar bronchi.Can handle the left lung bronchus to influence upper left leaf and/or left inferior lobe.Can handle the lobus dexter bronchus to influence right upper lobe, right middle lobe and/or right lower lobe.Can be side by side or one after the other handle the lobe of the lung.In some embodiments, the doctor can handle a lobe of the lung.Based on the effectiveness of handling, the doctor can simultaneously or one after the other handle other lobe of the lung.By this way, can handle the different separated region of bronchial tree.
Can be through handling each segmental bronchi to single treatment site delivery of energy along each segmental bronchi.For example, can be to each segmental bronchi delivery of energy of right lung.In some versions, apply 10 energy and can handle the most of or almost whole of right lung.In some versions, utilize the different energy that is less than 36 times to apply and to handle the most of or almost whole of two lungs.According to the anatomical structure of bronchial tree, often can utilizing once or twice, energy applies the innervation that cuts off segmental bronchi.
When nervous tissue is melted, can keep such as other tissue of mucous gland, cilium, smooth muscle, body pipe (for example blood vessel) etc. or the function of anatomical structure.Nervous tissue comprises neurocyte, nerve fiber, dendron and such as neuroglial supporting tissue.Neurocyte transmission electric pulse, and nerve fiber is the aixs cylinder of the prolongation of the said pulse of guiding.Said electric pulse is converted into chemical signal, thereby sets up communication with effector lymphocyte or other neurocyte.For instance, can cut off the innervation of the part air flue of bronchial tree 27, to weaken one or more nervous system signals by nervous tissue's transmission.Cut off innervation and can comprise destruction all nervous tissues, thereby the more distal location that makes all signals can't be passed to bronchial tree through the damaged section of nerve trunk basically perhaps conducts to more near the central nervous system from bronchial tree along one section nerve trunk of air flue.In addition; The directly sensory receptors of transmitting along nerve fiber from air flue (for example; Cough and costimulatory receptor) also will be interrupted near effector lymphocyte's (for example, joint back neurocyte, smooth muscle cell, myxocyte, inflammatory cell and vascular cell) signal.If a plurality of nerve trunk are extended along air flue, then can destroy each nerve trunk.Therefore, the nerve supply along segmental bronchus tree can be cut off.When signal was cut off, the distally airway smooth muscle can relax, and this causes air flue expansion, myxocyte to reduce the mucus generation or inflammatory cell stops to produce airway walls swelling and edema.These variations reduce gas-flow resistance and then increase the gas exchange in the lung 10, thereby reduce, restriction or eliminate one or more symptoms basically, such as dyspnea, asthma, uncomfortable in chest etc.The tissue of encirclement or vicinity purpose nervous tissue may be affected, but can not receive permanent damage.In some embodiments; For example; Before processing and after handling; The blood of analog quantity can be sent to the bronchial wall tissue along the bronchus blood vessel of the air flue that is processed, and the blood of analog quantity can be sent to the alveolar sac of bronchial tree 27 distal regions along the lung blood vessel of the air flue that is processed.These blood vessels can continue to transport blood to keep competent gas exchange.In some embodiments, the destruction of airway smooth muscle does not reach significant degree.For example, the not obvious smooth muscle than segment that influences respiratory function can be changed reversiblely in the airway walls.If energy is used to destroy the outer nervous tissue of air flue, the energy of treatment effective dose can not arrive the major part of non-purpose smooth muscle tissue.
Handle left principal bronchus 21 and one of right principal bronchus 22, thereby handle a side of bronchial tree 27.Can handle other main bronchus 21,22 based on the effectiveness of first processing.For example, can handle left principal bronchus 21 and handle left lung 11.Can handle right principal bronchus 22 to handle right lung 12.In some embodiments, single processing system can be destroyed the nervous tissue of one of bronchus 21,22, and in the nervous tissue that need not under the situation of trachea 20 taking-up processing systems, can also destroy other main bronchus 21,22.Therefore, just can destroy need not to take out under the situation of processing systems along the nervous tissue of main bronchus 21,22 from trachea 20.In some embodiments, can carry out all or at least quite a few (for example, bronchus air flue of at least 50%, 70%, 80%, 90%) basically that single operation comes management of patients bronchial tree easily.In other operation, after handling one of lung 11,12, can take out processing system from the patient.If desired, can in operation subsequently, handle other lung 11,12.
Fig. 4 A is the view in transverse section of healthy air flue 100, is example with the bronchus.Inner surface 102 is defined by 110 of epithelial cell plicated layers, and epithelial cell is surrounded by substrate 112a.Smooth muscle tissue's layer 114 surrounds substrate 112a.Hypothallus 112b is between muscular tissue 114 and connective tissue 124.Mucous gland 116, cartilaginous lamina 118, blood vessel 120 and nerve fiber 122 are in the hypothallus 112b.Arteriae bronchiales branch 130 and nerve trunk 45 are positioned at wall 103 outsides of air flue 100.Shown tremulous pulse 130 is positioned at the connective tissue 124 that surrounds airway walls 103 with nerve trunk 45, and its direction can be parallel to air flue 100 usually.In Fig. 1, for example, 45 of nerve trunk are extended to alveolar from vagus nerve 41,42 and along air flue 100.Nerve fiber 122 is arranged in airway walls 103 and extends to muscular tissue 114 from nerve trunk 45.The nervous system signal transmits to muscle 114 and mucous gland 116 from nerve trunk 45 through nerve fiber 122.In addition, signal transmits to the central nervous system through nerve trunk 45 from sensory receptors (for example, cough, stimulus object and stretching).
Can destroy, stimulate or otherwise change cilium to cause required replying along epithelial cell 110, thus the transportation of control (for example, increase or reduce) mucomembranous cilium.Can suck a lot of particulate matters when the people breathes, the function of air flue performance filter is removed particulate matter from air.Mucomembranous cilium transportation system is for the mechanism of all air flue performance self-cleanings of whole lung 10.Mucomembranous cilium transportation is to remove mucous main method from the distal part of lung 10, and then as the main immunologic barrier of lung 10.For example, the inner surface 102 of Fig. 4 A can be covered and be coated with mucus by cilium.As the part of mucomembranous cilium transportation system, mucus is caught the particulate matter (for example, deleterious pollutant are such as tobacco smoke) of many suctions and is made these particulate matters to laryngeal movement.The distal position mucous blanket that the fibre swing of cilium makes lung 10 moves through larynx with the pantostrat of the particulate matter of catching, and moves to pharynx and be used for discharging from respiratory system.Ablation member 208 can be destroyed cilium to reduce the mucomembranous cilium transportation or to stimulate cilium to improve the mucomembranous cilium transportation.
Ablation member 208 can be moved into the deployed condition of Fig. 4 B, thereby optionally handles the target area (for example, the anatomical structure among substrate 112a, the 112b, nerve trunk 45 etc.) in the airway walls 103.For example, can destroy mucous gland 116, make mucus produce the mucus accumulation that the amount that reduces is enough to prevent to cause the gas-flow resistance increase, simultaneously,, keep enough mucus to produce to keep effective mucomembranous cilium transportation like needs or hope.Also can destroy nervous ramification/fiber through other anatomical structure in airway walls 103 or the airway walls 103.Damage is formed at ad-hoc location to prevent significantly to reduce the narrow or scar tissue through the air-flow of air flue 100.
Natural body function can help prevent, reduces or limit the damage to tissue.130 blood can absorb heat energy in the blood vessel, can carry the heated zones of heat energy away from branch 130 then.By this way, blood can alleviate or avoid the damage to blood vessel 130.After handling, arteriae bronchiales branch 130 can continue to keep the health of lung tissue.Melt in the embodiment at some RF, the RF energy of ablation member 208 output q.s destroys whole vertical section of nerve trunk 45 and does not destroy blood vessel 130.
Assessment to treatment effect can be at least to a certain extent based on one or more air flue characteristics, pulmonary function test (pft), motor capacity test and/or questionnaire.Can assess to follow the tracks of and to monitor their progress individuality.If desired or hope, can carry out other process up to realizing required reaction.Can use the dissimilar instrument that is used to assess the air flue characteristic.During melting, can show from the feedback of instrument whether target tissue is melted.In case target tissue is melted, the non-destination organization of health followed destruction (if any) thereby can stop to treat minimizing or limiting.
Can assess to confirm on-unit the different qualities of air flue.Said air flue characteristic includes but not limited to; The physical property of air flue (for example; Air flue compliance, shrinkage etc.), the dimension in airway resistance, air flue chamber (for example; The shape of air flue, the diameter of air flue etc.), the reactivity of air flue (for example, reactivity), muscle property (for example, muscle tone, muscular tone etc.), inflammatory cell, inflammatory cytokine etc. to stimulating.In some embodiments, can change the variation of monitoring the air flue muscle property through the pressure that measurement is expanded in the ablation member 208 of known pressure.The effect (if any) that the doctor changes confirm handle according to pressure, said effect include but not limited to whether destination organization has been stimulated, melted etc.
Fig. 5 A and 5B are the view in transverse section of the part of air flue 100, and air flue 100 has the smooth muscle tissue 114 that is in contraction state, from the mucus 150 of the mucous gland 116 of undue growth and inflammatory swelling and the edema fluid do that airway walls 103 is thickened.Muscular tissue 114, mucus 150 of shrinking and the airway walls 103 that thickens cooperatively interact and occlusion lumen 101 partly, and this causes high relatively gas-flow resistance.Destroy nervous tissue 45 and come relaxed muscle tissue 114, expansion air flue 100, thus reduce gas-flow resistance, therefore allow more air to arrive the alveolar sac that is used for gas exchange process.Airway resistance reduces the channel opener that possibly show air flue, the channel opener that for example weakens in response to the nervous system input of these air flues.Can limit or minimize narrow, can significantly not increase with the gas-flow resistance after guaranteeing to handle.Therefore, processing should be guaranteed the permanent reduction of air flue gas-flow resistance, even after processing a very long time.
With (for example handle rudimentary air flue (low generation ariways); Main bronchus, lobar bronchi, segmental bronchi) decline of relevant airway resistance can be greater than the slippage of the airway resistance relevant with processing high level air flue (high generation ariways) (for example, inferior segmental bronchus).The air flue that the doctor can select to be suitable for handling is realized reducing of desired airway resistance, and can be in the patient oral cavity, and the bronchial tree of treatment site nearside, trachea or any other suitable position are measured.Can be before treating, in the treatment and/or treatment back measures airway resistance.In some embodiments, for example through using the position measurement airway resistance of exhaust-gas treatment system in bronchial tree, said exhaust-gas treatment system allows to breathe than the zone in distally from treatment site.
Ablation member 208 can utilize energy to melt nerve 45, thereby for good and all expands air flue 100.Term as used herein " energy " is with its extensive interpretation; (for example include but not limited to heat energy, cold energy; Cooling energy), electric energy, acoustic energy are (for example; Ultrasonic energy), RF energy, pulse high-voltage energy, mechanical energy, ionizing radiation, optical energy (for example, luminous energy) and above combination, and the energy that is suitable for handling other type of tissue.In some embodiments, conduit system 204 delivery of energy and one or more materials (for example, radioactive particle, radioactive substance etc.), therapeutic agent etc.Nonrestrictive example therapeutic agent includes but not limited to one or more antibiotic, anti-inflammatory agent, pharmaceutically active substance, bronchoconstriction agent, bronchodilator (for example, receptor, agonist, anticholinergic agents etc.), nerve block medicine, photoreaction agent or above combination.For example, can long-acting or fugitive nerve block medicine (for example, anticholinergic agents) be delivered to nervous tissue, thus the transmission of temporary transient or permanent attenuated signal.Can also material directly be delivered to neuropeptide 11 22 or nerve trunk 45 or both, thereby destroy nervous tissue with chemical mode.
Fig. 6 and 7 is presented in the ablation member 208 by the top layer heating of RF energy and cools off the effect that is produced with the deep layer heating and by the top layer of circulating coolant.Coolant absorbs heat energy, makes the tissue that contacts with the cooling section 209 of ablation member 208 be cooled.Cooling section 209 can damage the tissue between ablation member 208 and neural or other purpose tissue to limit or to prevent from the heat energy of airway walls 100 absorption capacities.
Transverse axis among Fig. 6 is corresponding to the degree of depth (unit be millimeter) from getting into airway walls tissue with the point of the contact point of electrode assemblie 214 or adjacent electrode assembly 214, and the longitudinal axis is corresponding to tissue temperature (unit be degree centigrade).Except as otherwise noted, the temperature among the figure is degree centigrade.Figure puts corresponding to contact point or contact area between electrode assemblie 214 and the airway walls tissue last " 0 ".Three curve A, B and C among the figure are corresponding to the RF energy of being sent into three kinds of different capacity levels of tissue.Temperature among the figure is high to about 100 ° of C.Shown about 100 ° of C or lower slightly temperature because this temperature is considered to RF melt during the upper limit of tissue temperature.When about 90 ° of C, tissue fluid comes to life, coagulation of tissues and carbonization, thus increase its impedance greatly and damage its ability to airway walls organized delivery RF energy.Therefore, tissue temperature maintains that to be lower than about 90 ° of C be desirable.When about 50 ° of C, the following temperature of line 216 expressions: be higher than this temperature histiocyte death then takes place; Being lower than this temperature then organizes and will can not receive secular substantial influence (or any The Long-term Effect).
Curve A shown in Figure 6 is illustrated in what happens when carrying out or not carrying out electrode assemblie 214 coolings under relatively low power (for example, the about 10 watts RF energy) level.Curve A is divided into three sections A1, A2 and A3.The extension of phantom line segments A2 representative exponential curve A3 when not applying cooling.As viewed through curve A, when not cooling off, the temperature at electrode tissue interface reaches 80 ° of C, and index descends along with the increase of the distance in the tissue that gets into air flue 100.As shown in the figure, curve A 3 intersects with the dead boundaries of 50 ° of C histiocytes being represented by line 216 at about 5 millimeters degree of depth place.Therefore, during electrodeless cooling, the degree of depth that cell death takes place is served as reasons apart from represented about 5 millimeters of d1.Under this power level, further cell death will stop.
If adopt initiatively cooling, temperature drops to obviously lower level, for example, as curve A 1 represented be about 35 ° of C at 0 millimeter place in the electrode tissue interface distance.Because this temperature is lower than 50 ° of C, thus the point that intersects at the cell death line of curve A 2 and 50 ° of C apart from d2 (for example 3 millimeters the degree of depth) apart from the surface before cell death can not take place.From 3 millimeters to as cell death will take place apart from 5 mm depths of d3 representative.This cooling ablation procedure is favourable, because it allows cell death and disorganization to locate to take place in distance electrode-organizational interface's one segment distance (or distance range), and can not destroy the tissue under epithelial cell and the epithelial cell.In some embodiments, can melt the nervous tissue of walking and do not destroy epithelial cell or understructure, such as substrate and smooth muscle cell along the air flue outside.
Curve B is illustrated in what happens when carrying out or not carrying out the electrode cooling under the higher power level (like 20 watts RF energy).The extension of the exponential curve of the non-refrigerated situation lower curtate B3 of section B 2 representatives of curve B.Can find out; Electrode tissue temperature at the interface is near 100 ° of C; This is worthless, because at this temperature undertissue-electrode interface place tissue fluid boiling and tissue coagulation and carbonization will take place, and then can significantly increase tissue impedance and damage the ability of in airway walls, sending extra RF energy.Through initiatively cooling is provided, the temperature at curve B 1 show electrode-organizational interface place drops to about 40 ° of C, and at 2 millimeters the degree of depth to curve B 3 and 50 ° of about 8 millimeters degree of depth generation cell deaths that intersect on the dead border of C histiocyte like the d4 representative.Therefore, can find out that it is possible using higher power level the cell death in darker and bigger zone to be provided and not to reach undesirable high temperature (temperature that for example, causes coagulation of tissues and carbonization in electrode tissue at the interface).Said system can be used in and realizes the subsurface cell death of airway epithelia, thus do not need deface, thus help the patient from treatment, to recover as early as possible.
Curve C is represented higher power level, for example, and 40 watts RF energy.Curve C comprises section C1, C2 and C3.Dotted line section C2 is the extension of exponential curve C3.Section C2 shows that electrode tissue temperature at the interface far surpasses 100 ° of C, and under less than the refrigerative situation of active, is inappropriate.Using under the refrigerative situation of active; The temperature at electrode tissue interface is near 80 ° of C; And progressively raise and near 95 ° of C, exponentially property decline subsequently intersects at by about 15 mm distance of representing apart from d6 in electrode tissue interface apart from the airway epithelia surface with 50 ° of C cell death lines 216.Because initial temperature is higher than 50 ° of C cell death lines 216, it is dead from epithelial surface to about 15 millimeters degree of depth histiocyte will to take place, thereby disorganization big and dark zone is provided.
Fig. 7 has showed the cross section TEMPERATURE SPECTROSCOPY of one section airway walls, thereby the RF energy is sent ablation tissue through this section airway walls.Term " melts (ablate) " or the material alterations of electrical properties, engineering properties, chemical property or other character that " melting (ablation) " (derivative words that comprises them) includes but not limited to organize.Melt and to relate to breaking-up or permanent damage, damage or tissue damage.For example, melt that disorganization, lysis, the cell size that can comprise localization reduce, downright bad or above combination.Under the pulmonary ablation application background, term " melts " and comprises the character that changes nervous tissue fully, thereby blocks the nervous tissue of signal of telecommunication transmission through melting basically.
Isothermal curve is represented when power being applied to electrode assemblie 214 and with coolant (for example; The saline of room temperature or brine ice) when being delivered in the capsule 212, the temperature that the temperature that electrode assemblie 214 reaches and distance electrode-organizational interface 215 get into the different depth place of airway walls 100.Term " element (element) " under the background of " deployable elements (expandable element) " or " deployable elements (deployable element) " comprises independent component or a plurality of independent component.For instance, deployable elements can be a plurality of capsules of single capsule or fluid communication with each other.
Feed the speed of capsule 212 and the temperature of coolant and the size of capsule 212 through power delivery rate, the coolant of regulating counter electrode assembly 214 and can change isothermal line.Through selecting the power delivery rate of suitable coolant temperature and flow velocity and counter electrode assembly 214, realize that the temperature of A=60 ° of C of isothermal line, B=55 ° C, C=50 ° C, D=45 ° C, E=40 ° C and F=37 ° of C is possible.Further regulate and make that the temperature that realizes A=50 ° of C of isothermal line, B=47.5 ° C, C=45 ° C, D=42.5 ° C, E=40 ° C and F=37 ° of C also is possible.Have only 50 ° of C isothermal lines can be heated to and be enough to inducing cell death with interior those zones that comprise.In some versions, the tissue at about 2mm to 8mm degree of depth place can be melted in the airway walls, and other the non-destination organization less than 2mm degree of depth place will remain below the temperature that can cause cell death in the airway walls.
With reference to Fig. 8, conduit system 204 comprises control module 210, and control module 210 links to each other with the conduit with elongate bars 230 207.Deployed condition shown in capsule 212 can expand into from collapsed mode.When capsule 212 expands, can electrode assemblie 214 be moved to airway walls.Expansible capsule 212 can help electrode assemblie 214 is maintained near (for example, be close to said tissue or contact with said tissue) of tissue that delivery of energy passes through.Coolant can absorb heat energy and come cooling bladder 212 or electrode assemblie 214 or both.
Control module 210 generally includes controller 244 and fluid delivery system 246.Controller 244 includes but not limited to one or more processors, microprocessor, digital signal processor (DSP), field programmable gate array (FPGA) and/or special IC (ASIC), storage device, bus (bus) and power supply etc.For example, controller 244 can comprise the processor with one or more storage device intercommunications.Bus can be connected to processor with inside or external power source.Memorizer can adopt various ways, comprises, for example, one or more buffers, buffer (register), random-access memory (ram) and/or read only memory (ROM).Controller 244 also can comprise the display screen 245 and input equipment 250 such as screen.Input equipment 250 can comprise keyboard, touch pad etc., and can be operated by user and control conduit 207.
Controller 244 can be stored different programs.User can select to be used for the program of the characteristic of record organization and required target area.For example, the lung that is filled with air has high relatively impedance, and lymph node can have medium impedance, and blood vessel can have low relatively impedance.Controller 244 can be confirmed suitable program based on impedance.Can optimize performance based on the feedback of the pick off of detected temperatures, tissue impedance etc.For example, controller 244 can be controlled the operation of ablation member 208 based on tissue temperature.If the tissue surface temperature overheating can strengthen cooling and/or reduce electrode power, protect surface texture simultaneously thereby produce the deep layer damage.
Internal electric source 248 (dotted line is represented among Fig. 8) can be a power generator, such as radio frequency (RF) electromotor.Can be with required frequency output RF energy.The instance of frequency includes but not limited to the frequency range of about 50KHZ to about 1000MHZ.When the RF energy was directed in the tissue, energy was converted to heat in tissue, made the temperature of tissue reach about 40 ° of C to about 99 ° of C.Can apply the RF energy and continue about 1 second to about 120 seconds.In some embodiments, RF generator 248 has single passage and about 1 watt to the 25 watts RF energy of transmissibility, and has the ability of continuous-flow.Also can use frequency, interval and the power output of other scope.In addition, internal electric source 248 can be an energy accumulating device, such as one or more batteries.Can be with energy delivery to electrode assemblie 214, it converts electric energy to RF energy or another kind of suitable form of energy.Other form of energy that can be sent comprises microwave, ultrasonic, unidirectional current or electromagnetic energy.In addition, can utilize cryogenic ablation.Can send through bar 230 and be used for cooling off the low temperature heat exchanger on the ablation member 208 being in cryogenic fluid.
Fluid delivery system 246 comprises fluid source 260 that is connected in supply pipe 268 and the fluid container 262 that is connected in return pipe 272.Fluid source 260 can comprise the container that is contained in the outer cover unit 264 (for example, bottle, jar, groove or be used to hold the container of fluidic other type).In the embodiment that can pressurize, fluid source 260 comprise one or more can be to the pressue device (for example, one or more pumps, compressor etc.) of coolant pressurization.Temperature control equipment (for example, Po Er pastes (Peltier) device, heat exchanger etc.) can cool off or regenerative fluid.Fluid can be a coolant, comprises saline, deionized water, cold-producing medium, cryogenic liquid, gas etc.In other embodiments, fluid source 260 can be can preserve cold coolant and it is delivered to the heat-insulated container of supply pipe 268.Coolant distad flows through elongate bars 230 along delivery lumen 326, and fills ablation member 208.Flow through elongate bars 230 through return cavity 324 proximads from the coolant in the ablation member 208, and finally flow into container 262.
Pick off 247 (shown in the dotted line) is connected with controller 244 communications.Controller 244 can be based on controlling conduit 207 from the signal of pick off 247 (for example, pressure transducer, temperature sensor, thermocouple, pressure transducer, touch sensor etc.).Pick off can also place on the electrode assemblie 214, places or places on any other position along elongate bars 230.In the close loop maneuver pattern; Can energy delivery be arrived electrode assemblie 214 based on the feedback signal from pick off 247, said pick off can be configured to transmit the signal that (or transmission) shows one or more tissue signatures, Energy distribution, tissue temperature or any other measurable purpose parameter.Based on these readings, controller 244 is regulated the operation of electrode assemblie 214.In the open loop operator scheme, the operation of electrode assemblie 214 can be set by user input.For example, user can tissues observed temperature or impedance readings and manual adjustments power level.In addition, power supply can be configured to fixed power mode.In other embodiments, conduit system 204 can be switched between close loop maneuver pattern and open loop operator scheme.
With reference to Fig. 8 and 9, elongate bars 230 comprises power line chamber 320a-h, delivery lumen 326 and return cavity 324.Power line 280a-280h (being referred to as " 280 ") extends through power line chamber 320a-320h (being referred to as " 320 ") respectively and controller 244 and electrode assemblie 214 is coupled together.Can being processed by one or more following materials in whole or in part of elongate bars 230: metal, alloy are (for example; Steel alloy; Such as rustless steel), plastics, polymer and above combination and other biocompatible materials; And can be flexible, thereby can easily pass through hyperbranched air flue.
With reference to Figure 10 and 11, power line 280 from power supply 248 to electrode assemblie 214 delivery of energy.In some embodiments, power line 280 passes the outer wall of chamber 234 and capsule 212.In other embodiments, the adapter of electrode assemblie 214 is arranged in chamber 234.Power line 280 can extend between adapter and elongate bars 230, thereby avoids being exposed to body fluid.
Electrode assemblie 214 can include but not limited to monopolar electrode, bipolar electrode, metal electrode, line electrode, needle electrode etc., and can form the array of circumferential damage, and the damage of every place is only extended along the part of the circumference of blood vessel or body structure.If body structure is an air flue, the damage of then every place can be surrounded the chamber of air flue at least in part.Damage can have less than the arc length of 360 degree (for example, about 25 degree are to about 45 degree).In some embodiments, damage separates with respect to the longitudinal axis of body structure.Damage jointly covers required circumference.For example, damage can be overlapping with the section start of next place damage on circumference (for example, when when the axial length of body structure is observed), and separate each other in the vertical, thereby guarantee to handle the whole circumference (or part of circumference) of air flue.
Electrode assemblie 214 comprises the electrode 229 that separates along on capsule 212 circumferencial directions.Each electrode 229 has a pair of exposed electrodes element.The electrode member 231d of electrode 229d and the element 231e of adjacent electrode 229e can cooperatively interact and form the RF arc that can melt adjacent tissue radially.Electrode 229 can be connected with the outer surface of capsule 212.In other embodiments, electrode 229 can embed the sidewall of capsule 212 or otherwise be fixed to capsule 212.
Can operate adjacent electrode 229 with bipolar fashion, one of them electrode is anodal, and another electrode is a negative pole, makes it possible to the RF power delivery through tissue.If electrode 229 is a monopolar electrode, this electrode can be connected to independent power line 280 so, thereby allows to control independently each electrode.Perhaps, electrode 229 can be connected to same power line so that co-operate.
Capsule 212 in whole or in part can be by polymer, plastics, silicon, rubber, polyethylene, polrvinyl chloride, chemical inert material, non-toxic materials, electrically insulating material or above materials such as combination are processed.Heat passage for strengthening, the capsule sidewall can comprise one or more Heat Conduction Materials with high heat conductance.For example, heat conduction bar (for example, bonding jumper) can help heat energy is come out from focus (if any) conduction.Capsule 212 (for example can conform to airway surface; Cartilaginous ring; Side is propped up etc.) on irregularly shaped, and can process by following material in whole or in part: expandable material, such as polyurethane (for example; Low hardness polyurethane) or the highly conforming properties material of other type, said material can be transparent, translucent or opaque.Capsule 212 can have different expanded shape, comprises hot dog shape, oval, cylindrical etc.For handler's bronchial tree, the diameter D of swelling bag 212 can for about 12mm to about 18mm.For the motility of enhancement process, the diameter of expansible capsule can for about 5mm to about 25mm.The size of capsule 212 can be set to other organ or tissue that can handle other animal.Shown in figure 11, expand in order to make capsule 212, fluid is sent and through inlet 225 along delivery lumen 326.Coolant flows along return cavity 324 proximads at chamber 234 internal recycle then.
Figure 12 and 13 has showed an illustrative methods utilizing processing system 200.With before implementing treatment, during the treatment and/or after treating, can observe air flue 100 and locate and evaluation process site and non-destination organization.Access to plant 206 can be guiding tube, delivery sheath, tracheascope or endoscope, and can comprise one or more finders, such as optical viewing arrangement (for example, photographing unit), optical system (for example a, set of shots) etc.Can stimulate (for example, electricity irritation) zones of different, to confirm the position of air flue nerve trunk or morbid state along the air flue circumference.The airway smooth muscle in distally that can be through measuring the point of implementing to stimulate along airway length shrinks the detection that realizes bronchoconstriction.Can change through the pressure of monitoring expansible capsule or the pick off of air flue nearside or other type of contacting with air flue is measured muscle contraction.Said technology can minimize or limit the circumferential area of the air flue that is processed, thereby reduces or eliminate the risk of airway constriction.Can confirm nerve location through following manner: measure the electroneurographic signal of the point on the air flue circumference, with the position of confirming that air flue is neural.Can use air flue nerve signal stimulus object to increase the nerve signal amplitude, thereby be convenient to the air flue nerve signal location around the air flue circumference such as cold air, histamine or phenyl two guanidines.
When body cavity moves the access to plant 206 of Figure 12, the ablation member 208 of subsiding is maintained in the service aisle 386.Ablation member 208 is distad shifted out working chamber 386 and makes its expansion, thereby electrode assemblie 214 is moved to (for example, contacting near airway walls or with airway walls) near the airway walls.The RF energy can come heat tissue (for example, textura epidermoidea and deep tissues) through tissue, thereby forms damage in the target area.Target area and relevant damage are substantially corresponding to the dotted line of Figure 13 and 14.
The term " damage " that this paper uses is meant that by the tissue of permanent destruction promptly, phalangeal cell is dead.In some cases, energy is sent the cell beyond the zone that is called " damage " is caused destruction temporary transient or non-lethality.For example, energy as herein described is sent and can temporarily be destroyed or change epithelial cell or smooth muscle cell.Yet advantageously, through using the difference cooling, these cells can recover and keep function, therefore are not considered to the part of said " damage ".By contrast, ablation member 208 can be to being positioned at the airway walls depths or causing permanent damage at airway walls outside nervous tissue or other destination organization, thereby weaken the nerve signal that causes some pneumonopathy.
The cooling section 209 contact airway walls 100 of Figure 13, thus can cools tissue when electrode assemblie 214 output energy.It is this that to carry out the heating of top layer and deep layer and carry out the refrigerative clean effect in top layer through circulating coolant through the RF energy be with the skin of heat accumulation to airway walls 100.The temperature of connective tissue can be higher than the temperature of epithelium, substrate and/or smooth muscle.For example, the temperature of connective tissue is can be enough high and can cause damage to nerve trunk tissue or other deep tissues, makes other non-destination organization of air flue remain on lower temperature to prevent or to limit the damage to non-destination organization simultaneously.
Figure 13 and 14 has shown the independent damage 237a-h in eight places (being referred to as " 237 ").Adjacent damage 237 axially departs from along the longitudinal axis 233 of ablation member 208 each other.Shown in figure 14, every place damage 237 can have the arc length of about 45 degree, makes the whole circumference of the basic upper edge of damage array airway walls 100 extend.The length of exposed electrodes element is corresponding to the width of damage 237.Can select the length (for example, the length of electrode member 231d, 231e) of exposed electrodes element based on the desired width of damage 237.Advantageously, can form damage 237 simultaneously.For example, can form all or most damage 237 simultaneously, to avoid between ablation process, to move ablation member.In other embodiments, thus can start different electrode 229 forms damage in succession.Can electrode assemblie 214 be moved to different positions and melt different tissues.Therefore, can side by side or one after the other carry out the one or many damage based on required processing.
Utilize conventional ablation catheter, ablation procedure can be enough to cause cicatrization, and said cicatrix possibly cause partial air flue constriction or narrow.Because the diverse location that damage 237 is in along airway length is so can alleviate narrow influence.Shown embodiment is very suitable for cutting off the innervation of air flue, avoids forming successive scar tissue ring simultaneously.The continuous scar tissue ring of spending along the inner periphery extension 360 of air flue 100 can significantly reduce the sectional area in air flue chamber, and then significantly increases gas-flow resistance.Staggered damage 237 can help to alleviate reducing of air flue chamber cross-sectional area.
Figure 14 has shown and has damaged 237 position.Shown in figure 14, damage 237 exterior contour along the major axis of air flue 100 and with the virtual plane of said axis on projection define successive basically closed hoop.Because nerve trunk 45 along air flue 100 longitudinal extensions, can be in the degree of depth that sufficient to guarantee melts all nerve trunk so damage 237.In other embodiments, electrode assemblie 214 can only be used to handle the part of air flue circumference, for example 180 of air flue circumference degree, 150 degree or 130 degree.This maybe be just enough for the innervation of effective cut-out air flue 100.Therefore, can effectively cut off nerve signal and can not form the damage of extending, and this can further reduce narrow formation along whole airway walls.
During RF melted, heat can be concentrated in one or more internal layers (for example, substrate) of airway walls or concentrate in the inner membrance (for example, epithelium) of airway walls.And the one or more blood vessels in the arteriae bronchiales branch can be positioned at damage.Can control the heat that uses electrode 214 to be produced, make that the ramose blood of the arteriae bronchiales of flowing through can protect these branches to avoid the hot injury, even said nervous tissue is positioned near the said arterial branch when the nerve trunk tissue is damaged.Conduit 207 can produce relative cell death than the zonule.For example, can destroy in the middle of the airway walls 100 or along the tissue of 2mm to the 3mm section of the outer surface of airway walls 100.Through using suitable power and suitable cooling, can produce damage in any desired degree of depth.
The resistance of air flue cartilaginous ring or cartilage layers is usually significantly greater than the resistance of air flue soft tissue (for example, smooth muscle or connective tissue).The air flue cartilage hinders energy stream (for example, electric radio-frequency current), and makes when electrode during near cartilage, forms therapeutic by radio-frequency electrical energy and damages and influence the air flue nerve trunk and become challenging.
Shown energy emitter 214 can be used as energy emitter between cartilage.The size of electrode member 227 can be set to the interval that meets cartilaginous ring 235a, 235b (being referred to as " 235 ") substantially.Shown in figure 13, each electrode member 227 is placed between two adjacent ring 235a, the 235b, makes damage 237 place fully in the space 333 of 235 of cartilaginous rings.
Electrode 229 can be used as localizer between cartilage, and its preferential help is seated in electrode member 227 in the space 333, and then makes and be easy to handle or be easy to examine correct positioning.For example, electrode member 227 can outwards be given prominence to and be easy to move into and coupling is more softish, in the better space 333 of compliance.Thereby electrode 229 can be used for indicating ablation member 208.
Figure 15 has shown electrode, and this electrode is the monopolar electrode that connects through a power line.Can simultaneously electric power be delivered to said electrode.Can place any amount of electrode along capsule 212.For example, can be along the circumference of said capsule one or more electrodes at interval equably or unevenly.
Figure 16 has shown that direction has the electrode 310a-310c (being referred to as " 310 ") at oblique angle with respect to the longitudinal axis 312 of ablation member 300.Power line 316a-316c (being referred to as " 316 ") is to dividing other electrode 310 that energy is provided.(although do not show, can other electrode be placed on the invisible rear side of ablation member 300).Electrode 310 can be a bipolar electrode.For instance, electrode 310a can comprise electrode member 318a, 319a, and electrode member 318a, 319a can positive and negative (or negative electrode and anodes), so as between element 318a, 319a transmission RF energy.
Can based on circle spacing of expecting between the length, adjacent damage of the damage that will form wait the angle [alpha] of selecting between electrode 310 and the longitudinal axis 312 directions.Shown angle [alpha] is about 45 degree.If desired or hope, also possibly be other angle.Can exist between the adjacent electrode 310 be untreated, unmarred tissue regions.
Shown in figure 16; Place damage by electrode or electrode pair 310a produce is overlapping with the start-up portion of next the place's damage that is produced by electrode adjacent on the circumference or electrode pair 310b in a circumferential direction, thereby guarantees to handle the whole circumference (or its part) of tubular body structure.If an end of the damage that is produced through electrode 310a is vertically drawn a virtual line, near the end of this virtual adjacent damage that line and 310b produced is crossing or approaching so.Therefore, the end of adjacent damage axially departs from and overlapping in a circumferential direction along axle 312.
Figure 17 has shown ablation member 400, and it comprises extensible basket 414 and electrode 413,415.Basket 414 comprises hollow member, and the coolant said hollow member of can flowing through is come cooling electrode 413,415.Can select the longitudinal length of basket 414, make basket 414 extend across a plurality of cartilaginous rings.Electrode 413,415 can be placed between the said ring.For example, microscler basket 414 can extend across at least three cartilaginous rings (by vertical dotted line 431,432,433 expressions of Figure 17).Electrode 413 is placed on cartilaginous ring 431, between 432.Electrode 415 is placed on cartilaginous ring 432, between 433.When basket 414 launched, the distance B that the electrode of adjacent rows is 413,415 was equivalent to the distance between cartilaginous ring substantially, and then guarantees that electrode 413,415 can be seated between cartilaginous ring.Electrode 413a can have first polarity, and electrode 413b can have antipole property, makes energy between said electrode, to flow.Electrode pair 413a, 413b and adjacent electrode depart from certain angle to 415a, 415b, thereby form on the circumferencial direction overlapping and in axially spaced damage.Overlapping D can handle the whole circumference of air flue apart from sufficient to guarantee.
Figure 18 has shown that along the chamber 427,429 flow and the fluid through decompression member 423,425 respectively.Term used herein " decompression member " is meant, and is not limited to, and is configured to reduce the device of the pressure of working fluid.Decompression member can be reduced to the pressure of working fluid the pressure for vaporization that is equal to or less than working fluid.Working fluid can comprise cold-producing medium (for example, low-temperature refrigerant or non-low-temperature refrigerant).In some embodiments, the form of decompression member is air relief valve or expansion valve, and they can make at least a portion vaporization of the working fluid that therefrom flows through.The working fluid (for example, cold-producing medium, cryogen etc.) of decompression member vaporization effective dose is to reduce the temperature of working fluid.In some patterns, the almost whole or most of working fluid through element 423,425 is converted into low temperature, low-pressure gas by weight.In some embodiments, decompression member 423,425 can be the valve that nozzle group valve, needle valve, Joule-Thomson valve, throttle element or any pressure that other is suitable for providing required descend.For example, Joule-Thomson valve can cause lower downstream temperature from the reclaiming by swelling work capacity of liquid.In some embodiments, can enough Flow-rate adjustment elements (for example, valve system) substitute decompression member, be under the situation such as the non-cold-producing medium of water especially at working fluid.
With reference to Figure 18, the gases at high pressure P of Figure 18 1Through delivery lumen 427,429.Gases at high pressure P 1Through element 423,425, and admission passage 436,438, pressure drops to P in passage 436,438 2Pressure is from P 1Drop to P 2Cause gas temperature from T 1Drop to T 2The amplitude of variations in temperature is by computes:
T 1-T 2=μ(P 1-P 2)
Wherein
T is the temperature of gas;
P is the pressure of gas;
μ is the Joule-Thomson coefficient of gas;
Subscript 1 expression condition of high voltage; And
Subscript 2 expression low pressure conditions.
As combine Figure 19 and 20 to be discussed, when the gas in the passage 436,438 is discharged through outlet and dropped to ambient pressure, second pressure takes place descend.If ablation member 400 is used for respiratory system, then ambient pressure is an atmospheric pressure.This temperature drops to:
T 2-T 3=μ(P 2-P ATM)
Joule-Thomson coefficient (μ) is special for every kind of gas or admixture of gas.The standard temperature value of μ is:
Carbon dioxide
μ CO 2 = 1.16 × 10 - 5 K Pa
Air
Figure BDA00001851039700282
These coefficients show, descend CO for given pressure 2The temperature suppression ratio that causes descends big 5 times by the similar pressure that air produces.
It is desirable in lung, using air.Can use carbon dioxide, but condition to be the flow velocity of coolant gas enough low and be no more than individuality this extra carbon dioxide is discharged the outer ability of lung.If the coolant in the ooling channel is the highly pressurised liquid such as liquid air or liquid carbon dioxide, then cooling effect can be enhanced.Also experience is from the heat absorption phase transformation of highly pressurised liquid to gases at high pressure through decompression member (for example, choke valve) for highly pressurised liquid, and this makes the temperature of gas be lower than the temperature of highly pressurised liquid.Then, discussed as combining Figure 19 and 20, before discharging through outlet 441, this gas is through the P that associates 1To P 2Joule-Thomson expansion, temperature is further descended.
Figure 19 and 20 has shown the ablation member 437 similar substantially with 18 ablation member 400 with Figure 17, but following details difference to some extent.Ablation member 437 comprises along the opening of long element setting or exports 439 array.The coolant of long element of flowing through can spill to cool off contiguous tissue from opening 439.In addition, be arranged on the opening of far-end 443 or export 441 and can discharge coolant.Shown in figure 20, the coolant of representing with arrow can spill from exporting 439,441.By this way, coolant can cool off ablation member 437 and direct tissue cooling can be provided.Randomly, the pressure that outlet 441 can be configured to provide suitable descends, thereby makes coolant Joule-Thomson expansion vaporization by mentioned earlier, reduces coolant temperature thus.
Figure 21 has shown ablation member 450, and it has along deployable member 453 at the isolated V-arrangement electrode of circumferencial direction.Electrode 455 has end 456,457, and the tip 459 of end 456,457 and adjacent electrode 455 is overlapping.Electrode can be to V-arrangement target area output energy, and said V-arrangement target area is opened and formed the V-arrangement damage along the air flue circle spacing equally.Untreated tissue between V-arrangement damage can assist in ensuring that the air flue chamber can be owing to scar tissue or narrow and significantly narrow down.
Figure 22 has shown ablation member 460, and it comprises the extensible element 462 that carries T shape electrode.Electrode 463 has free terminal 464, and free terminal 464 is overlapping with the end 465 of adjacent electrode 467.The electrode 461 of alignment can form the damage that many places are substantially T shape in a circumferential direction.In other embodiments, electrode can be U-shaped, S shape, W shape, L shaped or any other suitable shape.In addition, in any one of these embodiments, electrode can with electrode shown in Figure 16 similarly with the pattern vertical misalignment of oblique or spiral.
Figure 23 has shown ablation member 500, and it comprises and can electrode 512 be placed on first group leader's shape member 511a-511d (being referred to as " 511 ") between the cartilaginous ring 513,515 (showing with dotted line).Long element 521a-521d (being referred to as " 521 ") carries and is placed on cartilaginous ring 515, the electrode 523a between 518,523b, 523c, 523d (being referred to as " 523 ").Electrode 512 forms damage at ring 513, between 515.Electrode 523 forms damage at ring 515, between 518.Long element 511,521 can be flexible or elastic bar or line; They are radially outward setovered; Make electrode against airway walls; And they are configured to use each electrode pair can handle the different circumferential area of airway walls with being placed on the position of departing from a circumferential direction with respect to electrode 512 by electrode 523, making.One end of the damage between collagen in the gap in a circumferential direction can and adjacent collagen between the adjacent damage in gap overlapping.Thereby damage separates each other on can be axially, but overlapping with respect to body cavity in a circumferential direction.Long element 511,521 can be contracted in the tubular sheath 510, makes long element 511,521 collapse to the radial contraction configuration that is suitable for importing in the air flue.
Figure 24 has shown the ablation member 600 with extensible energy emitter assembly 610.Extensible electrode assemblie 623 can surround the whole or most of of extensible member 620, and extensible member 620 is shown as capsule.Insulator 625 extends between the end on the part of electrode assemblie 623.Electrode 623 can have zigzag configuration (demonstration), curl shape structure or waveform structure, thereby can allow expansion and can around capsule 620, extend about 90 degree to about 360 degree.During use, exposed electrodes 623 can be regional towards pending air flue, for example, and the rear side that nerve trunk is usually located at.Perhaps, emitter assemblies 610 can comprise a plurality of exposed electrodes, and said electrode is separated by insulated part, thereby produces dispersive damage.
Randomly, second energy emitter 618 is placed on the distally of energy emitter 610.Energy emitter 618 has exposed electrodes 621 and insulator 623.Electrode 621 can cooperate with electrode 623 and form and depart from a circumferential direction and damage at axially spaced-apart complementary (for example, eclipsed).For example, electrode 623 can form the damage that arc length is about 180 degree along the top of airway walls.Electrode 621 can form the damage that arc length is about 180 degree along the bottom of airway walls.The damage of two places is extended along the whole circumference of airway walls jointly.Can produce or produce in succession damage simultaneously.
Figure 25 has shown ablation member 700, and it comprises the energy emitter of electrode assemblie 710 forms, and electrode assemblie 710 is wrapped in around the extensible element 712.Electrode assemblie 710 comprises pipeline 731 and a plurality of electrode 715a-h (being referred to as " 715 ").Electrode 715 can while or formation damage in succession.
With reference to Figure 26, electrode 715a can be the tubular metallic member of hollow, and when capsule 712 expanded, said electrode was directed with the cardinal principle circumferencial direction.Pipeline 731 is sent coolant (saline or other coolant) continuously through electrode 716.
Can different coolants be sent through capsule 712 and pipeline 731.Can flow through delivery lumen 761, the pipeline 731 of flowing through of coolant come cooling electrode 715.Can flow through delivery lumen 751 and flow into capsule 712 of another coolant.Coolant in capsule 712 and the pipeline 731 can flow to nearside through return cavity 739.In other embodiments, the coolant Continuous Flow is through electrode assemblie 710 and capsule 712.
Can independent lead pair be electrically connected with each electrode 715.Can operate each electrode 715 independently.In other embodiments, electrode 715 is bipolar, and it is paired to be arranged to antipole property.As about before embodiment said, thereby electrode 715 is can be relative to each other directed and place and form the damage in the space between cartilage.With the U.S. Patent application of submitting on May 8th, 2009 the 12/463rd; The U.S. Patent application the 12/913rd that No. 304 and on October 27th, 2010 submit to; Incorporate this paper by reference in full into No. 702, above-mentioned patent application discloses can be with technology, material, conduit and the parts of ablation member 700 uses.
Electrode 715a-h arranges along spirality pipe 731, makes them to produce in a circumferential direction to depart from each other (although have some overlapping) and in the damage that axially departs from each other.To intersect with another dummy line among the electrode 715a-h with the dummy line of axial direction (parallel) through each drafting among the electrode 715a-h, thereby guarantee to handle the whole circumference of air flue with axle 719.Advantageously, electrode is spaced apart along spirality pipe 731, makes the damage that they produced vertically separate along air flue, thereby reduces to cause narrow chance.
Temperature through regulating coolant, coolant flow speed, the heat-carrying capacity of coolant, the thermodynamic behaviour (for example, the heat transfer performance of capsule) or the amount of delivered power of capsule can be controlled the damage shape.Figure 27 A-31B shows through formed temperature spectrogram of the cooling that progressively improves capsule and corresponding damage.Can be through reducing coolant temperature or improving coolant flow speed or both improve the cooling capacity of capsule.Change the coolant capacity of electrode simultaneously or, also can realize setting through the cooling capacity substantially constant that keeps capsule damage through improving or reducing the power that is delivered to tissue.For instance, the ablation member 700 of Figure 25 can be used in the damage that forms Figure 27 B, 27C, 28B, 29B, 30B and 31B.Because the diameter of capsule 712 is greater than the diameter of electrode channel 753, so than the high velocity stream through electrode 715a, relatively low along the flow velocity on capsule surface.Produced the difference cooling like this.Flow if electrode 715a and capsule 712 have independently, then coolant can be in different temperature and/or flow velocity to be used for the difference cooling.
80 ° of C of isothermal line in Figure 27 A display organization, 60 ° of C and 40 ° of C and Temperature Distribution.Figure 27 B shows the isothermal damage 804 corresponding to Figure 27 A.The only coolant that can absorb a large amount of heats of coolant in the cooling duct 753.Capsule 712 does not absorb great amount of heat energy and can be filled with temperature and equals room temperature or the fluid in the scope of about 20 ° of C-30 ° of C substantially.In some embodiments, utilize surrounding air to come swelling bag 712, and capsule 712 can keep electrode 715a against tissue 825.In other embodiments, utilize warm saline to come swelling bag 712.Damage 804 has and is substantially semicircular shape.Can increase or reduce radius r and depth D through the temperature that reduces or improve coolant in the cooling duct 753 respectively.In addition or alternatively, can increase or reduce radius r and depth D through the flow velocity that reduces or improve coolant respectively.
Can cold coolant be sent through capsule 712 to reduce the cross-sectional width of the damage on the tissue surface 825.Figure 28 A and Figure 28 B show when coolant cools electrode 715a and when cryogenic coolant with low-speed flow the isothermal line during through capsule 712 and be substantially oval-shaped damage 804 accordingly.Coolant in the capsule 712 absorbs the heat energy of capacity, thereby protection contacts with capsule-organizational interface or contiguous tissue.(comprise the embodiment shown in Figure 28 B) in some embodiments, damage 804 cross-sectional widths on the surface 825 are less than the cross-sectional width of the damage 804 on surface 825 among Figure 27 B.The cross-sectional width of the damage 804 of Figure 28 B increases to Breadth Maximum W with the degree of depth Maximum, and drop to the darkest zone 830 subsequently.Breadth Maximum W MaximumDepth D less than damage 804.The width of the damage 804 on Figure 28 B display surface 825 is not more than about 150% of electrode width.
Figure 29 A and Figure 29 B show when cryogenic coolant with high velocity stream through the coolant of capsule 712 or extremely low temperature with low-speed flow the isothermal line during through capsule 712 with damage 804.Similar lachrymal damage 804 is extended from tissue surface 825.The shallow-layer of damage 804 or the width of narrow zone 834 approximate the cross-sectional width W of electrode 715a ETherefore, the maximum cross-section width that has of the damage 804 of surface on 825 is not more than about 150% of electrode tissue interface.This has guaranteed to destroy the surface texture of minimum.Damage 804 outwards narrows down from shallow-layer part 834 to the zone 835 that enlarges gradually.The damage cross section width increases to Breadth Maximum W gradually with the degree of depth MaximumBreadth Maximum W MaximumCan be than the cross-sectional width about 1 on surface 825 to about 5 times.The darkest zone 830 of damage 804 is a part circular.
Figure 30 A and 30B show that the coolant when extremely low temperature damages 804 with isothermal line and tear drop shape that high velocity stream can form through through capsule 712 time.Damage 804 is from tissue surface 825 extensions and have narrow shallow-layer zone 834, and this shallow-layer zone 834 outwards extends to wide by dark regional 852 fast.The width in shallow-layer zone 834 is less than the width W of electrode 715a ECross-sectional width is rapidly increased to Breadth Maximum W with the degree of depth MaximumTherefore, most of volume of damage 804 is positioned at and organizes the depths.
Figure 31 A and Figure 31 B show that isothermal line that coolant when extremely low temperature can form during through capsule 712 with high velocity flow circularly damages 804 with corresponding.Damage 804 is positioned at from the depth D of tissue surface 825.The maximum cross-section width W of damage 804 MaximumIn depth D Breadth MaximumThe place.Damage 804 and electrode tissue interface be separate and can have different shapes according to the flow velocity and the temperature of coolant.The difference cooling can be used in and obtains other damage shape of imbedding, such as being substantially ellipse, elongated shape etc.
Can select D according to the position of target area Breadth MaximumIn order to destroy nervous tissue, D Maximum WidthCan be at least about 2mm to guarantee damage and comprise nervous tissue and to alleviate or avoid smooth muscle tissue is caused obvious impairment.These embodiments are highly suitable for handling airway walls, because the degree of depth of smooth muscle tissue is not less than 2mm usually.By this way, the cross-sectional width of target area can reach maximum in the degree of depth darker than smooth muscle tissue.Most (and whole basically in some embodiments) damage is arranged in the tissue of non-flat muscular tissue, and its position in airway walls is darker than smooth muscle tissue zone usually.In addition, can be to any destruction of the smooth muscle cell in the airway walls less than under the situation of not destroying nervous tissue, changing the reactive of air flue in fact or shrinking (such as because asthma, COPD or other pneumonopathy) required destructive amount.
Damage can separate through protection zone and tissue surface, a large amount of organizing not by permanent damage in the protection zone.Figure 31 B and Figure 32 B display depth are D PProtection zone 861.Advantageously, because organizing in a large number not by permanent damage in the protection zone 861, its function of organization can be retained.The D of the degree of depth PCan be at least about 1mm to about 2mm to melt nervous tissue.
Figure 32 has shown spiral type ablation member 900, and it comprises crooked (being shown as spiral type) main body 910 (be shown as be tapered with the coupling air flue gradually thin) and electrode 912a, 912b, 912c (being referred to as " 912 ").Randomly, can one or more decompression members be placed in the main body 910 and serve as Joule-Thomson valve, thus the temperature of reduction coolant.
Therefore electrode 912 can be similar each other substantially, and be applicable to other electrode for the description of an electrode with also being equal to, only if point out in addition.Electrode 912a comprises a plurality of outlets 916,918.The coolant of being represented by arrow can flow out outlet 916,918.Electrode 912a can be connected with the outer surface of main body 910.This allows electrode 912 outwards outstanding enough distances, thereby can contact with organizing physics.The arrangement of electrode 912 can produce such damage; Said damage departs from a circumferential direction each other; But have the overlapping of some circumferencial direction at its edge, the dummy line of promptly vertically drawing through the end of place damage downwards along air flue will intersect with the end of next place's damage.Because electrode 912 is spaced apart along spirillum 910, thus the damage that they produced air flue axially on also spaced apart, and then reduce narrow probability.
Main body 910 can comprise material (like Nitinol (Nitinol)) pliable and tough and conduction, and when starting, these materials can form spiral type or corkscrew shape.Can warm fluid be sent through main body 910, cause main body 910 to move to expansion configuration (for example, configuration of corkscrew shape or helical configuration) from sending configuration (configuration of for example, stretching).In other embodiments, main body 910 can be offset to launches configuration, and can be sent out sleeve pipe or working chamber launches configuration to appear.Thereby can ablation member 900 proximads be drawn in sleeve pipe or working chamber returns ablation member 900 to send configuration.In other embodiments, can use stretcher, draught line, draw bar etc. to make main body 910 present different configurations.
Randomly, can place capsule through interior zone 920.Can the capsule of the capsule that is substantially conical capsule, columniform capsule, hot dog shape or other suitable shape be inserted interior zone 920.
Figure 33 has shown the spiral type ablation member of being processed by tubulose conductivity internals 952; Said ablation member 952 has the exposure section that array of spaced forms electrode 960a, 960b, 960c (being referred to as " 960 "), and on spacer segment, has the insulation covering to form insulating regions 962a, 962b, 962c.Coolant can be through ablation member 520 circulations with cooling electrode 960.For extra tissue cooling is provided, randomly, the outlet (not shown) during coolant can cover through inner tubular member and/or insulating properties is sent away.
Figure 34 has shown the ablation member 1000 that comprises isolated bipolar electrode 1010a-f (being referred to as " 1010 ") array.Electrode arrangement is that opposite polarity is right, make each bipolar between obliquely produce damage.Electrode 1010 can form the oblique damage of crossing over cartilaginous ring.Shown in figure 35, ablation member 1000 is placed in the air flue 1012.Electrode 1010 is placed between the said ring.Electrode 1010a-c can produce the damage 1030 of Figure 36.One end 1032 of damage 1030 is near ring 1034.The other end 1036 adjacent loops 1038.Terminal 1032,1036 along axially skew each other of air flue 1012.Shown in figure 36, terminal 1032,1036 axial dipole field is significantly greater than terminal 1032,1036 circumferential distance.In some scheme, terminal 1032,1036 distance is at least 1 millimeter, 5 millimeters, 10 millimeters.In some embodiments, terminal 1032,1036 axial distance is greater than the distance between adjacent cartilaginous ring.This guaranteed the damage can cross over said ring.
The centre portion of the damage 1030 of Figure 36 is crossed over ring 1034, the ring between 1,038 1040. Electrode 1010d, 1010e, 1010f at ablation member 1000 dorsal parts form damage 1041.Shown damage 1041,1030 is positioned at offside and is in the different axial positions along air flue.
Electrode 1010 can protruding enough distances, thereby can interact with airway tissue, carry out electrode 1010 is remained between the cartilaginous ring.When operating with double pole mode, damage forms and crosses over said ring.After forming damage, can proximad retract conduit or distad promote conduit and be used to form the damage that axially departs from.In addition or alternatively, can steering nozzle, form oblique damage in position along the different angles of air flue 1012.The damage of Figure 36 is shown as successive damage.In other embodiments, damage can comprise the dispersive isolated damage in many places.For example, damage 1030 can comprise the array of isolated damage.
Figure 37 and 38 shown depart from a circumferential direction and spaced apart in the axial direction, can carry out refrigerative electrode 1050a, 1050b through internal spray.Coolant flow 1054 leaves through delivery lumen 1052 and after opening.The coolant that sprays flows with cooling electrode 1050a along the cooling duct 1056 of opening.Coolant leaves chamber 1060 through outlet 1062a, 1062b.Coolant flows along return cavity 1072.When cooling, can operate electrode 1050a, 1050b with monopolar mode or double pole mode.
Figure 39 A-40B has shown ablation member 1080, and it comprises the energy emitter of electrode assemblie 1082 forms.Electrode assemblie 1082 comprises electrode 1084a-f (being referred to as " the 1084 ") array that can form damage 1083 (Figure 39 B and 40B).Can form a large amount of dissimilar curl shape, curved, zigzag, Z-shaped or structure that other are different.Shown damage 1083 is substantially spiral type and crosses over a plurality of cartilaginous rings.Ablation member 1080 can have any amount of this type electrode assemblie 1082.For example, can a pair of spiral type ablation member 1082 be placed on the outside of ablation member 1080.
Shown damage 1083 is successive, and has the end of opening along major axis 1089 axially spaced-aparts of air flue 1085,1087. Terminal 1085,1087 also angled each other departing from.Shown in Figure 39 B and 40B, terminal 1085, between 1087 along the distance of axle 1089 greater than the distance between the adjacent ring.Like this, a plurality of rings are crossed in damage 1083.
Electrode 1084 can be closer to each other and the successive basically damage 1083 of formation.The distance that in other embodiments, can increase by 1084 at electrode is to provide many places isolated damage.Isolated damage can be arranged in and damage 1083 shapes similar, but also possibly be other shape and pattern of lesions.
Figure 41 has shown ablation member 1100, and it has the electrode assemblie 1110 that is wrapped in around the capsule 1111.Electrode assemblie 1110 comprises the pipe 1113 that is suitable for holding coolant, and has the far-end 1115 with the internal communication of capsule 1111.Electrode is installed, is adhered to, sprays or otherwise is connected in the outside of pipe 1113.By this way, can coolant be delivered to the inside of capsule 1111 through conduit, with swelling bag 1111, coolant is from capsule 1111 flowing pipes 1113, and then cooling electrode.Perhaps, coolant can cooling electrode, and cooling bladder 1111 subsequently.Electrode assemblie 1110 can provide difference cooling, the damage that has certain shape with formation with capsule 1111.
Figure 42-44 has shown and can move to the ablation member 1200 of launching configuration (Figure 43 and 44) from sending configuration (Figure 42).In sending configuration, the distal part of ablation member 1,200 1211 is lined up line with the portions of proximal of catheter shaft 1213, so that the air flue that is inserted with ablation member 1200 or the longitudinal axis of other body cavity align substantially.In launching configuration, the distal part 1211 crooked or distortion of ablation member 1200, thus form ring 1215, the plane that ring 1215 is positioned at transverse to the longitudinal axis of catheter shaft 1213 near-ends.By this way, ring 1215 can extend in the periphery of inner wall of air flue, thereby electrode 1220 is placed spaced positions place on a series of circumferencial directions of air flue.
In launching configuration, said ring can be spiral or can be positioned at the plane that becomes oblique angle with the longitudinal axis of catheter shaft 1213, makes electrode 1220 be placed in the position that axially separates along airway walls.Can utilize various known means to launch to encircle 1215.For example, draught line can extend through the chamber of catheter shaft slidably, and is fixed near the point the far-end, makes tension force on the draught line will encircle 1215 and is launched into required configuration.Perhaps, the distal part of conduit can be disposed for launching by pre-setting, and can be resilient, makes distal part between delivery period, can be compressed in the sheath, then, is released through the said sheath of withdrawing, and makes distal part recover to launch configuration.
Outlet 1210a-1210c (being referred to as " 1210 ") provides direct coolant cools for tissue.But independent operation electrode 1220a-c (being referred to as " 1120 ") is to form dispersive damage, and perhaps co-operate is formed for forming a total electrode of continuous damage.Can electrode 1220 be placed between bronchial two cartilaginous rings of nearside trunk, to handle about 1/3rd (for example, the front middle part zone of air flue or front and rear part zones) of air flue circumference.Then electrode 1220 is distad placed other 1/3rd front and rear part or the front middle part of handling airway walls between two distally cartilaginous rings again.Traveling electrode 120 is handled the rear portion 1/3rd of air flue, for example membrane portions once more.Coolant can be sent with cools tissue through exporting 1210.Ablation member 1200 can be used for the different sections of ablation vessels one after the other, and can distad move with proximad, between damage, enough intervals is provided, thereby alleviates scar tissue or narrow (if any).
Delivery apparatus disclosed herein can be handled digestive system, nervous system, vascular system or other system.For example, can handle vascular system through vascular delivery elongate member disclosed herein, tube chamber inner catheter and delivery apparatus.Processing system disclosed herein and parts thereof can be as the attached means of other medical care precess; Said other therapy is such as Wicresoft's operation, open-sky technique, semi open model operation or other operation technique (for example, lung volume dwindles operation) that arrives required target spot can be provided.Various thoracic surgeries can provide the entering lung tissue.Be used to provide the entering technology and the method that arrive the target area to carry out by doctor and/or robot system.Those skilled in the art understand the multiple diverse ways that can arrive the target area.
Lead, delivery sheath, optical instrument, introducer, sleeve pipe, biopsy needle or other suitable medical apparatus can be used to guide said delivery device.If the target processing site is in patient's distal position (for example, near the treatment site the radix pulmonis 24 of Fig. 1), then a lot of instruments and technology can be used in and arrive the site.For example, use such as the exercisable delivery apparatus of aforesaid endoscope and tracheascope and can be at an easy rate the elongate member of flexibility be positioned in the individual's body.
Semi-rigid or rigid elongate assembly can be sent in the following manner: use sleeve pipe, access port, use semi open model operable rigid delivery sheath, open-sky technique that more straight other means of delivery/method of sending passage maybe can be provided.Advantageously, the rigidity of semi-rigid or rigid elongate assembly can be enough strong, thereby arrive and handle tissue at a distance, such as vagus nerve, nervous ramification, nerve fiber and/or along the nerve trunk of air flue, and do not send elongate member through air flue.Embodiment disclosed herein and technology can be used with other operation, such as bronchus hot forming art.
Only if context has requirement in addition; Whole description and claim are all followed: word " comprises (comprise) " and alternative word; Such as " comprising (comprises) " and " comprising (comprising) "; All should be interpreted as implication open, that comprise, promptly be interpreted as " including but not limited to ".
Can be with above-mentioned different embodiments combination so that other embodiment to be provided.Under the instruction of the detailed description of preceding text, can carry out these to embodiment and change and other change.Embodiment disclosed herein, characteristic, system, device, material, method and technology in some embodiments with the described embodiment of following document, characteristic, system, device, material, method and technology in any one or a plurality of similar: the application the 12/463rd that on May 8th, 2009 submitted to; The U. S. application the 12/913rd that on October 27th, No. 304 1 submitted to; The U.S. Provisional Patent Application the 61/255th that on October 27th, No. 702 1 submitted to; No. the 61/260th, 348, the U.S. Provisional Patent Application of submitting in No. 367 and on November 11st, 2009.By reference each integral body in these applications is integrated with this paper.In addition; Embodiment described herein, characteristic, system, device, material, method and technology can be applied to above-mentioned U.S. Patent application series the 12/463rd in certain embodiments; Disclosed embodiment, characteristic, system, device, material, method and technology or use in No. the 12/913rd, 702, No. 304 and the U. S. application submitted on October 27th, 2010 with their combinations.For example, disclosed device can merge electrode disclosed herein or further feature in No. the 12/913rd, 702, No. the 12/463rd, 304, U.S. Patent application series and the U. S. application submitted on October 27th, 2010.
In addition; Embodiment described herein, characteristic, system, delivery apparatus, material, method and technology can be applied to the application the 12/463rd of submission on May 8th, 1 in certain embodiments; The U. S. application the 12/913rd that on October 27th, No. 304 1 submitted to; 702, the U.S. Provisional Patent Application of submitting on October 27th, 2009 the 61/255th; Any or multiple in U.S. Provisional Patent Application the 61/260th, No. 348 disclosed embodiment, characteristic, system, device, material, method and technology of submitting in No. 367 and on November 11st, 2009 or be used in combination with them.
Usually; In following claims; Used term should not be interpreted as claim is limited to description and the disclosed specific embodiments of claims, and should be interpreted as all possible embodiment of the equivalent way of the four corner that comprises that claim is represented.Therefore, claims do not receive the restriction of disclosure.
Can other embodiment be provided with each embodiment combination mentioned above.The whole United States Patent (USP)s, the U.S. Patent application that go out with the application materials tabular that this description is quoted is open, U.S. Patent application, foreign patent, foreign patent application and non-patent publications are incorporated this paper by reference in full into.If necessary can utilize the design of different patents, application and publication to change the various aspects of said embodiment, thereby other embodiment is provided.
Under the instruction of the similar description of preceding text, can carry out these to said embodiment and change and other change.Usually; In following claims; Term should not be interpreted as claims are limited to this description and the disclosed concrete embodiment of claims, and should be interpreted as all possible embodiment of the four corner of the equivalents that comprises that these claim is enjoyed.Therefore, claims should not receive the restriction of disclosure.

Claims (51)

1. energy delivery apparatus, it comprises catheter shaft and ablation member,
Said ablation member links to each other with said catheter shaft, and comprises energy emitter between cooling element and cartilage,
Said cooling element can move from collapsed mode and be deployed condition,
Energy emitter comprises a plurality of electrodes that the longitudinal axis around said ablation member squints at circumferencial direction each other between said cartilage; Said electrode is configured to can be to a plurality of target areas of air flue delivery of energy; Said a plurality of target area is spaced apart from each other with respect to the longitudinal axis of said ablation member; And wherein said energy emitter and said cooling element are configured to cooperatively interact and form and damage between cartilage, and the surface texture of damage and said air flue separates and between the cartilaginous ring of said air flue between said cartilage.
2. energy delivery apparatus as claimed in claim 1, wherein said energy emitter are configured to produce the damage that is spaced apart from each other along the major axis of said air flue.
3. energy delivery apparatus as claimed in claim 1, wherein said target area along the long axis direction of said air flue with the orthogonal virtual plane of the major axis of said air flue on projection limit basic closed ring.
4. energy delivery apparatus as claimed in claim 1, at least a portion of wherein said ablation member are spirally or spiral type.
5. energy delivery apparatus as claimed in claim 1, wherein when when the chamber of said air flue is observed downwards, at least a portion of two target areas is eclipsed.
6. energy delivery apparatus as claimed in claim 1, wherein said catheter shaft have and are used for the delivery lumen of sending coolant to said cooling element and said energy emitter.
7. energy delivery apparatus as claimed in claim 1; The cooling duct of wherein said energy emitter is what to separate with the chamber of said cooling element; Thereby allow the passage of first coolant, and allow chamber the second coolant independent delivery to said cooling element from said catheter shaft independent delivery to said energy emitter.
8. energy delivery apparatus as claimed in claim 1, wherein said energy emitter comprises the electrode with coolant channel, said coolant channel is used to make coolant from wherein flowing through.
9. energy delivery apparatus as claimed in claim 1, wherein said cooling element comprises extensible basket, and said extensible basket has the hollow elongated member, and said hollow elongated member has coolant channel.
10. energy delivery apparatus as claimed in claim 1; Wherein at least one electrode is configured to when said cooling element is in deployed condition, to export the part that enough RF energies melt the nerve trunk of extending along bronchial tree; Thereby weaken the nervous system signal of a part that transfers to said bronchial tree; And wherein said cooling element absorbs enough heat energy from the wall of said air flue, thereby can limit or prevent the tissue between said energy emitter and the said nervous tissue is damaged.
11. delivery apparatus in the tube chamber, it comprises:
Ablation member; Said ablation member comprises extensible device and a plurality of electrode; The circle spacing of the said extensible member in said electrode edge opens and can be to dispersive target area output energy; Thereby it is form damage in said target area, and at least a portion of wherein first damage is spaced apart with second damage in the axial direction, and contiguous or overlapping with second damage in a circumferential direction.
12. delivery apparatus in the tube chamber as claimed in claim 11, wherein said electrode is configured to form one group of damage, and said one group of damage axially separates with the longitudinal axis of second group of damage along said ablation member.
13. delivery apparatus in the tube chamber as claimed in claim 11, wherein said electrode is V-arrangement or T shape.
14. delivery apparatus in the tube chamber as claimed in claim 11, wherein said extensible device comprises a plurality of teeth, and said tooth has the free terminal that carries said electrode.
15. delivery apparatus in the tube chamber as claimed in claim 11, wherein at least one electrode has the cooling duct, and fluid can flow through said cooling duct and cool off said electrode, and wherein said extensible device comprises capsule or extensible basket.
16. delivery apparatus in the tube chamber as claimed in claim 11; Wherein said extensible device can be that spiral launches configuration from sending configuration mobile; And when said extensible device was in the expansion configuration, said electrode is placed in can be to the position of target area delivery of energy.
17. delivery apparatus in the tube chamber as claimed in claim 11, wherein said electrode can be by such placements: make the target area along the y direction of said ablation member with the orthogonal virtual plane of the said longitudinal axis on projection limit basic closed ring.
18. delivery apparatus in the tube chamber as claimed in claim 11, wherein said electrode can be by such placements: make the target area along the y direction of said ablation member with the orthogonal virtual plane of the said longitudinal axis on projection limit arc processing region.
19. delivery apparatus in the tube chamber as claimed in claim 11, wherein said electrode are configured to can be to the contiguous target area output energy in two places, makes that the eclipsed distance of circumference is at least 0.5mm between the contiguous target area, said two places.
20. the method that treatment is individual, it comprises:
Place ablation member with respect to air flue; And
To target area that the axially spaced-apart of said air flue is opened output energy, and wherein when along the long axis direction observation of said air flue, the profile of said target area is overlapping from said ablation member.
21. method as claimed in claim 20; First place that also is included in said target area forms first damage; And in second place of said target area formation, second damage; And wherein when when the long axis direction of said air flue is observed, it is a part of overlapping that the part of said first damage and said second is damaged.
22. method as claimed in claim 20, wherein said ablation member are configured to and can form damage in said target area, the chamber of said air flue is surrounded in the damage of every place at least in part.
23. method as claimed in claim 20; Comprise that also heating is in the degree of depth in the said airway walls and causes cell death greater than the tissue at about 2mm place, will be in the degree of depth in the said airway walls simultaneously and maintain the temperature that is lower than the cell death occurrence temperature less than the tissue at 2mm place.
24. method as claimed in claim 20 also comprises coolant sent through said ablation member and comes in the cooling airway degree of depth less than the tissue at 2mm place.
25. the method that treatment is individual, it comprises:
Move the energy emitter of delivery apparatus along air flue;
At least one electrode of said energy emitter is placed between the cartilaginous ring of said air flue; And
From the target area delivery of energy of said electrode, damage to form between cartilaginous ring to the position that axially separates along said air flue major axis.
26., comprise that also the wall that cools off said air flue is to protect the interior tissue of said air flue like the said method of claim 25.
27., also comprise at least two places damage that formation overlaps each other in a circumferential direction like the said method of claim 25.
28. like the said method of claim 25; One of wherein said damage is positioned at and orthogonal first virtual plane of the major axis of said air flue; And another place's damage is positioned at and orthogonal second virtual plane of the major axis of said air flue, and wherein said first virtual plane and said second virtual plane are along the major axis axially-spaced of said air flue.
29. like the said method of claim 25, when also being included in delivery of energy, cool off the wall of said air flue, thereby limit or prevent the cells of tissues death between nerve trunk and said energy emitter.
30. like the said method of claim 25; Comprise that also heating is in the degree of depth in the said airway walls and causes cell death at least about the tissue at 2mm place, will be in the degree of depth in the said airway walls simultaneously and maintain the temperature that is lower than the cell death occurrence temperature less than the tissue at 2mm place.
31. like the said method of claim 25, also comprise when said electrode is exported energy, coolant sent through said electrode.
32. handle the method for tissue, it comprises:
Ablation member is placed on the air flue intracavity; And
Utilize and be placed near the organize delivery of energy of at least one electrode of said air flue inner surface in the said ablation member to said air flue; Wherein said energy destroys the target area that axially separates along said air flue, and the target area part of the maximum cross-section width of the said target area of feasible qualification is separated with the inner surface of said air flue.
33., when also being included in delivery of energy a plurality of electrodes are placed between the cartilaginous ring like the said method of claim 32.
34., comprise that also delivery of energy is to form spiral type damage of at least one place or spirally damage like the said method of claim 32.
35. like the said method of claim 32, the maximum cross-section width of target area, wherein at least one place is positioned at apart from the air flue inner surface degree of depth place of 2mm at least of the said ablation member of contact.
36. like the said method of claim 32, also comprise the tissue that destroys target area, at least one place, make the darker degree of depth place, cross-sectional width smooth muscle tissue zone in of destructive tissue than said tissue reach maximum.
37. like the said method of claim 32, wherein delivery of energy comprises destruction target area, at least one place, makes the major part of this target area be positioned at outside the smooth muscle tissue zone of said tissue.
38. like the said method of claim 37, wherein most of volume of destructive tissue be positioned at outside the smooth muscle tissue zone.
39. delivery apparatus comprises
Catheter shaft; And
The ablation member that is connected with said catheter shaft; Said ablation member comprises and can move extensible element and energy emitter into deployed condition from sending state; When said extensible element is in deployed condition; Said energy emitter can produce damage by emitted energy, and said damage has the end that is axially offset to one another along the axial length of body structure.
40. delivery apparatus as claimed in claim 39, wherein said energy emitter comprises a plurality of electrodes, and said electrode is configured to form spirally damage, spiral type damage or Z-shaped damage.
41. delivery apparatus as claimed in claim 39, wherein said energy emitter are wrapped in said extensible component ambient.
42. delivery apparatus as claimed in claim 39; One end of wherein said energy emitter extends around said extensible element in a circumferential direction; The other end of said energy emitter extends around said extensible element in a circumferential direction, and the zone line of said energy emitter around said extensible element with respect to the oblique extension of the longitudinal axis of said ablation member.
43. delivery apparatus as claimed in claim 39, a plurality of electrodes of wherein said energy emitter along said ablation member with respect to the oblique extension of the longitudinal axis of said ablation member.
44. delivery apparatus as claimed in claim 39, wherein said energy emitter comprise a plurality of isolated electrodes, thereby can form spirally, spiral type or Z-shaped damage.
45. delivery apparatus as claimed in claim 44, wherein said damage are successive damage.
46. delivery apparatus as claimed in claim 45, wherein said damage are discontinuous damage.
47. the method that treatment is individual comprises:
Ablation member is positioned in the air flue, and
From said ablation member delivery of energy, thereby form the damage of at least one place, said damage has the opposite end that on the long axis direction of said air flue, axially departs from each other.
48. method as claimed in claim 47, wherein when the major axis of said ablation member is measured, said opposite end is at a distance of the distance of 5mm at least.
49. method as claimed in claim 47 comprises that also delivery of energy is to form spirally or spiral successive damage.
50. method as claimed in claim 47 also comprises forming spirally or spiral discontinuous damage.
51. method as claimed in claim 47, the damage of wherein at least one place comprises along a plurality of isolated damages of said air flue.
CN201080060627.6A 2009-11-11 2010-11-11 For processing tissue and controlling narrow system and device Active CN102711645B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201611095404.9A CN106618731B (en) 2009-11-11 2010-11-11 Systems, devices, and methods for treating tissue and controlling stenosis

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26034909P 2009-11-11 2009-11-11
US61/260,349 2009-11-11
PCT/US2010/056424 WO2011060200A1 (en) 2009-11-11 2010-11-11 Systems, apparatuses, and methods for treating tissue and controlling stenosis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201611095404.9A Division CN106618731B (en) 2009-11-11 2010-11-11 Systems, devices, and methods for treating tissue and controlling stenosis

Publications (2)

Publication Number Publication Date
CN102711645A true CN102711645A (en) 2012-10-03
CN102711645B CN102711645B (en) 2016-12-28

Family

ID=43480739

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201080060627.6A Active CN102711645B (en) 2009-11-11 2010-11-11 For processing tissue and controlling narrow system and device
CN201611095404.9A Active CN106618731B (en) 2009-11-11 2010-11-11 Systems, devices, and methods for treating tissue and controlling stenosis

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201611095404.9A Active CN106618731B (en) 2009-11-11 2010-11-11 Systems, devices, and methods for treating tissue and controlling stenosis

Country Status (9)

Country Link
US (5) US9149328B2 (en)
EP (3) EP2842510B1 (en)
JP (3) JP6000851B2 (en)
KR (1) KR101820542B1 (en)
CN (2) CN102711645B (en)
AU (1) AU2010319477A1 (en)
CA (1) CA2780608C (en)
IL (1) IL219605A0 (en)
WO (1) WO2011060200A1 (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103735307A (en) * 2014-01-14 2014-04-23 沈诚亮 Bronchial thermoplasty catheter
CN103860258A (en) * 2012-12-12 2014-06-18 北京中孵友信医药科技股份有限公司 Self-adaptive annular positioning endovascular catheter
CN105555220A (en) * 2013-07-22 2016-05-04 波士顿科学国际有限公司 Medical devices for renal nerve ablation
CN105636538A (en) * 2013-10-18 2016-06-01 波士顿科学国际有限公司 Balloon catheters with flexible conducting wires and related methods of use and manufacture
CN105744907A (en) * 2013-11-19 2016-07-06 伊西康公司 Thoracoscopic methods for treatment of bronchial disease
CN106264715A (en) * 2015-06-29 2017-01-04 韦伯斯特生物官能(以色列)有限公司 There is the conduit of closed loop array with plane internal linear electrode part
CN106880400A (en) * 2015-12-16 2017-06-23 上海微创电生理医疗科技有限公司 Electrophysiologicalcatheter catheter and radio frequency ablation system
CN110944581A (en) * 2017-07-28 2020-03-31 美敦力公司 Expandable element for delivery of electric fields
US11039772B2 (en) 2015-06-29 2021-06-22 Biosense Webster (Israel) Ltd. Catheter with stacked spine electrode assembly
US11083400B2 (en) 2014-11-20 2021-08-10 Biosense Webster (Israel) Ltd. Catheter with high density electrode spine array
US11116436B2 (en) 2015-06-30 2021-09-14 Biosense Webster (Israel) Ltd. Catheter having closed electrode assembly with spines of uniform length
US12144629B2 (en) 2023-06-20 2024-11-19 Biosense Webster (Israel) Ltd. Catheter having closed electrode assembly with spines of uniform length

Families Citing this family (112)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7027869B2 (en) 1998-01-07 2006-04-11 Asthmatx, Inc. Method for treating an asthma attack
US7921855B2 (en) 1998-01-07 2011-04-12 Asthmatx, Inc. Method for treating an asthma attack
US6702811B2 (en) 1999-04-05 2004-03-09 Medtronic, Inc. Ablation catheter assembly with radially decreasing helix and method of use
US7617005B2 (en) 2002-04-08 2009-11-10 Ardian, Inc. Methods and apparatus for thermally-induced renal neuromodulation
US20140018880A1 (en) 2002-04-08 2014-01-16 Medtronic Ardian Luxembourg S.A.R.L. Methods for monopolar renal neuromodulation
US8347891B2 (en) 2002-04-08 2013-01-08 Medtronic Ardian Luxembourg S.A.R.L. Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen
US7756583B2 (en) 2002-04-08 2010-07-13 Ardian, Inc. Methods and apparatus for intravascularly-induced neuromodulation
US7653438B2 (en) 2002-04-08 2010-01-26 Ardian, Inc. Methods and apparatus for renal neuromodulation
US20040226556A1 (en) 2003-05-13 2004-11-18 Deem Mark E. Apparatus for treating asthma using neurotoxin
US7803168B2 (en) 2004-12-09 2010-09-28 The Foundry, Llc Aortic valve repair
US7608275B2 (en) 2005-07-22 2009-10-27 The Foundry, Llc Systems and methods for delivery of a therapeutic agent
WO2007136566A2 (en) 2006-05-19 2007-11-29 Prorhythm, Inc. Ablation device with optimized input power profile and method of using the same
US8483831B1 (en) 2008-02-15 2013-07-09 Holaira, Inc. System and method for bronchial dilation
EP2662046B1 (en) 2008-05-09 2023-03-15 Nuvaira, Inc. Systems and assemblies for treating a bronchial tree
US11376061B2 (en) * 2008-11-11 2022-07-05 Covidien Lp Energy delivery device and methods of use
EP2376011B1 (en) 2009-01-09 2019-07-03 ReCor Medical, Inc. Apparatus for treatment of mitral valve insufficiency
US8903488B2 (en) 2009-05-28 2014-12-02 Angiodynamics, Inc. System and method for synchronizing energy delivery to the cardiac rhythm
US9895189B2 (en) 2009-06-19 2018-02-20 Angiodynamics, Inc. Methods of sterilization and treating infection using irreversible electroporation
CN107049479B (en) * 2009-10-27 2020-10-16 努瓦拉公司 Delivery device with coolable energy emitting assembly
US8911439B2 (en) 2009-11-11 2014-12-16 Holaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
EP2842510B1 (en) 2009-11-11 2022-08-24 Nuvaira, Inc. Device for treating tissue and controlling stenosis
US10575893B2 (en) 2010-04-06 2020-03-03 Nuvaira, Inc. System and method for pulmonary treatment
US20120029512A1 (en) * 2010-07-30 2012-02-02 Willard Martin R Balloon with surface electrodes and integral cooling for renal nerve ablation
EP2627274B1 (en) 2010-10-13 2022-12-14 AngioDynamics, Inc. System for electrically ablating tissue of a patient
US9028417B2 (en) 2010-10-18 2015-05-12 CardioSonic Ltd. Ultrasound emission element
US20130218068A1 (en) 2010-10-18 2013-08-22 CardioSonic Ltd. Therapeutics reservoir
US8585601B2 (en) 2010-10-18 2013-11-19 CardioSonic Ltd. Ultrasound transducer
US9566456B2 (en) 2010-10-18 2017-02-14 CardioSonic Ltd. Ultrasound transceiver and cooling thereof
JP2013544133A (en) 2010-10-25 2013-12-12 メドトロニック アーディアン ルクセンブルク ソシエテ ア レスポンサビリテ リミテ Catheter apparatus having a multi-electrode array for renal neuromodulation and related systems and methods
WO2012086492A1 (en) 2010-12-21 2012-06-28 テルモ株式会社 Balloon catheter and electrification system
EP2694150A1 (en) 2011-04-08 2014-02-12 Covidien LP Iontophoresis drug delivery system and method for denervation of the renal sympathetic nerve and iontophoretic drug delivery
US8936594B2 (en) * 2011-06-14 2015-01-20 Aerin Medical Inc. Methods and devices to treat nasal airways
US11304746B2 (en) 2011-06-14 2022-04-19 Aerin Medical Inc. Method of treating airway tissue to reduce mucus secretion
US11033318B2 (en) 2011-06-14 2021-06-15 Aerin Medical, Inc. Methods and devices to treat nasal airways
US11241271B2 (en) 2011-06-14 2022-02-08 Aerin Medical Inc. Methods of treating nasal airways
US9078665B2 (en) 2011-09-28 2015-07-14 Angiodynamics, Inc. Multiple treatment zone ablation probe
CN106823131B (en) * 2011-09-30 2019-12-20 柯惠有限合伙公司 Energy transfer device and method of use
WO2013052501A1 (en) 2011-10-05 2013-04-11 Innovative Pulmonary Solutions, Inc. Apparatus for injuring nerve tissue
US20130123770A1 (en) * 2011-11-14 2013-05-16 Boston Scientific Scimed, Inc. Ablation catheter with cryothermal balloon
WO2013086461A1 (en) 2011-12-09 2013-06-13 Metavention, Inc. Therapeutic neuromodulation of the hepatic system
US9414881B2 (en) 2012-02-08 2016-08-16 Angiodynamics, Inc. System and method for increasing a target zone for electrical ablation
EP3135237B1 (en) * 2012-04-13 2019-07-24 Covidien LP Energy delivery device
CN102631240A (en) * 2012-04-13 2012-08-15 上海微创电生理医疗科技有限公司 Cold brine infusion type radiofrequency ablation catheter
WO2013157009A2 (en) * 2012-04-18 2013-10-24 CardioSonic Ltd. Tissue treatment
WO2013157011A2 (en) 2012-04-18 2013-10-24 CardioSonic Ltd. Tissue treatment
EP4079245A1 (en) 2012-05-11 2022-10-26 Medtronic Ireland Manufacturing Unlimited Company Multi-electrode catheter assemblies for renal neuromodulation and associated systems
US20130310822A1 (en) * 2012-05-18 2013-11-21 Holaira, Inc. Compact delivery pulmonary treatment systems and methods for improving pulmonary function
US11357447B2 (en) 2012-05-31 2022-06-14 Sonivie Ltd. Method and/or apparatus for measuring renal denervation effectiveness
US12082868B2 (en) 2012-11-13 2024-09-10 Pulnovo Medical (Wuxi) Co., Ltd. Multi-pole synchronous pulmonary artery radiofrequency ablation catheter
US11241267B2 (en) 2012-11-13 2022-02-08 Pulnovo Medical (Wuxi) Co., Ltd Multi-pole synchronous pulmonary artery radiofrequency ablation catheter
CN102908191A (en) 2012-11-13 2013-02-06 陈绍良 Multipolar synchronous pulmonary artery radiofrequency ablation catheter
WO2014089373A1 (en) * 2012-12-05 2014-06-12 University Of Rochester Catheter with integrated transeptal puncture needle
US9398933B2 (en) 2012-12-27 2016-07-26 Holaira, Inc. Methods for improving drug efficacy including a combination of drug administration and nerve modulation
US20140221994A1 (en) * 2013-02-05 2014-08-07 Covidien Lp Electrosurgical instrument
JP2016511027A (en) * 2013-02-08 2016-04-14 コビディエン エルピー Lung denervation system and method
US10076384B2 (en) 2013-03-08 2018-09-18 Symple Surgical, Inc. Balloon catheter apparatus with microwave emitter
EP4410338A3 (en) 2013-03-13 2024-10-16 Nuvaira, Inc. Fluid delivery system and method for treatment
WO2014143898A1 (en) * 2013-03-15 2014-09-18 Holaira, Inc. Systems, devices, and methods for treating a pulmonary disorder with an agent
US9179974B2 (en) 2013-03-15 2015-11-10 Medtronic Ardian Luxembourg S.A.R.L. Helical push wire electrode
US10933259B2 (en) 2013-05-23 2021-03-02 CardioSonic Ltd. Devices and methods for renal denervation and assessment thereof
US20160128767A1 (en) 2013-06-05 2016-05-12 Metavention, Inc. Modulation of targeted nerve fibers
EP3019106A1 (en) * 2013-07-11 2016-05-18 Boston Scientific Scimed, Inc. Medical device with stretchable electrode assemblies
DE102013109505B4 (en) * 2013-08-30 2015-11-12 Karl Storz Gmbh & Co. Kg Medical instrument and electrosurgical system
US20150073515A1 (en) 2013-09-09 2015-03-12 Medtronic Ardian Luxembourg S.a.r.I. Neuromodulation Catheter Devices and Systems Having Energy Delivering Thermocouple Assemblies and Associated Methods
WO2015038886A1 (en) * 2013-09-12 2015-03-19 Holaira, Inc. Systems, devices, and methods for treating a pulmonary disease with ultrasound energy
DE102013219509A1 (en) 2013-09-27 2015-04-02 Olympus Winter & Ibe Gmbh Expandable cooled electrode
AU2014240225A1 (en) 2013-10-01 2015-04-16 Uptake Medical Technology Inc. Preferential volume reduction of diseased segments of a heterogeneous lobe
WO2015089377A1 (en) 2013-12-12 2015-06-18 Holaira, Inc. Catheter and handle assembly, systems, and methods
US9579149B2 (en) 2014-03-13 2017-02-28 Medtronic Ardian Luxembourg S.A.R.L. Low profile catheter assemblies and associated systems and methods
US10736690B2 (en) 2014-04-24 2020-08-11 Medtronic Ardian Luxembourg S.A.R.L. Neuromodulation catheters and associated systems and methods
US10709490B2 (en) 2014-05-07 2020-07-14 Medtronic Ardian Luxembourg S.A.R.L. Catheter assemblies comprising a direct heating element for renal neuromodulation and associated systems and methods
US20150342669A1 (en) * 2014-05-29 2015-12-03 Boston Scientific Scimed, Inc. Devices and methods for controlled energy delivery to airways
RU2692219C2 (en) * 2014-07-11 2019-06-21 Пулново Медикал (Уси) Ко., Лтд. Multipolar synchronous radio-frequency ablation catheter for pulmonary artery
US12114911B2 (en) 2014-08-28 2024-10-15 Angiodynamics, Inc. System and method for ablating a tissue site by electroporation with real-time pulse monitoring
US10485604B2 (en) 2014-12-02 2019-11-26 Uptake Medical Technology Inc. Vapor treatment of lung nodules and tumors
US9795780B2 (en) * 2014-12-18 2017-10-24 Abbott Cardiovascular Systems Inc. System for denervation
US10531906B2 (en) 2015-02-02 2020-01-14 Uptake Medical Technology Inc. Medical vapor generator
US10376308B2 (en) 2015-02-05 2019-08-13 Axon Therapies, Inc. Devices and methods for treatment of heart failure by splanchnic nerve ablation
CA2988609C (en) 2015-06-12 2023-09-05 The University Of Sydney Microwave ablation device
US10207110B1 (en) 2015-10-13 2019-02-19 Axon Therapies, Inc. Devices and methods for treatment of heart failure via electrical modulation of a splanchnic nerve
DE102016106478A1 (en) * 2016-04-08 2017-10-12 Biotronik Ag Device for emitting energy and / or measuring electrical activity
US10524859B2 (en) * 2016-06-07 2020-01-07 Metavention, Inc. Therapeutic tissue modulation devices and methods
WO2018013570A1 (en) * 2016-07-11 2018-01-18 Retrovascular, Inc. Bi-polar tissue ablation device and methods of use thereof
CN109843160B (en) 2016-07-29 2022-04-15 阿克松疗法公司 Devices, systems, and methods for treating heart failure through cardiac nerve ablation
MX2019003483A (en) 2016-10-04 2019-09-02 Avent Inc Cooled rf probes.
US10905492B2 (en) 2016-11-17 2021-02-02 Angiodynamics, Inc. Techniques for irreversible electroporation using a single-pole tine-style internal device communicating with an external surface electrode
EP3551109A4 (en) 2016-12-07 2020-07-22 Nuvaira, Inc. Method and systems for reducing treatment variability and increasing treatment efficacy and durability
CN110621345A (en) 2017-03-20 2019-12-27 索尼维有限公司 Pulmonary hypertension treatment
US20180280080A1 (en) 2017-03-31 2018-10-04 Biosense Webster (Israel) Ltd. Balloon catheter with large area electrodes
US10617867B2 (en) * 2017-04-28 2020-04-14 Farapulse, Inc. Systems, devices, and methods for delivery of pulsed electric field ablative energy to esophageal tissue
US11129673B2 (en) 2017-05-05 2021-09-28 Uptake Medical Technology Inc. Extra-airway vapor ablation for treating airway constriction in patients with asthma and COPD
US11344364B2 (en) 2017-09-07 2022-05-31 Uptake Medical Technology Inc. Screening method for a target nerve to ablate for the treatment of inflammatory lung disease
US11350988B2 (en) 2017-09-11 2022-06-07 Uptake Medical Technology Inc. Bronchoscopic multimodality lung tumor treatment
US11419658B2 (en) 2017-11-06 2022-08-23 Uptake Medical Technology Inc. Method for treating emphysema with condensable thermal vapor
US10561461B2 (en) 2017-12-17 2020-02-18 Axon Therapies, Inc. Methods and devices for endovascular ablation of a splanchnic nerve
AU2019206388B2 (en) * 2018-01-10 2021-10-14 Adagio Medical, Inc. Cryoablation element with conductive liner
CN111886043B (en) 2018-01-26 2024-03-29 阿克松疗法公司 Method and apparatus for intravascular ablation of visceral nerves
JP2020018606A (en) * 2018-08-01 2020-02-06 テルモ株式会社 Medical device
US20200038101A1 (en) * 2018-08-03 2020-02-06 Biosense Webster (Israel) Ltd. Unipolar reference electrode for electrophysiology mapping catheter
DE102018120761A1 (en) * 2018-08-24 2020-02-27 Biotronik Se & Co. Kg Electrode lead with integrated deformation sensor
US11653927B2 (en) 2019-02-18 2023-05-23 Uptake Medical Technology Inc. Vapor ablation treatment of obstructive lung disease
US20200390496A1 (en) * 2019-06-14 2020-12-17 Avolt, Llc Electromagnetic radiation ablation tips made of magnetic materials
EP4241836A3 (en) 2019-06-20 2023-11-29 Axon Therapies, Inc. Devices for endovascular ablation of a splanchnic nerve
CN110507406A (en) * 2019-08-29 2019-11-29 上海市东方医院(同济大学附属东方医院) Cryoablation catheter and application thereof
US11291500B2 (en) 2019-11-05 2022-04-05 Sirona Medical Technologies, Inc. Multi-modal catheter for improved electrical mapping and ablation
WO2021146724A1 (en) 2020-01-17 2021-07-22 Axon Therapies, Inc. Methods and devices for endovascular ablation of a splanchnic nerve
WO2021157100A1 (en) * 2020-02-08 2021-08-12 日本ライフライン株式会社 Balloon-type electrode catheter
CA3188689A1 (en) * 2020-08-11 2022-02-17 Alexis G. Nahama Treating pulmonary inflammatory disease by neural ablation
US20220087739A1 (en) * 2020-09-18 2022-03-24 Acclarent, Inc. Ent instrument with expandable ablation feature
KR20220061898A (en) * 2020-11-06 2022-05-13 연세대학교 산학협력단 Biological data acquisition apparatus and biological data processing apparatus using the same
US12082877B2 (en) 2021-01-22 2024-09-10 CRC EP, Inc. Ablation catheter and operation method of same
US20240164842A1 (en) * 2022-11-21 2024-05-23 Nuvaira, Inc. Utilization of three-dimensional navigation technology during lung denervation procedures

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997025917A1 (en) * 1996-01-19 1997-07-24 Ep Technologies, Inc. Multi-function electrode structures for electrically analyzing and heating body tissue
WO1999042047A1 (en) * 1998-02-19 1999-08-26 Conway-Stuart Medical, Inc. Method for electrosurgically treating a sphincter
WO2000066017A1 (en) * 1999-05-04 2000-11-09 Curon Medical, Inc. Electrodes for creating lesions in tissue regions at or near a sphincter
US20080262489A1 (en) * 2007-04-23 2008-10-23 Minnow Medical, Llc Thrombus removal
US20090131928A1 (en) * 1998-01-14 2009-05-21 Respiratory Diagnostic, Inc. GERD treatment apparatus and method

Family Cites Families (1126)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US612724A (en) 1898-10-18 Bert j
US1155169A (en) 1914-11-28 1915-09-28 John Starkweather Surgical instrument.
US1207479A (en) 1915-03-05 1916-12-05 Holger Bisgaard Self-retaining gatheter.
US1216183A (en) 1916-09-18 1917-02-13 Charles M Swingle Electrotherapeutic rejuvenator.
US1695107A (en) 1926-11-24 1928-12-11 Willi Landau Therapeutic implement
US2072346A (en) 1934-10-04 1937-03-02 Ward R Smith Drainage tube
US2279714A (en) 1940-10-26 1942-04-14 Firm Asclepio Mira Limitada Cystoscope
US3320957A (en) 1964-05-21 1967-05-23 Sokolik Edward Surgical instrument
US3568659A (en) 1968-09-24 1971-03-09 James N Karnegis Disposable percutaneous intracardiac pump and method of pumping blood
US3667476A (en) 1970-04-27 1972-06-06 Bio Data Corp Apparatus for monitoring body temperature and controlling a heating device to maintain a selected temperature
US3692029A (en) 1971-05-03 1972-09-19 Edwin Lloyd Adair Retention catheter and suprapubic shunt
US3995617A (en) 1972-05-31 1976-12-07 Watkins David H Heart assist method and catheter
US3949743A (en) 1973-03-19 1976-04-13 Schick Incorporated Medicated vapor production method and apparatus
GB1459397A (en) 1973-03-22 1976-12-22 Biopulse Co Ltd Apparatus for treating organisms by applying an electrical signal thereto
FR2232331B1 (en) 1973-06-06 1978-03-24 Guerin A Ets
SU545358A1 (en) 1974-07-11 1977-02-05 Предприятие П/Я В-2481 Circulatory Support Device
US4078864A (en) 1976-07-08 1978-03-14 United Technologies Corporation Method and apparatus for viewing and measuring damage in an inaccessible area
US4095602A (en) 1976-09-27 1978-06-20 Leveen Harry H Multi-portal radiofrequency generator
US4129129A (en) 1977-03-18 1978-12-12 Sarns, Inc. Venous return catheter and a method of using the same
US4116589A (en) 1977-04-15 1978-09-26 Avco Corporation Extracorporeal pulsatile blood pump comprised of side by side bladders
US4154246A (en) 1977-07-25 1979-05-15 Leveen Harry H Field intensification in radio frequency thermotherapy
US4351330A (en) 1978-01-30 1982-09-28 Scarberry Eugene N Emergency internal defibrillation
JPS54154759U (en) 1978-04-20 1979-10-27
US4503863A (en) 1979-06-29 1985-03-12 Katims Jefferson J Method and apparatus for transcutaneous electrical stimulation
US4305402A (en) 1979-06-29 1981-12-15 Katims Jefferson J Method for transcutaneous electrical stimulation
US4557272A (en) 1980-03-31 1985-12-10 Microwave Associates, Inc. Microwave endoscope detection and treatment system
US4565200A (en) 1980-09-24 1986-01-21 Cosman Eric R Universal lesion and recording electrode system
US4502490A (en) 1980-10-28 1985-03-05 Antec Systems Limited Patient monitoring equipment, probe for use therewith, and method of measuring anesthesia based on oesophagal contractions
JPS57168656A (en) 1981-04-10 1982-10-18 Medos Kenkyusho Kk Endoscope laser coagulator
US4706688A (en) 1981-05-18 1987-11-17 Don Michael T Anthony Non-invasive cardiac device
US4612934A (en) 1981-06-30 1986-09-23 Borkan William N Non-invasive multiprogrammable tissue stimulator
US4584998A (en) 1981-09-11 1986-04-29 Mallinckrodt, Inc. Multi-purpose tracheal tube
JPS5883966A (en) 1981-11-13 1983-05-19 テルモ株式会社 Blood circuit for membrane type artificial lung
DE3247793C2 (en) 1981-12-31 1986-01-09 Harald 7200 Tuttlingen Maslanka High frequency surgical loop electrode
US5370675A (en) 1992-08-12 1994-12-06 Vidamed, Inc. Medical probe device and method
US4512762A (en) 1982-11-23 1985-04-23 The Beth Israel Hospital Association Method of treatment of atherosclerosis and a balloon catheter for same
US4773899A (en) 1982-11-23 1988-09-27 The Beth Israel Hospital Association Method of treatment of artherosclerosis and balloon catheter the same
US4567882A (en) 1982-12-06 1986-02-04 Vanderbilt University Method for locating the illuminated tip of an endotracheal tube
US4784135A (en) 1982-12-09 1988-11-15 International Business Machines Corporation Far ultraviolet surgical and dental procedures
JPS59167707A (en) 1983-03-14 1984-09-21 Toshiba Corp Sample value controller
ZW6584A1 (en) 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
US4646737A (en) 1983-06-13 1987-03-03 Laserscope, Inc. Localized heat applying medical device
US4704121A (en) 1983-09-28 1987-11-03 Nimbus, Inc. Anti-thrombogenic blood pump
US4625712A (en) 1983-09-28 1986-12-02 Nimbus, Inc. High-capacity intravascular blood pump utilizing percutaneous access
US4522212A (en) 1983-11-14 1985-06-11 Mansfield Scientific, Inc. Endocardial electrode
FR2561929B1 (en) 1984-03-27 1989-02-03 Atesys IMPLANTED AUTOMATIC APPARATUS FOR VENTRICULAR DEFIBRILLATION
US4621882A (en) 1984-05-14 1986-11-11 Beta Phase, Inc. Thermally responsive electrical connector
US4649935A (en) 1984-05-21 1987-03-17 Symtonic Sa Method of treating neurovegetative disorders and apparatus therefor
US4573481A (en) 1984-06-25 1986-03-04 Huntington Institute Of Applied Research Implantable electrode array
US4649924A (en) 1984-08-14 1987-03-17 Consiglio Nazionale Delle Ricerche Method for the detection of intracardiac electrical potential fields
JPS6148350A (en) 1984-08-15 1986-03-10 オリンパス光学工業株式会社 Medical laser apparatus
US4799479A (en) 1984-10-24 1989-01-24 The Beth Israel Hospital Association Method and apparatus for angioplasty
US5019075A (en) 1984-10-24 1991-05-28 The Beth Israel Hospital Method and apparatus for angioplasty
US4772112A (en) 1984-11-30 1988-09-20 Cvi/Beta Ventures, Inc. Eyeglass frame including shape-memory elements
US4754065A (en) 1984-12-18 1988-06-28 Cetus Corporation Precursor to nucleic acid probe
EP0189329A3 (en) 1985-01-25 1987-06-03 Robert E. Fischell A tunneling catheter system for transluminal arterial angioplasty
GB2171309B (en) 1985-02-26 1988-11-02 North China Res I Electro Opti Microwave therapeutic apparatus
US4739759A (en) 1985-02-26 1988-04-26 Concept, Inc. Microprocessor controlled electrosurgical generator
US4862886A (en) 1985-05-08 1989-09-05 Summit Technology Inc. Laser angioplasty
US4658836A (en) 1985-06-28 1987-04-21 Bsd Medical Corporation Body passage insertable applicator apparatus for electromagnetic
US4976709A (en) 1988-12-15 1990-12-11 Sand Bruce J Method for collagen treatment
US4989604A (en) 1985-10-03 1991-02-05 Accu Science Corporation Electromagnetic device
US4643186A (en) 1985-10-30 1987-02-17 Rca Corporation Percutaneous transluminal microwave catheter angioplasty
US4683890A (en) 1985-12-23 1987-08-04 Brunswick Manufacturing Co., Inc. Method and apparatus for controlled breathing employing internal and external electrodes
DE8607358U1 (en) 1986-03-18 1986-05-28 Ruß, Jürgen, 5300 Bonn Tubular, flexible probe for insertion into the trachea and bronchi
US4827935A (en) 1986-04-24 1989-05-09 Purdue Research Foundation Demand electroventilator
US4709698A (en) 1986-05-14 1987-12-01 Thomas J. Fogarty Heatable dilation catheter
US4790305A (en) 1986-06-23 1988-12-13 The Johns Hopkins University Medication delivery system
US4767402A (en) 1986-07-08 1988-08-30 Massachusetts Institute Of Technology Ultrasound enhancement of transdermal drug delivery
IE60941B1 (en) 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
US4754752A (en) 1986-07-28 1988-07-05 Robert Ginsburg Vascular catheter
US5215103A (en) 1986-11-14 1993-06-01 Desai Jawahar M Catheter for mapping and ablation and method therefor
US5231995A (en) 1986-11-14 1993-08-03 Desai Jawahar M Method for catheter mapping and ablation
US5027829A (en) 1986-12-15 1991-07-02 Larsen Lawrence E Apparatus for diathermy treatment and control
US4976710A (en) 1987-01-28 1990-12-11 Mackin Robert A Working well balloon method
GB8704104D0 (en) 1987-02-21 1987-03-25 Manitoba University Of Respiratory system load apparatus
IT1203503B (en) 1987-02-25 1989-02-15 Cardiosistemi Spa VENOUS DRAINAGE CANNULA
GB8705451D0 (en) 1987-03-09 1987-04-15 Driver Southall Combinational weighing systems
US4802492A (en) 1987-03-11 1989-02-07 National Jewish Center For Immunology And Respiratory Medicine Method for determining respiratory function
SU1457935A1 (en) 1987-03-17 1989-02-15 Предприятие П/Я А-1405 Apparatus for electroanalgesia
US4779614A (en) 1987-04-09 1988-10-25 Nimbus Medical, Inc. Magnetically suspended rotor axial flow blood pump
US4904472A (en) 1987-04-10 1990-02-27 The University Of Virginia Alumni Patent Foundation Use of adenosine antagonists in the treatment of bradyarrhythmias and mechanical dysfunction associated with cardiopulmonary resuscitation
MC1921A1 (en) 1987-04-10 1989-04-06 Sankei Yakuhin Kk ACYL DERIVATIVES
CN87208158U (en) 1987-05-20 1988-10-19 张雪珊 Dual-functional domestic lamp
US5849026A (en) 1987-05-20 1998-12-15 Zhou; Lin Physiotherapy method
EP0293068A1 (en) 1987-05-27 1988-11-30 Teijin Limited An electric therapeutic apparatus
US4808164A (en) 1987-08-24 1989-02-28 Progressive Angioplasty Systems, Inc. Catheter for balloon angioplasty
JPS6446056U (en) 1987-09-17 1989-03-22
US4846152A (en) 1987-11-24 1989-07-11 Nimbus Medical, Inc. Single-stage axial flow blood pump
US4817586A (en) 1987-11-24 1989-04-04 Nimbus Medical, Inc. Percutaneous bloom pump with mixed-flow output
US4895557A (en) 1987-12-07 1990-01-23 Nimbus Medical, Inc. Drive mechanism for powering intravascular blood pumps
US5588432A (en) 1988-03-21 1996-12-31 Boston Scientific Corporation Catheters for imaging, sensing electrical potentials, and ablating tissue
US4907589A (en) 1988-04-29 1990-03-13 Cosman Eric R Automatic over-temperature control apparatus for a therapeutic heating device
US4906229A (en) 1988-05-03 1990-03-06 Nimbus Medical, Inc. High-frequency transvalvular axisymmetric blood pump
US5010892A (en) 1988-05-04 1991-04-30 Triangle Research And Development Corp. Body lumen measuring instrument
EP0415997A4 (en) 1988-05-18 1992-04-08 Kasevich Associates, Inc. Microwave balloon angioplasty
DE3821544C2 (en) 1988-06-25 1994-04-28 H Prof Dr Med Just Dilatation catheter
US4967765A (en) 1988-07-28 1990-11-06 Bsd Medical Corporation Urethral inserted applicator for prostate hyperthermia
US4908012A (en) 1988-08-08 1990-03-13 Nimbus Medical, Inc. Chronic ventricular assist system
US4920978A (en) 1988-08-31 1990-05-01 Triangle Research And Development Corporation Method and apparatus for the endoscopic treatment of deep tumors using RF hyperthermia
JP2686982B2 (en) 1988-09-02 1997-12-08 日産自動車株式会社 Method for forming clear coating film
US4902129A (en) 1988-09-06 1990-02-20 Schott Fiber Optics Orientation indicator for a flexible fiberscope or endoscope including method of manufacture
US5151100A (en) 1988-10-28 1992-09-29 Boston Scientific Corporation Heating catheters
US4955377A (en) 1988-10-28 1990-09-11 Lennox Charles D Device and method for heating tissue in a patient's body
US5191883A (en) 1988-10-28 1993-03-09 Prutech Research And Development Partnership Ii Device for heating tissue in a patient's body
US4945912A (en) 1988-11-25 1990-08-07 Sensor Electronics, Inc. Catheter with radiofrequency heating applicator
US4969865A (en) 1989-01-09 1990-11-13 American Biomed, Inc. Helifoil pump
US5779698A (en) 1989-01-18 1998-07-14 Applied Medical Resources Corporation Angioplasty catheter system and method for making same
US4944722A (en) 1989-02-23 1990-07-31 Nimbus Medical, Inc. Percutaneous axial flow blood pump
US5057107A (en) 1989-04-13 1991-10-15 Everest Medical Corporation Ablation catheter with selectively deployable electrodes
US5433730A (en) 1989-05-03 1995-07-18 Intermedics, Inc. Conductive pouch electrode for defibrillation
US5152286A (en) 1989-05-08 1992-10-06 Mezhotraslevoi Nauchnoinzhenerny Tsentr "Vidguk" Method of microwave resonance therapy and device therefor
US5114423A (en) 1989-05-15 1992-05-19 Advanced Cardiovascular Systems, Inc. Dilatation catheter assembly with heated balloon
US5107835A (en) 1989-05-22 1992-04-28 Physiodynamics Electrotherapeutic treatment
US5006119A (en) 1989-05-25 1991-04-09 Engineering & Research Associates, Inc. Hollow core coaxial catheter
US5074860A (en) 1989-06-09 1991-12-24 Heraeus Lasersonics, Inc. Apparatus for directing 10.6 micron laser radiation to a tissue site
DE3920862A1 (en) 1989-06-26 1991-01-03 Teves Gmbh Alfred AUXILIARY STEERING FOR MOTOR VEHICLES
US4985014A (en) 1989-07-11 1991-01-15 Orejola Wilmo C Ventricular venting loop
US5084044A (en) 1989-07-14 1992-01-28 Ciron Corporation Apparatus for endometrial ablation and method of using same
US5005559A (en) 1989-07-27 1991-04-09 Massachusetts Institute Of Technology Video-graphic arthroscopy system
US5292331A (en) 1989-08-24 1994-03-08 Applied Vascular Engineering, Inc. Endovascular support device
US5562608A (en) 1989-08-28 1996-10-08 Biopulmonics, Inc. Apparatus for pulmonary delivery of drugs with simultaneous liquid lavage and ventilation
US5057105A (en) 1989-08-28 1991-10-15 The University Of Kansas Med Center Hot tip catheter assembly
WO1991003267A1 (en) 1989-08-28 1991-03-21 Sekins K Michael Lung cancer hyperthermia via ultrasound and/or convection with perfluorocarbon liquids
EP0490979B1 (en) 1989-09-08 1996-11-13 Boston Scientific Corporation Physiologic low stress angioplasty
US5270305A (en) 1989-09-08 1993-12-14 Glaxo Group Limited Medicaments
US5167223A (en) 1989-09-08 1992-12-01 Tibor Koros Heart valve retractor and sternum spreader surgical instrument
US5100388A (en) 1989-09-15 1992-03-31 Interventional Thermodynamics, Inc. Method and device for thermal ablation of hollow body organs
DE3931041C2 (en) 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Esters of thienyl carboxylic acids with amino alcohols, their quaternization products, processes for their preparation and medicaments containing them
US5117828A (en) 1989-09-25 1992-06-02 Arzco Medical Electronics, Inc. Expandable esophageal catheter
US5007908A (en) 1989-09-29 1991-04-16 Everest Medical Corporation Electrosurgical instrument having needle cutting electrode and spot-coag electrode
US5036848A (en) 1989-10-16 1991-08-06 Brunswick Biomedical Technologies, Inc. Method and apparatus for controlling breathing employing internal and external electrodes
US4991603A (en) 1989-10-30 1991-02-12 Siemens-Pacesetter, Inc. Transvenously placed defibrillation leads via an inferior vena cava access site and method of use
US5203832A (en) 1989-11-17 1993-04-20 Long Manufacturing Ltd. Circumferential flow heat exchanger
US5009636A (en) 1989-12-06 1991-04-23 The Kendall Company Dual-lumen catheter apparatus and method
US5254088A (en) 1990-02-02 1993-10-19 Ep Technologies, Inc. Catheter steering mechanism
ATE120377T1 (en) 1990-02-08 1995-04-15 Howmedica INFLATABLE DILATATOR.
US6536427B2 (en) 1990-03-02 2003-03-25 Glaxo Group Limited Inhalation device
FR2659240B1 (en) 1990-03-06 1997-07-04 Daniel Galley EPIDURAL ELECTRODE SYSTEM CALLED TO BE INTRODUCED INTO THE EPIDURAL SPACE.
US5549559A (en) 1990-03-22 1996-08-27 Argomed Ltd. Thermal treatment apparatus
US5056529A (en) 1990-04-03 1991-10-15 Groot William J De Apparatus and method for performing a transbroncheal biopsy
US5139029A (en) 1990-04-06 1992-08-18 Henry Fishman Allergy testing apparatus and method
US5096916A (en) 1990-05-07 1992-03-17 Aegis Technology, Inc. Treatment of chronic obstructive pulmonary disease (copd) by inhalation of an imidazoline
US5236413B1 (en) 1990-05-07 1996-06-18 Andrew J Feiring Method and apparatus for inducing the permeation of medication into internal tissue
US5078716A (en) 1990-05-11 1992-01-07 Doll Larry F Electrosurgical apparatus for resecting abnormal protruding growth
US5624392A (en) 1990-05-11 1997-04-29 Saab; Mark A. Heat transfer catheters and methods of making and using same
US5265604A (en) 1990-05-14 1993-11-30 Vince Dennis J Demand - diaphragmatic pacing (skeletal muscle pressure modified)
US5056519A (en) 1990-05-14 1991-10-15 Vince Dennis J Unilateral diaphragmatic pacer
US5054486A (en) 1990-05-31 1991-10-08 Mamoru Yamada Remedial techniques for the treatment of painful disorders such as intervertebral disc hernia and the like
US5190540A (en) 1990-06-08 1993-03-02 Cardiovascular & Interventional Research Consultants, Inc. Thermal balloon angioplasty
US5360443A (en) 1990-06-11 1994-11-01 Barone Hector D Aortic graft for repairing an abdominal aortic aneurysm
CA2081896A1 (en) 1990-06-15 1991-12-16 James E. Shapland Drug delivery apparatus and method
SE500550C2 (en) 1990-06-18 1994-07-11 Siemens Elema Ab Methods and apparatus for reducing gas re-breathing from the harmful space
US5103804A (en) 1990-07-03 1992-04-14 Boston Scientific Corporation Expandable tip hemostatic probes and the like
US5188602A (en) 1990-07-12 1993-02-23 Interventional Thermodynamics, Inc. Method and device for delivering heat to hollow body organs
US5135517A (en) 1990-07-19 1992-08-04 Catheter Research, Inc. Expandable tube-positioning apparatus
US5100423A (en) 1990-08-21 1992-03-31 Medical Engineering & Development Institute, Inc. Ablation catheter
AU664157B2 (en) 1990-09-14 1995-11-09 American Medical Systems, Inc. Combined hyperthermia and dilation catheter
US5170803A (en) 1990-09-28 1992-12-15 Brunswick Biomedical Technologies, Inc. Esophageal displacement electrode
US5053033A (en) 1990-10-10 1991-10-01 Boston Advanced Technologies, Inc. Inhibition of restenosis by ultraviolet radiation
US5030645A (en) 1990-10-15 1991-07-09 Merck & Co., Inc. Method of treating asthma using (S)-α-fluoromethyl-histidine and esters thereof
US5105826A (en) 1990-10-26 1992-04-21 Medtronic, Inc. Implantable defibrillation electrode and method of manufacture
US5174288A (en) 1990-11-30 1992-12-29 Medtronic, Inc. Method and apparatus for cardiac defibrillation
US5165420A (en) 1990-12-21 1992-11-24 Ballard Medical Products Bronchoalveolar lavage catheter
US5224491A (en) 1991-01-07 1993-07-06 Medtronic, Inc. Implantable electrode for location within a blood vessel
US5170802A (en) 1991-01-07 1992-12-15 Medtronic, Inc. Implantable electrode for location within a blood vessel
US5324255A (en) 1991-01-11 1994-06-28 Baxter International Inc. Angioplasty and ablative devices having onboard ultrasound components and devices and methods for utilizing ultrasound to treat or prevent vasopasm
US5409453A (en) 1992-08-12 1995-04-25 Vidamed, Inc. Steerable medical probe with stylets
US5415166A (en) 1991-02-15 1995-05-16 Cardiac Pathways Corporation Endocardial mapping apparatus and cylindrical semiconductor device mounting structure for use therewith and method
US5345936A (en) 1991-02-15 1994-09-13 Cardiac Pathways Corporation Apparatus with basket assembly for endocardial mapping
US5465717A (en) 1991-02-15 1995-11-14 Cardiac Pathways Corporation Apparatus and Method for ventricular mapping and ablation
RU2091054C1 (en) 1991-03-25 1997-09-27 Владивостокский государственный медицинский университет Method for treating asthmatic bronchitis in children affected with constitutional diathesis
US5116864A (en) 1991-04-09 1992-05-26 Indiana University Foundation Method for preventing restenosis following reconfiguration of body vessels
EP0588988A4 (en) 1991-04-10 1996-08-07 British Tech Group Usa Defibrillator and demand pacer catheter and method
US5405362A (en) 1991-04-29 1995-04-11 The Board Of Regents For The University Of Texas System Interactive external defibrillation and drug injection system
US5239982A (en) 1991-06-07 1993-08-31 Baxter International Inc. Catheter depth gauge and method of use
US5213576A (en) 1991-06-11 1993-05-25 Cordis Corporation Therapeutic porous balloon catheter
US5379765A (en) 1991-06-12 1995-01-10 Kajiwara; Nagao Monitoring apparatus for use in obtaining bronchial electrocardiogram
US5255678A (en) 1991-06-21 1993-10-26 Ecole Polytechnique Mapping electrode balloon
US5383917A (en) 1991-07-05 1995-01-24 Jawahar M. Desai Device and method for multi-phase radio-frequency ablation
JPH0522345A (en) 1991-07-12 1993-01-29 Hitachi Ltd Optimum management decision system for maximum transfer unit
WO1993001862A1 (en) 1991-07-22 1993-02-04 Cyberonics, Inc. Treatment of respiratory disorders by nerve stimulation
GB9120306D0 (en) 1991-09-24 1991-11-06 Graham Herbert K Method and compositions for the treatment of cerebral palsy
JPH05121329A (en) 1991-10-30 1993-05-18 Toshiba Corp Method and apparatus for manufacturing compound thin film
US5405366A (en) 1991-11-12 1995-04-11 Nepera, Inc. Adhesive hydrogels having extended use lives and process for the preparation of same
DE4140689B4 (en) 1991-12-10 2007-11-22 Boehringer Ingelheim Kg Inhalable powders and process for their preparation
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
US5658549A (en) 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
ATE204743T1 (en) 1991-12-18 2001-09-15 Minnesota Mining & Mfg AEROSOL COMPOSITIONS FOR MEDICINAL SUSPENSIONS
CA2058179C (en) 1991-12-20 1999-02-09 Roland Drolet Basic electrophysiological conditioning system and method
FR2685208B1 (en) 1991-12-23 1998-02-27 Ela Medical Sa VENTRICULAR CANNULA DEVICE.
US5366443A (en) 1992-01-07 1994-11-22 Thapliyal And Eggers Partners Method and apparatus for advancing catheters through occluded body lumens
US6159194A (en) 1992-01-07 2000-12-12 Arthrocare Corporation System and method for electrosurgical tissue contraction
US6053172A (en) 1995-06-07 2000-04-25 Arthrocare Corporation Systems and methods for electrosurgical sinus surgery
US5231996A (en) 1992-01-28 1993-08-03 Medtronic, Inc. Removable endocardial lead
RU2053814C1 (en) 1992-02-11 1996-02-10 Новиков Валерий Николаевич Method for treatment of local endobronchitis
US5555883A (en) 1992-02-24 1996-09-17 Avitall; Boaz Loop electrode array mapping and ablation catheter for cardiac chambers
US5263493A (en) 1992-02-24 1993-11-23 Boaz Avitall Deflectable loop electrode array mapping and ablation catheter for cardiac chambers
US5344398A (en) 1992-02-25 1994-09-06 Japan Crescent, Inc. Heated balloon catheter
US5540681A (en) 1992-04-10 1996-07-30 Medtronic Cardiorhythm Method and system for radiofrequency ablation of tissue
US5269758A (en) 1992-04-29 1993-12-14 Taheri Syde A Intravascular catheter and method for treatment of hypothermia
US5443470A (en) 1992-05-01 1995-08-22 Vesta Medical, Inc. Method and apparatus for endometrial ablation
US5331947A (en) 1992-05-01 1994-07-26 Shturman Cardiology Systems, Inc. Inflatable sheath for introduction of ultrasonic catheter through the lumen of a fiber optic endoscope
US5255679A (en) 1992-06-02 1993-10-26 Cardiac Pathways Corporation Endocardial catheter for mapping and/or ablation with an expandable basket structure having means for providing selective reinforcement and pressure sensing mechanism for use therewith, and method
US5281218A (en) 1992-06-05 1994-01-25 Cardiac Pathways Corporation Catheter having needle electrode for radiofrequency ablation
US5324284A (en) 1992-06-05 1994-06-28 Cardiac Pathways, Inc. Endocardial mapping and ablation system utilizing a separately controlled ablation catheter and method
US5271383A (en) 1992-06-05 1993-12-21 Wilk Peter J Method for reducing intussusception
US5772590A (en) 1992-06-30 1998-06-30 Cordis Webster, Inc. Cardiovascular catheter with laterally stable basket-shaped electrode array with puller wire
US5782239A (en) 1992-06-30 1998-07-21 Cordis Webster, Inc. Unique electrode configurations for cardiovascular electrode catheter with built-in deflection method and central puller wire
US5411025A (en) 1992-06-30 1995-05-02 Cordis Webster, Inc. Cardiovascular catheter with laterally stable basket-shaped electrode array
AU4686993A (en) 1992-07-30 1994-03-03 Temple University - Of The Commonwealth System Of Higher Education Direct manual cardiac compression device and method of use thereof
US5630794A (en) 1992-08-12 1997-05-20 Vidamed, Inc. Catheter tip and method of manufacturing
GB9219102D0 (en) 1992-09-09 1992-10-21 Fairfax Andrew J Flowmeters
US5662108A (en) 1992-09-23 1997-09-02 Endocardial Solutions, Inc. Electrophysiology mapping system
US6647617B1 (en) 1992-09-23 2003-11-18 Graydon Ernest Beatty Method of construction an endocardial mapping catheter
US7189208B1 (en) 1992-09-23 2007-03-13 Endocardial Solutions, Inc. Method for measuring heart electrophysiology
US5553611A (en) 1994-01-06 1996-09-10 Endocardial Solutions, Inc. Endocardial measurement method
US6603996B1 (en) 2000-06-07 2003-08-05 Graydon Ernest Beatty Software for mapping potential distribution of a heart chamber
US5311866A (en) 1992-09-23 1994-05-17 Endocardial Therapeutics, Inc. Heart mapping catheter
DE69315354T2 (en) 1992-09-23 1998-03-19 Endocardial Solutions Inc ENDOCARD-MAPPING SYSTEM
US6240307B1 (en) 1993-09-23 2001-05-29 Endocardial Solutions, Inc. Endocardial mapping system
US7930012B2 (en) 1992-09-23 2011-04-19 St. Jude Medical, Atrial Fibrillation Division, Inc. Chamber location method
US5309910A (en) 1992-09-25 1994-05-10 Ep Technologies, Inc. Cardiac mapping and ablation systems
US5313943A (en) 1992-09-25 1994-05-24 Ep Technologies, Inc. Catheters and methods for performing cardiac diagnosis and treatment
US5293869A (en) 1992-09-25 1994-03-15 Ep Technologies, Inc. Cardiac probe with dynamic support for maintaining constant surface contact during heart systole and diastole
US5471982A (en) 1992-09-29 1995-12-05 Ep Technologies, Inc. Cardiac mapping and ablation systems
US6086581A (en) 1992-09-29 2000-07-11 Ep Technologies, Inc. Large surface cardiac ablation catheter that assumes a low profile during introduction into the heart
DE669839T1 (en) 1992-10-01 1996-10-10 Cardiac Pacemakers STENT-LIKE STRUCTURE FOR DEFLICTION ELECTRODES.
WO1994007446A1 (en) 1992-10-05 1994-04-14 Boston Scientific Corporation Device and method for heating tissue
US5431696A (en) 1992-10-13 1995-07-11 Atlee, Iii; John L. Esophageal probe for transeophageal cardiac stimulation
US5807306A (en) 1992-11-09 1998-09-15 Cortrak Medical, Inc. Polymer matrix drug delivery apparatus
US5391197A (en) 1992-11-13 1995-02-21 Dornier Medical Systems, Inc. Ultrasound thermotherapy probe
US5956501A (en) 1997-01-10 1999-09-21 Health Hero Network, Inc. Disease simulation system and method
US5348554A (en) 1992-12-01 1994-09-20 Cardiac Pathways Corporation Catheter for RF ablation with cooled electrode
US5545161A (en) 1992-12-01 1996-08-13 Cardiac Pathways Corporation Catheter for RF ablation having cooled electrode with electrically insulated sleeve
US5256141A (en) 1992-12-22 1993-10-26 Nelson Gencheff Biological material deployment method and apparatus
US5393207A (en) 1993-01-21 1995-02-28 Nimbus, Inc. Blood pump with disposable rotor assembly
US5409483A (en) 1993-01-22 1995-04-25 Jeffrey H. Reese Direct visualization surgical probe
US5797960A (en) 1993-02-22 1998-08-25 Stevens; John H. Method and apparatus for thoracoscopic intracardiac procedures
JP3423719B2 (en) 1993-03-16 2003-07-07 ボストン サイエンティフィック リミテッド Multiple electrode support mechanism
US5893847A (en) 1993-03-16 1999-04-13 Ep Technologies, Inc. Multiple electrode support structures with slotted hub and hoop spline elements
US5823189A (en) 1993-03-16 1998-10-20 Ep Technologies, Inc. Multiple electrode support structures with spline elements and over-molded hub
US5725525A (en) 1993-03-16 1998-03-10 Ep Technologies, Inc. Multiple electrode support structures with integral hub and spline elements
WO1994021170A1 (en) 1993-03-16 1994-09-29 Ep Technologies, Inc. Flexible circuit assemblies employing ribbon cable
US5409710A (en) 1993-04-20 1995-04-25 Endocon, Inc. Foam cell drug delivery
US5417687A (en) 1993-04-30 1995-05-23 Medical Scientific, Inc. Bipolar electrosurgical trocar
US6749604B1 (en) 1993-05-10 2004-06-15 Arthrocare Corporation Electrosurgical instrument with axially-spaced electrodes
US5456667A (en) 1993-05-20 1995-10-10 Advanced Cardiovascular Systems, Inc. Temporary stenting catheter with one-piece expandable segment
JPH06339453A (en) 1993-06-01 1994-12-13 Olympus Optical Co Ltd Cover-equipped endoscope device
ES2329232T3 (en) 1993-06-10 2009-11-24 Allergan, Inc. TREATMENT OF NEUROMUSCULAR DISORDERS AND AFFECTIONS WITH A DIFFERENT BOTULINIC SEROTYPE.
FI96815C (en) 1993-06-23 1996-08-26 Nokia Telecommunications Oy Procedure for making a call
US5860974A (en) 1993-07-01 1999-01-19 Boston Scientific Corporation Heart ablation catheter with expandable electrode and method of coupling energy to an electrode on a catheter shaft
WO1995001751A1 (en) 1993-07-01 1995-01-19 Boston Scientific Corporation Imaging, electrical potential sensing, and ablation catheters
US5571088A (en) 1993-07-01 1996-11-05 Boston Scientific Corporation Ablation catheters
GB9314640D0 (en) 1993-07-15 1993-08-25 Salim Aws S M Tunnellimg catheter
US5422362A (en) 1993-07-29 1995-06-06 Quadra Logic Technologies, Inc. Method to inhibit restenosis
US5490521A (en) 1993-08-31 1996-02-13 Medtronic, Inc. Ultrasound biopsy needle
US5507791A (en) 1993-08-31 1996-04-16 Sit'ko; Sergei P. Microwave resonance therapy
US5396887A (en) 1993-09-23 1995-03-14 Cardiac Pathways Corporation Apparatus and method for detecting contact pressure
US6947785B1 (en) 1993-09-23 2005-09-20 Endocardial Solutions, Inc. Interface system for endocardial mapping catheter
US5908446A (en) 1994-07-07 1999-06-01 Cardiac Pathways Corporation Catheter assembly, catheter and multi-port introducer for use therewith
US5607462A (en) 1993-09-24 1997-03-04 Cardiac Pathways Corporation Catheter assembly, catheter and multi-catheter introducer for use therewith
US5626618A (en) 1993-09-24 1997-05-06 The Ohio State University Mechanical adjunct to cardiopulmonary resuscitation (CPR), and an electrical adjunct to defibrillation countershock, cardiac pacing, and cardiac monitoring
US5415656A (en) 1993-09-28 1995-05-16 American Medical Systems, Inc. Electrosurgical apparatus
US5496312A (en) 1993-10-07 1996-03-05 Valleylab Inc. Impedance and temperature generator control
US5400783A (en) 1993-10-12 1995-03-28 Cardiac Pathways Corporation Endocardial mapping apparatus with rotatable arm and method
US5437665A (en) 1993-10-12 1995-08-01 Munro; Malcolm G. Electrosurgical loop electrode instrument for laparoscopic surgery
US5582609A (en) 1993-10-14 1996-12-10 Ep Technologies, Inc. Systems and methods for forming large lesions in body tissue using curvilinear electrode elements
US5881727A (en) 1993-10-14 1999-03-16 Ep Technologies, Inc. Integrated cardiac mapping and ablation probe
US5991650A (en) 1993-10-15 1999-11-23 Ep Technologies, Inc. Surface coatings for catheters, direct contacting diagnostic and therapeutic devices
US5545193A (en) 1993-10-15 1996-08-13 Ep Technologies, Inc. Helically wound radio-frequency emitting electrodes for creating lesions in body tissue
WO1995010322A1 (en) 1993-10-15 1995-04-20 Ep Technologies, Inc. Creating complex lesion patterns in body tissue
US5470352A (en) 1993-10-29 1995-11-28 Northeastern University Balloon angioplasty device
US5599346A (en) 1993-11-08 1997-02-04 Zomed International, Inc. RF treatment system
US6071280A (en) 1993-11-08 2000-06-06 Rita Medical Systems, Inc. Multiple electrode ablation apparatus
US6641580B1 (en) 1993-11-08 2003-11-04 Rita Medical Systems, Inc. Infusion array ablation apparatus
US5536267A (en) 1993-11-08 1996-07-16 Zomed International Multiple electrode ablation apparatus
US5487385A (en) 1993-12-03 1996-01-30 Avitall; Boaz Atrial mapping and ablation catheter system
US5641326A (en) 1993-12-13 1997-06-24 Angeion Corporation Method and apparatus for independent atrial and ventricular defibrillation
US6986893B2 (en) 1993-12-28 2006-01-17 Allergan, Inc. Method for treating a mucus secretion
US6974578B1 (en) 1993-12-28 2005-12-13 Allergan, Inc. Method for treating secretions and glands using botulinum toxin
US6245040B1 (en) 1994-01-14 2001-06-12 Cordis Corporation Perfusion balloon brace and method of use
US5423812A (en) 1994-01-31 1995-06-13 Ellman; Alan G. Electrosurgical stripping electrode for palatopharynx tissue
AUPM411494A0 (en) 1994-02-25 1994-03-24 Central Sydney Area Health Service Method and device for the provocation of upper or lower airway narrowing and/or the induction of sputum
US6216043B1 (en) 1994-03-04 2001-04-10 Ep Technologies, Inc. Asymmetric multiple electrode support structures
US5394880A (en) 1994-03-17 1995-03-07 Atlee, Iii; John L. Esophageal stethoscope
US5598848A (en) 1994-03-31 1997-02-04 Ep Technologies, Inc. Systems and methods for positioning multiple electrode structures in electrical contact with the myocardium
US5454840A (en) 1994-04-05 1995-10-03 Krakovsky; Alexander A. Potency package
US5766605A (en) 1994-04-15 1998-06-16 Mount Sinai School Of Medicine Of The City University Of New York Treatment of autonomic nerve dysfunction with botulinum toxin
JPH07289557A (en) 1994-04-25 1995-11-07 Inter Noba Kk Heating treatment method of constricted part of blood vessel and local heating type catheter therefor
CA2189004A1 (en) 1994-04-29 1995-11-09 Charles D. Lennox Resecting coagulated tissue
US5458596A (en) 1994-05-06 1995-10-17 Dorsal Orthopedic Corporation Method and apparatus for controlled contraction of soft tissue
US5807308A (en) 1996-02-23 1998-09-15 Somnus Medical Technologies, Inc. Method and apparatus for treatment of air way obstructions
US5843021A (en) * 1994-05-09 1998-12-01 Somnus Medical Technologies, Inc. Cell necrosis apparatus
US6152143A (en) 1994-05-09 2000-11-28 Somnus Medical Technologies, Inc. Method for treatment of air way obstructions
US5547469A (en) 1994-05-13 1996-08-20 Boston Scientific Corporation Apparatus for performing diagnostic and therapeutic modalities in the biliary tree
US5478309A (en) 1994-05-27 1995-12-26 William P. Sweezer, Jr. Catheter system and method for providing cardiopulmonary bypass pump support during heart surgery
NZ272354A (en) 1994-06-17 1997-10-24 Trudell Medical Ltd Catheter system; method and apparatus for delivering an aerosol form of medication to the lungs, details of method and of catheter apparatus
US5836905A (en) 1994-06-20 1998-11-17 Lemelson; Jerome H. Apparatus and methods for gene therapy
US6405732B1 (en) 1994-06-24 2002-06-18 Curon Medical, Inc. Method to treat gastric reflux via the detection and ablation of gastro-esophageal nerves and receptors
US6056744A (en) 1994-06-24 2000-05-02 Conway Stuart Medical, Inc. Sphincter treatment apparatus
US5505730A (en) 1994-06-24 1996-04-09 Stuart D. Edwards Thin layer ablation apparatus
US5843077A (en) 1994-06-24 1998-12-01 Somnus Medical Technologies, Inc. Minimally invasive apparatus for internal ablation of turbinates with surface cooling
US5681308A (en) 1994-06-24 1997-10-28 Stuart D. Edwards Ablation apparatus for cardiac chambers
US5827277A (en) 1994-06-24 1998-10-27 Somnus Medical Technologies, Inc. Minimally invasive apparatus for internal ablation of turbinates
US5746224A (en) 1994-06-24 1998-05-05 Somnus Medical Technologies, Inc. Method for ablating turbinates
US6006755A (en) 1994-06-24 1999-12-28 Edwards; Stuart D. Method to detect and treat aberrant myoelectric activity
US6092528A (en) 1994-06-24 2000-07-25 Edwards; Stuart D. Method to treat esophageal sphincters
US5735846A (en) 1994-06-27 1998-04-07 Ep Technologies, Inc. Systems and methods for ablating body tissue using predicted maximum tissue temperature
ATE257675T1 (en) 1994-06-27 2004-01-15 Boston Scient Ltd NON-LINEAR CONTROL SYSTEMS FOR HEATING AND REMOVING BODY TISSUE
US5680860A (en) 1994-07-07 1997-10-28 Cardiac Pathways Corporation Mapping and/or ablation catheter with coilable distal extremity and method for using same
US5496304A (en) 1994-07-20 1996-03-05 University Of Utah Research Foundation Surgical marking pen
DE4427106A1 (en) 1994-07-30 1996-02-01 Otto Werner Woelky Process for control of tumours and skin cancer
US5623940A (en) 1994-08-02 1997-04-29 S.L.T. Japan Co., Ltd. Catheter apparatus with a sensor
US5454782A (en) 1994-08-11 1995-10-03 Perkins; Rodney C. Translumenal circumferential energy delivery device
US8025661B2 (en) 1994-09-09 2011-09-27 Cardiofocus, Inc. Coaxial catheter instruments for ablation with radiant energy
US5522862A (en) 1994-09-21 1996-06-04 Medtronic, Inc. Method and apparatus for treating obstructive sleep apnea
US5549655A (en) 1994-09-21 1996-08-27 Medtronic, Inc. Method and apparatus for synchronized treatment of obstructive sleep apnea
US5885278A (en) 1994-10-07 1999-03-23 E.P. Technologies, Inc. Structures for deploying movable electrode elements
CA2201881C (en) 1994-10-07 2005-12-06 Sidney D. Fleischman Flexible structures for supporting electrode elements
US5836947A (en) 1994-10-07 1998-11-17 Ep Technologies, Inc. Flexible structures having movable splines for supporting electrode elements
US6142994A (en) 1994-10-07 2000-11-07 Ep Technologies, Inc. Surgical method and apparatus for positioning a diagnostic a therapeutic element within the body
US5740808A (en) 1996-10-28 1998-04-21 Ep Technologies, Inc Systems and methods for guilding diagnostic or therapeutic devices in interior tissue regions
US5722401A (en) 1994-10-19 1998-03-03 Cardiac Pathways Corporation Endocardial mapping and/or ablation catheter probe
US5899882A (en) 1994-10-27 1999-05-04 Novoste Corporation Catheter apparatus for radiation treatment of a desired area in the vascular system of a patient
US5630813A (en) 1994-12-08 1997-05-20 Kieturakis; Maciej J. Electro-cauterizing dissector and method for facilitating breast implant procedure
US5669930A (en) 1994-12-08 1997-09-23 Fuji Systems Corporation Stent for intracorporeal retention
EP2314244A1 (en) 1994-12-13 2011-04-27 Torben Lorentzen An electrosurgical instrument for tissue ablation, an apparatus, and a method for providing a lesion in damaged and diseased tissue from a mammal
US5707336A (en) 1995-01-09 1998-01-13 Cardassist Incorporated Ventricular assist device
IT1277790B1 (en) 1995-02-17 1997-11-12 Tecres Spa METACARPO-FALANGEA AND INTERPHALANGE PROSTHESES FOR HAND OR FOOT JOINTS
US5722416A (en) 1995-02-17 1998-03-03 Ep Technologies, Inc. Systems and methods for analyzing biopotential morphologies in heart tissue to locate potential ablation sites
US5605157A (en) 1995-02-17 1997-02-25 Ep Technologies, Inc. Systems and methods for filtering signals derived from biological events
US5630425A (en) 1995-02-17 1997-05-20 Ep Technologies, Inc. Systems and methods for adaptive filtering artifacts from composite signals
US5595183A (en) 1995-02-17 1997-01-21 Ep Technologies, Inc. Systems and methods for examining heart tissue employing multiple electrode structures and roving electrodes
US5601088A (en) 1995-02-17 1997-02-11 Ep Technologies, Inc. Systems and methods for filtering artifacts from composite signals
US5711305A (en) 1995-02-17 1998-01-27 Ep Technologies, Inc. Systems and methods for acquiring endocardially or epicardially paced electrocardiograms
ATE220307T1 (en) 1995-02-17 2002-07-15 Boston Scient Ltd ARRANGEMENT FOR SEQUENTIAL MEASURING BIOLOGICAL EVENTS
US5792064A (en) 1995-02-17 1998-08-11 Panescu; Dorin Systems and methods for analyzing cardiac biopotential morphologies by cross-correlation
US6409722B1 (en) 1998-07-07 2002-06-25 Medtronic, Inc. Apparatus and method for creating, maintaining, and controlling a virtual electrode used for the ablation of tissue
EP0827383B1 (en) 1995-02-28 2007-05-30 Boston Scientific Corporation Polymer implements for torque transmission
US6106524A (en) 1995-03-03 2000-08-22 Neothermia Corporation Methods and apparatus for therapeutic cauterization of predetermined volumes of biological tissue
US5868740A (en) 1995-03-24 1999-02-09 Board Of Regents-Univ Of Nebraska Method for volumetric tissue ablation
EA000891B1 (en) 1995-04-14 2000-06-26 Глаксо Веллкам Инк. Metered dose inhaler for fluticasone propionate
EP1366777B1 (en) 1995-04-14 2005-06-15 SmithKline Beecham Corporation Metered dose inhaler for salmeterol
US5588812A (en) 1995-04-19 1996-12-31 Nimbus, Inc. Implantable electric axial-flow blood pump
US5707218A (en) 1995-04-19 1998-01-13 Nimbus, Inc. Implantable electric axial-flow blood pump with blood cooled bearing
US5620438A (en) 1995-04-20 1997-04-15 Angiomedics Ii Incorporated Method and apparatus for treating vascular tissue following angioplasty to minimize restenosis
US5678535A (en) 1995-04-21 1997-10-21 Dimarco; Anthony Fortunato Method and apparatus for electrical stimulation of the respiratory muscles to achieve artificial ventilation in a patient
GB9508204D0 (en) 1995-04-21 1995-06-07 Speywood Lab Ltd A novel agent able to modify peripheral afferent function
US5607419A (en) 1995-04-24 1997-03-04 Angiomedics Ii Inc. Method and apparatus for treating vessel wall with UV radiation following angioplasty
DE69606845T2 (en) 1995-04-28 2000-06-15 Target Therapeutics, Inc. High performance catheter with braided element
US5688267A (en) 1995-05-01 1997-11-18 Ep Technologies, Inc. Systems and methods for sensing multiple temperature conditions during tissue ablation
WO1996034570A1 (en) 1995-05-01 1996-11-07 Ep Technologies, Inc. Systems and methods for obtaining desired lesion characteristics while ablating body tissue
US5681280A (en) 1995-05-02 1997-10-28 Heart Rhythm Technologies, Inc. Catheter control system
US6575969B1 (en) 1995-05-04 2003-06-10 Sherwood Services Ag Cool-tip radiofrequency thermosurgery electrode system for tumor ablation
US5755753A (en) 1995-05-05 1998-05-26 Thermage, Inc. Method for controlled contraction of collagen tissue
US5817073A (en) 1995-06-02 1998-10-06 Krespi; Yosef P. Apparatus for administering local anesthetics and therapeutic medications during endoscopic surgery
US5540730A (en) 1995-06-06 1996-07-30 Cyberonics, Inc. Treatment of motility disorders by nerve stimulation
US6363937B1 (en) 1995-06-07 2002-04-02 Arthrocare Corporation System and methods for electrosurgical treatment of the digestive system
US5741248A (en) 1995-06-07 1998-04-21 Temple University-Of The Commonwealth System Of Higher Education Fluorochemical liquid augmented cryosurgery
US6132438A (en) 1995-06-07 2000-10-17 Ep Technologies, Inc. Devices for installing stasis reducing means in body tissue
US6090104A (en) 1995-06-07 2000-07-18 Cordis Webster, Inc. Catheter with a spirally wound flat ribbon electrode
US6837888B2 (en) 1995-06-07 2005-01-04 Arthrocare Corporation Electrosurgical probe with movable return electrode and methods related thereto
US5868737A (en) 1995-06-09 1999-02-09 Engineering Research & Associates, Inc. Apparatus and method for determining ablation
US5697925A (en) 1995-06-09 1997-12-16 Engineering & Research Associates, Inc. Apparatus and method for thermal ablation
JPH0947518A (en) 1995-06-26 1997-02-18 Lederle Japan Ltd Optical fiber laser probe for photodynamic therapy
US5873852A (en) 1995-07-10 1999-02-23 Interventional Technologies Device for injecting fluid into a wall of a blood vessel
US6008211A (en) 1995-07-27 1999-12-28 Pdt Pharmaceuticals, Inc. Photoactivatable compounds comprising benzochlorin and furocoumarin
US6023638A (en) 1995-07-28 2000-02-08 Scimed Life Systems, Inc. System and method for conducting electrophysiological testing using high-voltage energy pulses to stun tissue
WO1997004702A1 (en) 1995-07-28 1997-02-13 Ep Technologies, Inc. Systems and methods for conducting electrophysiological testing using high-voltage energy pulses to stun heart tissue
US5782827A (en) 1995-08-15 1998-07-21 Rita Medical Systems, Inc. Multiple antenna ablation apparatus and method with multiple sensor feedback
US5624439A (en) 1995-08-18 1997-04-29 Somnus Medical Technologies, Inc. Method and apparatus for treatment of air way obstructions
US5660175A (en) 1995-08-21 1997-08-26 Dayal; Bimal Endotracheal device
US6037149A (en) 1995-08-24 2000-03-14 Magainin Pharmaceuticals Inc. DNA encoding human asthma associated factor 1
US6496738B2 (en) 1995-09-06 2002-12-17 Kenneth L. Carr Dual frequency microwave heating apparatus
US6210367B1 (en) 1995-09-06 2001-04-03 Microwave Medical Systems, Inc. Intracorporeal microwave warming method and apparatus
US5848972A (en) 1995-09-15 1998-12-15 Children's Medical Center Corporation Method for endocardial activation mapping using a multi-electrode catheter
US5707400A (en) 1995-09-19 1998-01-13 Cyberonics, Inc. Treating refractory hypertension by nerve stimulation
US5658322A (en) 1995-10-11 1997-08-19 Regeneration Technology Bio-active frequency generator and method
US5891182A (en) 1995-10-11 1999-04-06 Regeneration Tech Bio-active frequency generator and method
AU7328796A (en) 1995-10-11 1997-05-15 Regeneration Technology Bio-active frequency generator and method
DE69531399T2 (en) 1995-10-16 2004-06-09 Sun Medical Technology Research Corp., Suwa artificial heart
US5574059A (en) 1995-10-27 1996-11-12 Cornell Research Foundation, Inc. Treating disorders mediated by vascular smooth muscle cell proliferation
US6198970B1 (en) 1995-10-27 2001-03-06 Esd Limited Liability Company Method and apparatus for treating oropharyngeal respiratory and oral motor neuromuscular disorders with electrical stimulation
US5733316A (en) 1995-10-27 1998-03-31 Dornier Medical Systems, Inc. Organ separation for thermal therapy
US5837001A (en) 1995-12-08 1998-11-17 C. R. Bard Radio frequency energy delivery system for multipolar electrode catheters
US5836874A (en) 1996-04-08 1998-11-17 Ep Technologies, Inc. Multi-function electrode structures for electrically analyzing and heating body tissue
US5891135A (en) 1996-01-19 1999-04-06 Ep Technologies, Inc. Stem elements for securing tubing and electrical wires to expandable-collapsible electrode structures
US5925038A (en) 1996-01-19 1999-07-20 Ep Technologies, Inc. Expandable-collapsible electrode structures for capacitive coupling to tissue
US5846238A (en) 1996-01-19 1998-12-08 Ep Technologies, Inc. Expandable-collapsible electrode structures with distal end steering or manipulation
US5891136A (en) 1996-01-19 1999-04-06 Ep Technologies, Inc. Expandable-collapsible mesh electrode structures
US5871483A (en) 1996-01-19 1999-02-16 Ep Technologies, Inc. Folding electrode structures
US5904711A (en) 1996-02-08 1999-05-18 Heartport, Inc. Expandable thoracoscopic defibrillation catheter system and method
US5695471A (en) 1996-02-20 1997-12-09 Kriton Medical, Inc. Sealless rotary blood pump with passive magnetic radial bearings and blood immersed axial bearings
US5727569A (en) 1996-02-20 1998-03-17 Cardiothoracic Systems, Inc. Surgical devices for imposing a negative pressure to fix the position of cardiac tissue during surgery
US5730726A (en) 1996-03-04 1998-03-24 Klingenstein; Ralph James Apparatus and method for removing fecal impaction
US6033397A (en) 1996-03-05 2000-03-07 Vnus Medical Technologies, Inc. Method and apparatus for treating esophageal varices
US6139527A (en) 1996-03-05 2000-10-31 Vnus Medical Technologies, Inc. Method and apparatus for treating hemorrhoids
US6036687A (en) 1996-03-05 2000-03-14 Vnus Medical Technologies, Inc. Method and apparatus for treating venous insufficiency
US6152899A (en) 1996-03-05 2000-11-28 Vnus Medical Technologies, Inc. Expandable catheter having improved electrode design, and method for applying energy
EP0921765B1 (en) 1996-03-05 2007-05-02 Vnus Medical Technologies, Inc. Vascular catheter-based system for heating tissue
GB9620620D0 (en) 1996-10-03 1996-11-20 Ici Plc Illumination system
US5755760A (en) 1996-03-11 1998-05-26 Medtronic, Inc. Deflectable catheter
NL1002598C2 (en) 1996-03-13 1997-09-17 Bootsman Holding Bv Method and device for processing substrate.
JPH09243837A (en) 1996-03-14 1997-09-19 Hitachi Cable Ltd Laser waveguide
US6458121B1 (en) 1996-03-19 2002-10-01 Diapulse Corporation Of America Apparatus for athermapeutic medical treatments
US5699799A (en) 1996-03-26 1997-12-23 Siemens Corporate Research, Inc. Automatic determination of the curved axis of a 3-D tube-shaped object in image volume
US6258083B1 (en) 1996-03-29 2001-07-10 Eclipse Surgical Technologies, Inc. Viewing surgical scope for minimally invasive procedures
US5863291A (en) 1996-04-08 1999-01-26 Cardima, Inc. Linear ablation assembly
US5694934A (en) 1996-04-17 1997-12-09 Beth Israel Hospital MR studies in which a paramagnetic gas is administered to a living patient
US5979456A (en) 1996-04-22 1999-11-09 Magovern; George J. Apparatus and method for reversibly reshaping a body part
US5733319A (en) 1996-04-25 1998-03-31 Urologix, Inc. Liquid coolant supply system
US6036640A (en) 1996-04-29 2000-03-14 Medtronic, Inc. Device and method for repositioning the heart during surgery
AUPN957296A0 (en) 1996-04-30 1996-05-23 Cardiac Crc Nominees Pty Limited A system for simultaneous unipolar multi-electrode ablation
US6532388B1 (en) 1996-04-30 2003-03-11 Medtronic, Inc. Method and system for endotracheal/esophageal stimulation prior to and during a medical procedure
US6006134A (en) 1998-04-30 1999-12-21 Medtronic, Inc. Method and device for electronically controlling the beating of a heart using venous electrical stimulation of nerve fibers
US5820589A (en) 1996-04-30 1998-10-13 Medtronic, Inc. Implantable non-invasive rate-adjustable pump
US7269457B2 (en) 1996-04-30 2007-09-11 Medtronic, Inc. Method and system for vagal nerve stimulation with multi-site cardiac pacing
US6735471B2 (en) 1996-04-30 2004-05-11 Medtronic, Inc. Method and system for endotracheal/esophageal stimulation prior to and during a medical procedure
US5861022A (en) 1996-04-30 1999-01-19 Hipskind; S. Gregory Method for the treatment of hiccups
US7022105B1 (en) 1996-05-06 2006-04-04 Novasys Medical Inc. Treatment of tissue in sphincters, sinuses and orifices
US5810807A (en) 1996-05-22 1998-09-22 Ganz; Robert A. Sphincterotome with deflectable cutting plane and method of using the same
US5669932A (en) 1996-05-29 1997-09-23 Isostent, Inc. Means for accurately positioning an expandable stent
US5976709A (en) 1996-05-31 1999-11-02 Hitachi Kinzoku Kabushiki Kaisha Aluminum alloy member, with insert provided therein, possessing improved damping capacity and process for producing the same
CN1096283C (en) 1996-05-31 2002-12-18 松浦优之 Low frequency therapy method, apparatus and system
US5782797A (en) 1996-06-06 1998-07-21 Scimed Life Systems, Inc. Therapeutic infusion device
GB2314273B (en) 1996-06-17 2000-09-27 Spes The use of TCET in the prophylaxis and treatment of allergies
US5800486A (en) 1996-06-17 1998-09-01 Urologix, Inc. Device for transurethral thermal therapy with cooling balloon
US6743197B1 (en) 1996-07-10 2004-06-01 Novasys Medical, Inc. Treatment of discrete tissues in respiratory, urinary, circulatory, reproductive and digestive systems
JPH1026709A (en) 1996-07-11 1998-01-27 Harufumi Kato Device for laterally irradiating with laser beam
US5882346A (en) 1996-07-15 1999-03-16 Cardiac Pathways Corporation Shapable catheter using exchangeable core and method of use
US5919172A (en) 1996-07-17 1999-07-06 Becton, Dickinson And Company Hypodermic needle having a differential surface finish
US7440800B2 (en) 1996-08-19 2008-10-21 Mr3 Medical, Llc System and method for managing detrimental cardiac remodeling
US5755714A (en) 1996-09-17 1998-05-26 Eclipse Surgical Technologies, Inc. Shaped catheter for transmyocardial revascularization
US5855577A (en) 1996-09-17 1999-01-05 Eclipse Surgical Technologies, Inc. Bow shaped catheter
US5906636A (en) 1996-09-20 1999-05-25 Texas Heart Institute Heat treatment of inflamed tissue
US6464697B1 (en) 1998-02-19 2002-10-15 Curon Medical, Inc. Stomach and adjoining tissue regions in the esophagus
US5891027A (en) 1996-10-21 1999-04-06 Irvine Biomedical, Inc. Cardiovascular catheter system with an inflatable soft tip
US6016437A (en) 1996-10-21 2000-01-18 Irvine Biomedical, Inc. Catheter probe system with inflatable soft shafts
WO1998018170A1 (en) 1996-10-23 1998-04-30 Tdk Corporation Method for manufacturing electrode for battery
US5848969A (en) 1996-10-28 1998-12-15 Ep Technologies, Inc. Systems and methods for visualizing interior tissue regions using expandable imaging structures
US5722403A (en) 1996-10-28 1998-03-03 Ep Technologies, Inc. Systems and methods using a porous electrode for ablating and visualizing interior tissue regions
US5779669A (en) 1996-10-28 1998-07-14 C. R. Bard, Inc. Steerable catheter with fixed curve
US5752518A (en) 1996-10-28 1998-05-19 Ep Technologies, Inc. Systems and methods for visualizing interior regions of the body
US5904651A (en) 1996-10-28 1999-05-18 Ep Technologies, Inc. Systems and methods for visualizing tissue during diagnostic or therapeutic procedures
US5908445A (en) 1996-10-28 1999-06-01 Ep Technologies, Inc. Systems for visualizing interior tissue regions including an actuator to move imaging element
WO1998018391A1 (en) 1996-10-30 1998-05-07 Ekos Corporation Intraluminal wall drug delivery device
US5919147A (en) 1996-11-01 1999-07-06 Jain; Krishna M. Method and apparatus for measuring the vascular diameter of a vessel
US6197013B1 (en) 1996-11-06 2001-03-06 Setagon, Inc. Method and apparatus for drug and gene delivery
US6091995A (en) 1996-11-08 2000-07-18 Surx, Inc. Devices, methods, and systems for shrinking tissues
US6480746B1 (en) 1997-08-13 2002-11-12 Surx, Inc. Noninvasive devices, methods, and systems for shrinking of tissues
US5833651A (en) 1996-11-08 1998-11-10 Medtronic, Inc. Therapeutic intraluminal stents
US6081749A (en) 1997-08-13 2000-06-27 Surx, Inc. Noninvasive devices, methods, and systems for shrinking of tissues
US6073052A (en) 1996-11-15 2000-06-06 Zelickson; Brian D. Device and method for treatment of gastroesophageal reflux disease
GB9626960D0 (en) 1996-12-27 1997-02-12 Glaxo Group Ltd Valve for aerosol container
US5730741A (en) 1997-02-07 1998-03-24 Eclipse Surgical Technologies, Inc. Guided spiral catheter
US5873865A (en) 1997-02-07 1999-02-23 Eclipse Surgical Technologies, Inc. Spiral catheter with multiple guide holes
US6056769A (en) 1997-02-11 2000-05-02 Biointerventional Corporation Expansile device for use in blood vessels and tracts in the body and tension application device for use therewith and method
US5882329A (en) 1997-02-12 1999-03-16 Prolifix Medical, Inc. Apparatus and method for removing stenotic material from stents
JP4052690B2 (en) 1997-02-19 2008-02-27 株式会社エス・エフ・シー Shiatsu type water heater
US7591814B2 (en) * 1997-02-27 2009-09-22 Cryocath Technologies Inc. Extended treatment zone catheter
US5999855A (en) 1997-02-28 1999-12-07 Dimarco; Anthony F. Method and apparatus for electrical activation of the expiratory muscles to restore cough
US5897554A (en) 1997-03-01 1999-04-27 Irvine Biomedical, Inc. Steerable catheter having a loop electrode
US7220257B1 (en) 2000-07-25 2007-05-22 Scimed Life Systems, Inc. Cryotreatment device and method
US6063078A (en) 1997-03-12 2000-05-16 Medtronic, Inc. Method and apparatus for tissue ablation
US5954661A (en) 1997-03-31 1999-09-21 Thomas Jefferson University Tissue characterization and treatment using pacing
US7992572B2 (en) 1998-06-10 2011-08-09 Asthmatx, Inc. Methods of evaluating individuals having reversible obstructive pulmonary disease
US7425212B1 (en) 1998-06-10 2008-09-16 Asthmatx, Inc. Devices for modification of airways by transfer of energy
US6083255A (en) 1997-04-07 2000-07-04 Broncus Technologies, Inc. Bronchial stenter
US6273907B1 (en) 1997-04-07 2001-08-14 Broncus Technologies, Inc. Bronchial stenter
US6411852B1 (en) 1997-04-07 2002-06-25 Broncus Technologies, Inc. Modification of airways by application of energy
US6200333B1 (en) 1997-04-07 2001-03-13 Broncus Technologies, Inc. Bronchial stenter
US5972026A (en) 1997-04-07 1999-10-26 Broncus Technologies, Inc. Bronchial stenter having diametrically adjustable electrodes
US6283988B1 (en) 1997-04-07 2001-09-04 Broncus Technologies, Inc. Bronchial stenter having expandable electrodes
US7027869B2 (en) 1998-01-07 2006-04-11 Asthmatx, Inc. Method for treating an asthma attack
US6488673B1 (en) 1997-04-07 2002-12-03 Broncus Technologies, Inc. Method of increasing gas exchange of a lung
US6634363B1 (en) 1997-04-07 2003-10-21 Broncus Technologies, Inc. Methods of treating lungs having reversible obstructive pulmonary disease
US5876340A (en) 1997-04-17 1999-03-02 Irvine Biomedical, Inc. Ablation apparatus with ultrasonic imaging capabilities
US5861014A (en) 1997-04-30 1999-01-19 Medtronic, Inc. Method and apparatus for sensing a stimulating gastrointestinal tract on-demand
US6012457A (en) 1997-07-08 2000-01-11 The Regents Of The University Of California Device and method for forming a circumferential conduction block in a pulmonary vein
US5971983A (en) 1997-05-09 1999-10-26 The Regents Of The University Of California Tissue ablation device and method of use
US6024740A (en) 1997-07-08 2000-02-15 The Regents Of The University Of California Circumferential ablation device assembly
US6416740B1 (en) 1997-05-13 2002-07-09 Bristol-Myers Squibb Medical Imaging, Inc. Acoustically active drug delivery systems
US6217576B1 (en) 1997-05-19 2001-04-17 Irvine Biomedical Inc. Catheter probe for treating focal atrial fibrillation in pulmonary veins
US6050992A (en) 1997-05-19 2000-04-18 Radiotherapeutics Corporation Apparatus and method for treating tissue with multiple electrodes
US7255693B1 (en) 1997-05-23 2007-08-14 Csa Medical, Inc. Heated catheter used in cryotherapy
US5876399A (en) 1997-05-28 1999-03-02 Irvine Biomedical, Inc. Catheter system and methods thereof
US6201023B1 (en) 1997-06-10 2001-03-13 Agrogene Ltd. Methods and compositions to protect crops against plant parasitic nematodes
EP0998248A4 (en) 1997-06-13 2001-03-21 Arthrocare Corp Electrosurgical systems and methods for recanalization of occluded body lumens
US6251109B1 (en) 1997-06-27 2001-06-26 Daig Corporation Process and device for the treatment of atrial arrhythmia
US5957919A (en) 1997-07-02 1999-09-28 Laufer; Michael D. Bleb reducer
US6117101A (en) 1997-07-08 2000-09-12 The Regents Of The University Of California Circumferential ablation device assembly
US6652515B1 (en) 1997-07-08 2003-11-25 Atrionix, Inc. Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall
US6547788B1 (en) 1997-07-08 2003-04-15 Atrionx, Inc. Medical device with sensor cooperating with expandable member
US6500174B1 (en) 1997-07-08 2002-12-31 Atrionix, Inc. Circumferential ablation device assembly and methods of use and manufacture providing an ablative circumferential band along an expandable member
US6139571A (en) 1997-07-09 2000-10-31 Fuller Research Corporation Heated fluid surgical instrument
US6010500A (en) 1997-07-21 2000-01-04 Cardiac Pathways Corporation Telescoping apparatus and method for linear lesion ablation
US6014579A (en) 1997-07-21 2000-01-11 Cardiac Pathways Corp. Endocardial mapping catheter with movable electrode
US6626903B2 (en) 1997-07-24 2003-09-30 Rex Medical, L.P. Surgical biopsy device
AUPO826597A0 (en) 1997-07-25 1997-08-21 Platt, Harry Louis Cardiac patient remote monitoring apparatus
US6711436B1 (en) 1997-08-08 2004-03-23 Duke University Compositions, apparatus and methods for facilitating surgical procedures
WO1999007354A2 (en) 1997-08-08 1999-02-18 Duke University Compositions, apparatus and methods for facilitating surgical procedures
US5891138A (en) 1997-08-11 1999-04-06 Irvine Biomedical, Inc. Catheter system having parallel electrodes
US5916235A (en) 1997-08-13 1999-06-29 The Regents Of The University Of California Apparatus and method for the use of detachable coils in vascular aneurysms and body cavities
US9023031B2 (en) 1997-08-13 2015-05-05 Verathon Inc. Noninvasive devices, methods, and systems for modifying tissues
ATE326913T1 (en) 1997-08-13 2006-06-15 Solarant Medical Inc NON-INVASIVE DEVICES AND SYSTEMS FOR SHRINKING TISSUES
US6479523B1 (en) 1997-08-26 2002-11-12 Emory University Pharmacologic drug combination in vagal-induced asystole
US6063768A (en) 1997-09-04 2000-05-16 First; Eric R. Application of botulinum toxin to the management of neurogenic inflammatory disorders
US5964782A (en) 1997-09-18 1999-10-12 Scimed Life Systems, Inc. Closure device and method
US5954717A (en) 1997-09-25 1999-09-21 Radiotherapeutics Corporation Method and system for heating solid tissue
US6045549A (en) 1997-09-30 2000-04-04 Somnus Medical Technologies, Inc. Tissue ablation apparatus and device for use therein and method
EP0908713A1 (en) 1997-10-06 1999-04-14 Claud S. Gordon Company Temperature instrumented semiconductor wafer
US5893835A (en) 1997-10-10 1999-04-13 Ethicon Endo-Surgery, Inc. Ultrasonic clamp coagulator apparatus having dual rotational positioning
US6645200B1 (en) 1997-10-10 2003-11-11 Scimed Life Systems, Inc. Method and apparatus for positioning a diagnostic or therapeutic element within the body and tip electrode for use with same
US6071281A (en) 1998-05-05 2000-06-06 Ep Technologies, Inc. Surgical method and apparatus for positioning a diagnostic or therapeutic element within the body and remote power control unit for use with same
US5893887A (en) 1997-10-14 1999-04-13 Iowa-India Investments Company Limited Stent for positioning at junction of bifurcated blood vessel and method of making
WO1999027991A1 (en) 1997-11-28 1999-06-10 Matsura Masayuki Method of wave therapy and apparatus therefor
US5971979A (en) 1997-12-02 1999-10-26 Odyssey Technologies, Inc. Method for cryogenic inhibition of hyperplasia
US6917834B2 (en) 1997-12-03 2005-07-12 Boston Scientific Scimed, Inc. Devices and methods for creating lesions in endocardial and surrounding tissue to isolate focal arrhythmia substrates
JP3980140B2 (en) 1997-12-04 2007-09-26 村越 寧根 Therapeutic instrument
US6464680B1 (en) 1998-07-29 2002-10-15 Pharmasonics, Inc. Ultrasonic enhancement of drug injection
US7921855B2 (en) 1998-01-07 2011-04-12 Asthmatx, Inc. Method for treating an asthma attack
DE69941252D1 (en) 1998-01-14 2009-09-24 Ams Res Corp RIBBED ELECTRODES
US6440128B1 (en) 1998-01-14 2002-08-27 Curon Medical, Inc. Actively cooled electrode assemblies for forming lesions to treat dysfunction in sphincters and adjoining tissue regions
WO1999035988A1 (en) 1998-01-14 1999-07-22 Conway-Stuart Medical, Inc. Electrosurgical device for sphincter treatment
AU2317899A (en) 1998-01-14 1999-08-02 Conway-Stuart Medical, Inc. Gerd treatment apparatus and method
US6200311B1 (en) 1998-01-20 2001-03-13 Eclipse Surgical Technologies, Inc. Minimally invasive TMR device
US6231595B1 (en) 1998-03-31 2001-05-15 Innercool Therapies, Inc. Circulating fluid hypothermia method and apparatus
US6447505B2 (en) 1998-02-11 2002-09-10 Cosman Company, Inc. Balloon catheter method for intra-urethral radio-frequency urethral enlargement
US6273886B1 (en) 1998-02-19 2001-08-14 Curon Medical, Inc. Integrated tissue heating and cooling apparatus
US6358245B1 (en) 1998-02-19 2002-03-19 Curon Medical, Inc. Graphical user interface for association with an electrode structure deployed in contact with a tissue region
US6258087B1 (en) 1998-02-19 2001-07-10 Curon Medical, Inc. Expandable electrode assemblies for forming lesions to treat dysfunction in sphincters and adjoining tissue regions
US7165551B2 (en) 1998-02-19 2007-01-23 Curon Medical, Inc. Apparatus to detect and treat aberrant myoelectric activity
US8906010B2 (en) 1998-02-19 2014-12-09 Mederi Therapeutics, Inc. Graphical user interface for association with an electrode structure deployed in contact with a tissue region
US6402744B2 (en) 1998-02-19 2002-06-11 Curon Medical, Inc. Systems and methods for forming composite lesions to treat dysfunction in sphincters and adjoining tissue regions
US6325798B1 (en) 1998-02-19 2001-12-04 Curon Medical, Inc. Vacuum-assisted systems and methods for treating sphincters and adjoining tissue regions
US6423058B1 (en) 1998-02-19 2002-07-23 Curon Medical, Inc. Assemblies to visualize and treat sphincters and adjoining tissue regions
US6355031B1 (en) 1998-02-19 2002-03-12 Curon Medical, Inc. Control systems for multiple electrode arrays to create lesions in tissue regions at or near a sphincter
CA2319517A1 (en) * 1998-02-19 1999-08-26 Curon Medical, Inc. Electrosurgical sphincter treatment apparatus
US20100114087A1 (en) 1998-02-19 2010-05-06 Edwards Stuart D Methods and devices for treating urinary incontinence
US6142993A (en) 1998-02-27 2000-11-07 Ep Technologies, Inc. Collapsible spline structure using a balloon as an expanding actuator
JP2002505138A (en) 1998-03-06 2002-02-19 キューロン メディカル,インコーポレイテッド Instrument for electrosurgically treating the esophageal sphincter
AU3104999A (en) 1998-03-19 1999-10-11 Oratec Interventions, Inc. Catheter for delivery of energy to a surgical site
US6053909A (en) 1998-03-27 2000-04-25 Shadduck; John H. Ionothermal delivery system and technique for medical procedures
US8128595B2 (en) 1998-04-21 2012-03-06 Zoll Circulation, Inc. Method for a central venous line catheter having a temperature control system
US6338727B1 (en) 1998-08-13 2002-01-15 Alsius Corporation Indwelling heat exchange catheter and method of using same
WO1999055245A1 (en) 1998-04-30 1999-11-04 Edwards Stuart D Electrosurgical sphincter treatment apparatus
US6003517A (en) 1998-04-30 1999-12-21 Ethicon Endo-Surgery, Inc. Method for using an electrosurgical device on lung tissue
US6161047A (en) 1998-04-30 2000-12-12 Medtronic Inc. Apparatus and method for expanding a stimulation lead body in situ
US6045550A (en) 1998-05-05 2000-04-04 Cardiac Peacemakers, Inc. Electrode having non-joined thermocouple for providing multiple temperature-sensitive junctions
US6558378B2 (en) 1998-05-05 2003-05-06 Cardiac Pacemakers, Inc. RF ablation system and method having automatic temperature control
US6493589B1 (en) 1998-05-07 2002-12-10 Medtronic, Inc. Methods and apparatus for treatment of pulmonary conditions
US6001054A (en) 1998-05-19 1999-12-14 Regulla; D. F. Method and apparatus for differential energy application for local dose enhancement of ionizing radiation
US6241727B1 (en) 1998-05-27 2001-06-05 Irvine Biomedical, Inc. Ablation catheter system having circular lesion capabilities
US6599311B1 (en) 1998-06-05 2003-07-29 Broncus Technologies, Inc. Method and assembly for lung volume reduction
US6174323B1 (en) 1998-06-05 2001-01-16 Broncus Technologies, Inc. Method and assembly for lung volume reduction
US6997189B2 (en) 1998-06-05 2006-02-14 Broncus Technologies, Inc. Method for lung volume reduction
US5997534A (en) 1998-06-08 1999-12-07 Tu; Hosheng Medical ablation device and methods thereof
US20070123958A1 (en) 1998-06-10 2007-05-31 Asthmatx, Inc. Apparatus for treating airways in the lung
US8181656B2 (en) 1998-06-10 2012-05-22 Asthmatx, Inc. Methods for treating airways
US7198635B2 (en) 2000-10-17 2007-04-03 Asthmatx, Inc. Modification of airways by application of energy
US20070106348A1 (en) 1998-06-10 2007-05-10 Asthmatx, Inc. Method for treating airways in the lung
US7187973B2 (en) 1998-06-30 2007-03-06 Endocardial Solutions, Inc. Congestive heart failure pacing optimization method and device
US6322559B1 (en) 1998-07-06 2001-11-27 Vnus Medical Technologies, Inc. Electrode catheter having coil structure
US5995873A (en) 1998-07-07 1999-11-30 Rhodes; Donald A. Treatment of pain and of the nervous system
US6029091A (en) 1998-07-09 2000-02-22 Irvine Biomedical, Inc. Catheter system having lattice electrodes
US6296639B1 (en) 1999-02-12 2001-10-02 Novacept Apparatuses and methods for interstitial tissue removal
US6212433B1 (en) 1998-07-28 2001-04-03 Radiotherapeutics Corporation Method for treating tumors near the surface of an organ
US6322584B2 (en) 1998-07-31 2001-11-27 Surx, Inc. Temperature sensing devices and methods to shrink tissues
US6366813B1 (en) 1998-08-05 2002-04-02 Dilorenzo Daniel J. Apparatus and method for closed-loop intracranical stimulation for optimal control of neurological disease
US5992419A (en) 1998-08-20 1999-11-30 Mmtc, Inc. Method employing a tissue-heating balloon catheter to produce a "biological stent" in an orifice or vessel of a patient's body
US6610083B2 (en) 1998-08-24 2003-08-26 Radiant Medical, Inc. Multiple lumen heat exchange catheters
US6673098B1 (en) 1998-08-24 2004-01-06 Radiant Medical, Inc. Disposable cassette for intravascular heat exchange catheter
GB9818548D0 (en) 1998-08-25 1998-10-21 Microbiological Res Authority Treatment of mucas hypersecretion
US5980563A (en) 1998-08-31 1999-11-09 Tu; Lily Chen Ablation apparatus and methods for treating atherosclerosis
US6123702A (en) 1998-09-10 2000-09-26 Scimed Life Systems, Inc. Systems and methods for controlling power in an electrosurgical probe
US6245065B1 (en) 1998-09-10 2001-06-12 Scimed Life Systems, Inc. Systems and methods for controlling power in an electrosurgical probe
US6183468B1 (en) 1998-09-10 2001-02-06 Scimed Life Systems, Inc. Systems and methods for controlling power in an electrosurgical probe
US6123703A (en) 1998-09-19 2000-09-26 Tu; Lily Chen Ablation catheter and methods for treating tissues
US6036689A (en) 1998-09-24 2000-03-14 Tu; Lily Chen Ablation device for treating atherosclerotic tissues
WO2000016684A1 (en) 1998-09-24 2000-03-30 Super Dimension Ltd. System and method for determining the location of a catheter during an intra-body medical procedure
US20040006268A1 (en) 1998-09-24 2004-01-08 Super Dimension Ltd Was Filed In Parent Case System and method of recording and displaying in context of an image a location of at least one point-of-interest in a body during an intra-body medical procedure
US20030074011A1 (en) 1998-09-24 2003-04-17 Super Dimension Ltd. System and method of recording and displaying in context of an image a location of at least one point-of-interest in a body during an intra-body medical procedure
IL126333A0 (en) 1998-09-24 1999-05-09 Super Dimension Ltd System and method of recording and displaying in context of an image a location of at least one point-of-interest in body during an intra-body medical procedure
US20040230252A1 (en) 1998-10-21 2004-11-18 Saul Kullok Method and apparatus for affecting the autonomic nervous system
US7076307B2 (en) 2002-05-09 2006-07-11 Boveja Birinder R Method and system for modulating the vagus nerve (10th cranial nerve) with electrical pulses using implanted and external components, to provide therapy neurological and neuropsychiatric disorders
US6366814B1 (en) 1998-10-26 2002-04-02 Birinder R. Boveja External stimulator for adjunct (add-on) treatment for neurological, neuropsychiatric, and urological disorders
US6123718A (en) 1998-11-02 2000-09-26 Polymerex Medical Corp. Balloon catheter
AU1727400A (en) 1998-11-16 2000-06-05 United States Surgical Corporation Apparatus for thermal treatment of tissue
KR20010040761A (en) 1998-12-09 2001-05-15 쿡 인코포레이티드 Hollow, Curved, Superelastic Medical Needle
WO2000040281A1 (en) 1999-01-06 2000-07-13 United States Surgical Corporation Tissue mapping injection device
US6269813B1 (en) 1999-01-15 2001-08-07 Respironics, Inc. Tracheal gas insufflation bypass and phasic delivery system and method
US6230052B1 (en) 1999-01-29 2001-05-08 Andy Wolff Device and method for stimulating salivation
US6097985A (en) 1999-02-09 2000-08-01 Kai Technologies, Inc. Microwave systems for medical hyperthermia, thermotherapy and diagnosis
US6293908B1 (en) 1999-02-12 2001-09-25 Fuji Photo Optical Co., Ltd. Mouthpiece and insertion assisting device for endoscope
US6019783A (en) 1999-03-02 2000-02-01 Alsius Corporation Cooling system for therapeutic catheter
US6582427B1 (en) 1999-03-05 2003-06-24 Gyrus Medical Limited Electrosurgery system
US6161049A (en) 1999-03-26 2000-12-12 Urologix, Inc. Thermal therapy catheter
JP2000271235A (en) 1999-03-26 2000-10-03 Olympus Optical Co Ltd Prostate-treating apparatus
US6786889B1 (en) 1999-03-31 2004-09-07 Scimed Life Systems, Inc Textured and/or marked balloon for stent delivery
US6425877B1 (en) 1999-04-02 2002-07-30 Novasys Medical, Inc. Treatment of tissue in the digestive circulatory respiratory urinary and reproductive systems
US6409723B1 (en) 1999-04-02 2002-06-25 Stuart D. Edwards Treating body tissue by applying energy and substances
US6325797B1 (en) 1999-04-05 2001-12-04 Medtronic, Inc. Ablation catheter and method for isolating a pulmonary vein
US6546932B1 (en) 1999-04-05 2003-04-15 Cryocath Technologies Inc. Cryogenic method and apparatus for promoting angiogenesis
US20010007070A1 (en) * 1999-04-05 2001-07-05 Medtronic, Inc. Ablation catheter assembly and method for isolating a pulmonary vein
US6776990B2 (en) 1999-04-08 2004-08-17 Allergan, Inc. Methods and compositions for the treatment of pancreatitis
US6593130B1 (en) 1999-04-16 2003-07-15 The Regents Of The University Of California Method and apparatus for ex vivo and in vivo cellular electroporation of gene protein or drug therapy
US6317615B1 (en) 1999-04-19 2001-11-13 Cardiac Pacemakers, Inc. Method and system for reducing arterial restenosis in the presence of an intravascular stent
US6149647A (en) 1999-04-19 2000-11-21 Tu; Lily Chen Apparatus and methods for tissue treatment
US6939346B2 (en) 1999-04-21 2005-09-06 Oratec Interventions, Inc. Method and apparatus for controlling a temperature-controlled probe
US6270476B1 (en) 1999-04-23 2001-08-07 Cryocath Technologies, Inc. Catheter
US6302870B1 (en) 1999-04-29 2001-10-16 Precision Vascular Systems, Inc. Apparatus for injecting fluids into the walls of blood vessels, body cavities, and the like
US6341236B1 (en) 1999-04-30 2002-01-22 Ivan Osorio Vagal nerve stimulation techniques for treatment of epileptic seizures
WO2000069376A1 (en) 1999-05-18 2000-11-23 Silhouette Medical Inc. Surgical weight control device
US7171263B2 (en) 1999-06-04 2007-01-30 Impulse Dynamics Nv Drug delivery device
DK1185200T3 (en) 1999-06-05 2008-04-07 Wilson Cook Medical Inc Characteristics of an endoscopic medical device
US6235024B1 (en) 1999-06-21 2001-05-22 Hosheng Tu Catheters system having dual ablation capability
EP1281366B1 (en) 1999-06-23 2006-10-11 Novasys Medical, Inc. Treatment of sphincters with electrosurgery and active substances
ATE470414T1 (en) 1999-06-25 2010-06-15 Vahid Saadat TISSUE TREATMENT DEVICE
WO2001000273A1 (en) 1999-06-25 2001-01-04 Emory University Devices and methods for vagus nerve stimulation
RU2164424C1 (en) 1999-06-28 2001-03-27 Коноплев Сергей Петрович Method and device for applying low frequency electromagnetic therapy
US6238392B1 (en) 1999-06-29 2001-05-29 Ethicon Endo-Surgery, Inc. Bipolar electrosurgical instrument including a plurality of balloon electrodes
US6361554B1 (en) 1999-06-30 2002-03-26 Pharmasonics, Inc. Methods and apparatus for the subcutaneous delivery of acoustic vibrations
US6587719B1 (en) 1999-07-01 2003-07-01 Cyberonics, Inc. Treatment of obesity by bilateral vagus nerve stimulation
US6364878B1 (en) 1999-07-07 2002-04-02 Cardiac Pacemakers, Inc. Percutaneous transluminal ablation catheter manipulation tool
US6200332B1 (en) 1999-07-09 2001-03-13 Ceramoptec Industries, Inc. Device and method for underskin laser treatments
US20030070676A1 (en) 1999-08-05 2003-04-17 Cooper Joel D. Conduits having distal cage structure for maintaining collateral channels in tissue and related methods
US20050137715A1 (en) 1999-08-05 2005-06-23 Broncus Technologies, Inc. Methods and devices for maintaining patency of surgically created channels in a body organ
US6749606B2 (en) 1999-08-05 2004-06-15 Thomas Keast Devices for creating collateral channels
US7815590B2 (en) 1999-08-05 2010-10-19 Broncus Technologies, Inc. Devices for maintaining patency of surgically created channels in tissue
US20050060044A1 (en) 1999-08-05 2005-03-17 Ed Roschak Methods and devices for maintaining patency of surgically created channels in a body organ
EP1143864B1 (en) 1999-08-05 2004-02-04 Broncus Technologies, Inc. Methods and devices for creating collateral channels in the lungs
US7462162B2 (en) 2001-09-04 2008-12-09 Broncus Technologies, Inc. Antiproliferative devices for maintaining patency of surgically created channels in a body organ
US20050177144A1 (en) 1999-08-05 2005-08-11 Broncus Technologies, Inc. Methods and devices for maintaining patency of surgically created channels in a body organ
US6712812B2 (en) 1999-08-05 2004-03-30 Broncus Technologies, Inc. Devices for creating collateral channels
US7422563B2 (en) 1999-08-05 2008-09-09 Broncus Technologies, Inc. Multifunctional tip catheter for applying energy to tissue and detecting the presence of blood flow
US20030130657A1 (en) 1999-08-05 2003-07-10 Tom Curtis P. Devices for applying energy to tissue
US7422584B2 (en) 2002-07-05 2008-09-09 Broncus Technologies, Inc. Extrapleural airway device and method
US7022088B2 (en) 1999-08-05 2006-04-04 Broncus Technologies, Inc. Devices for applying energy to tissue
US7175644B2 (en) 2001-02-14 2007-02-13 Broncus Technologies, Inc. Devices and methods for maintaining collateral channels in tissue
US6767544B2 (en) 2002-04-01 2004-07-27 Allergan, Inc. Methods for treating cardiovascular diseases with botulinum toxin
US6315778B1 (en) 1999-09-10 2001-11-13 C. R. Bard, Inc. Apparatus for creating a continuous annular lesion
US6264653B1 (en) 1999-09-24 2001-07-24 C. R. Band, Inc. System and method for gauging the amount of electrode-tissue contact using pulsed radio frequency energy
WO2001022897A1 (en) 1999-09-28 2001-04-05 Novasys Medical, Inc. Treatment of tissue by application of energy and drugs
US6338836B1 (en) 1999-09-28 2002-01-15 Siemens Aktiengesellschaft Asthma analysis method employing hyperpolarized gas and magnetic resonance imaging
US7229469B1 (en) 1999-10-02 2007-06-12 Quantumcor, Inc. Methods for treating and repairing mitral valve annulus
US20030069570A1 (en) 1999-10-02 2003-04-10 Witzel Thomas H. Methods for repairing mitral valve annulus percutaneously
US20040249401A1 (en) 1999-10-05 2004-12-09 Omnisonics Medical Technologies, Inc. Apparatus and method for an ultrasonic medical device with a non-compliant balloon
US6587718B2 (en) 1999-10-08 2003-07-01 Scimed Life Systems, Inc. Iontophoretic delivery to heart tissue
US6265379B1 (en) 1999-10-13 2001-07-24 Allergan Sales, Inc. Method for treating otic disorders
US6287304B1 (en) 1999-10-15 2001-09-11 Neothermia Corporation Interstitial cauterization of tissue volumes with electrosurgically deployed electrodes
US6838429B2 (en) 1999-10-22 2005-01-04 Paslin David A Atopic dermatitis treatment method
DE19952505A1 (en) 1999-10-29 2001-05-03 Gerd Hausdorf An expandable balloon for medical use comprises a thin-walled polymer shell coated with radio-opaque material in a pattern and is expandable on introduction of liquid and increasing pressure
US6303509B1 (en) 1999-10-29 2001-10-16 Taiwan Semiconductor Manufacturing Company Method to calibrate the wafer transfer for oxide etcher (with clamp)
US20040215235A1 (en) 1999-11-16 2004-10-28 Barrx, Inc. Methods and systems for determining physiologic characteristics for treatment of the esophagus
US20040215296A1 (en) 1999-11-16 2004-10-28 Barrx, Inc. System and method for treating abnormal epithelium in an esophagus
US20060095032A1 (en) 1999-11-16 2006-05-04 Jerome Jackson Methods and systems for determining physiologic characteristics for treatment of the esophagus
CA2388861C (en) 1999-11-16 2013-09-03 Robert A. Ganz System and method of treating abnormal tissue in the human esophagus
US6529756B1 (en) 1999-11-22 2003-03-04 Scimed Life Systems, Inc. Apparatus for mapping and coagulating soft tissue in or around body orifices
US6626855B1 (en) 1999-11-26 2003-09-30 Therus Corpoation Controlled high efficiency lesion formation using high intensity ultrasound
US6752765B1 (en) 1999-12-01 2004-06-22 Medtronic, Inc. Method and apparatus for monitoring heart rate and abnormal respiration
US6139845A (en) 1999-12-07 2000-10-31 Allergan Sales, Inc. Method for treating cancer with a neurotoxin
US6719694B2 (en) 1999-12-23 2004-04-13 Therus Corporation Ultrasound transducers for imaging and therapy
US6547776B1 (en) 2000-01-03 2003-04-15 Curon Medical, Inc. Systems and methods for treating tissue in the crura
US7483743B2 (en) 2000-01-11 2009-01-27 Cedars-Sinai Medical Center System for detecting, diagnosing, and treating cardiovascular disease
US6451013B1 (en) * 2000-01-19 2002-09-17 Medtronic Xomed, Inc. Methods of tonsil reduction using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions
US6356787B1 (en) 2000-02-24 2002-03-12 Electro Core Techniques, Llc Method of treating facial blushing by electrical stimulation of the sympathetic nerve chain
US6438423B1 (en) 2000-01-20 2002-08-20 Electrocore Technique, Llc Method of treating complex regional pain syndromes by electrical stimulation of the sympathetic nerve chain
US6885888B2 (en) 2000-01-20 2005-04-26 The Cleveland Clinic Foundation Electrical stimulation of the sympathetic nerve chain
US6356786B1 (en) 2000-01-20 2002-03-12 Electrocore Techniques, Llc Method of treating palmar hyperhydrosis by electrical stimulation of the sympathetic nervous chain
US6589235B2 (en) 2000-01-21 2003-07-08 The Regents Of The University Of California Method and apparatus for cartilage reshaping by radiofrequency heating
US20030050591A1 (en) 2000-02-08 2003-03-13 Patrick Mchale Anthony Loading system and method for using the same
US6663622B1 (en) 2000-02-11 2003-12-16 Iotek, Inc. Surgical devices and methods for use in tissue ablation procedures
US6524580B1 (en) 2000-02-15 2003-02-25 Allergan Sales, Inc. Method for treating thyroid disorders
US6773711B2 (en) 2000-02-15 2004-08-10 Allergan, Inc. Botulinum toxin therapy for Hashimoto's thyroiditis
US6649161B1 (en) 2000-02-22 2003-11-18 Allergan, Inc. Method for treating hypocalcemia
US6723091B2 (en) 2000-02-22 2004-04-20 Gyrus Medical Limited Tissue resurfacing
US6708064B2 (en) 2000-02-24 2004-03-16 Ali R. Rezai Modulation of the brain to affect psychiatric disorders
US6551274B2 (en) 2000-02-29 2003-04-22 Biosense Webster, Inc. Cryoablation catheter with an expandable cooling chamber
US6394956B1 (en) 2000-02-29 2002-05-28 Scimed Life Systems, Inc. RF ablation and ultrasound catheter for crossing chronic total occlusions
US6679264B1 (en) 2000-03-04 2004-01-20 Emphasys Medical, Inc. Methods and devices for use in performing pulmonary procedures
US6544226B1 (en) 2000-03-13 2003-04-08 Curon Medical, Inc. Operative devices that can be removably fitted on catheter bodies to treat tissue regions in the body
US6770070B1 (en) 2000-03-17 2004-08-03 Rita Medical Systems, Inc. Lung treatment apparatus and method
US8251070B2 (en) 2000-03-27 2012-08-28 Asthmatx, Inc. Methods for treating airways
US6514290B1 (en) 2000-03-31 2003-02-04 Broncus Technologies, Inc. Lung elastic recoil restoring or tissue compressing device and method
US20010031981A1 (en) 2000-03-31 2001-10-18 Evans Michael A. Method and device for locating guidewire and treating chronic total occlusions
US6673068B1 (en) 2000-04-12 2004-01-06 Afx, Inc. Electrode arrangement for use in a medical instrument
US20060100666A1 (en) 2000-04-20 2006-05-11 Pulmosonix Pty. Ltd. Apparatus and method for lung analysis
AU2001255713A1 (en) 2000-04-25 2001-11-07 Harumi Naganuma Noninvasive detection and activation of the lymphatic system in treating diseaseand alleviating pain
US6652517B1 (en) 2000-04-25 2003-11-25 Uab Research Foundation Ablation catheter, system, and method of use thereof
US20010044596A1 (en) 2000-05-10 2001-11-22 Ali Jaafar Apparatus and method for treatment of vascular restenosis by electroporation
US6599288B2 (en) * 2000-05-16 2003-07-29 Atrionix, Inc. Apparatus and method incorporating an ultrasound transducer onto a delivery member
US8914114B2 (en) 2000-05-23 2014-12-16 The Feinstein Institute For Medical Research Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
US6610713B2 (en) 2000-05-23 2003-08-26 North Shore - Long Island Jewish Research Institute Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
US6306423B1 (en) 2000-06-02 2001-10-23 Allergan Sales, Inc. Neurotoxin implant
US6306403B1 (en) 2000-06-14 2001-10-23 Allergan Sales, Inc. Method for treating parkinson's disease with a botulinum toxin
EP1365800B1 (en) 2000-06-28 2013-03-06 Ira Sanders Methods for using tetanus toxin for benificial purposes in animals (mammals)
US6477396B1 (en) 2000-07-07 2002-11-05 Biosense Webster, Inc. Mapping and ablation catheter
EP1299035B1 (en) 2000-07-13 2013-02-13 ReCor Medical, Inc. Thermal treatment apparatus with focussed energy application
EP2430997A3 (en) 2000-07-13 2014-05-07 ReCor Medical, Inc. Ultrasonic emitter with reflective interface
US20030125786A1 (en) 2000-07-13 2003-07-03 Gliner Bradford Evan Methods and apparatus for effectuating a lasting change in a neural-function of a patient
EP1172445A1 (en) 2000-07-14 2002-01-16 Praenadia GmbH A method for direct genetic analysis of target cells by using fluorescence probes
US6903187B1 (en) 2000-07-21 2005-06-07 Allergan, Inc. Leucine-based motif and clostridial neurotoxins
IT1319170B1 (en) 2000-07-28 2003-09-26 Lorenzo Piccone APPARATUS ABLE TO MODULATE THE NEUROVEGETATIVE SYSTEM AND INTEGRATE ITS ACTION WITH THAT OF THE CENTRAL NERVOUS SYSTEM:
JP2002078809A (en) 2000-09-07 2002-03-19 Shutaro Satake Balloon catheter for electrically isolating pulmonary vein
US6640120B1 (en) 2000-10-05 2003-10-28 Scimed Life Systems, Inc. Probe assembly for mapping and ablating pulmonary vein tissue and method of using same
JP2002112946A (en) 2000-10-11 2002-04-16 Olympus Optical Co Ltd Hood for endoscope
PT1292281E (en) 2000-10-12 2004-11-30 Boehringer Ingelheim Pharma NEW POSSESSION FOR INHALATION CONTAINING TIOTROPIO
US6908928B2 (en) 2000-10-12 2005-06-21 Bi Pharma Kg. Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
UA75375C2 (en) 2000-10-12 2006-04-17 Boehringer Ingelheim Pharma Method for producing powdery preparations for inhaling
US6475160B1 (en) 2000-10-13 2002-11-05 Nathan Sher Skin testing device
CA2426144C (en) 2000-10-17 2010-08-10 Broncus Technologies, Inc. Modification of airways by application of energy
US7104987B2 (en) 2000-10-17 2006-09-12 Asthmatx, Inc. Control system and process for application of energy to airway walls and other mediums
US6549808B1 (en) 2000-10-19 2003-04-15 Heinz R. Gisel Devices and methods for the transcutaneous delivery of ions and the electrical stimulation of tissue and cells at targeted areas in the eye
US6827931B1 (en) 2000-10-20 2004-12-07 Allergan, Inc. Method for treating endocrine disorders
US6601581B1 (en) 2000-11-01 2003-08-05 Advanced Medical Applications, Inc. Method and device for ultrasound drug delivery
US6575623B2 (en) 2000-11-10 2003-06-10 Cardiostream, Inc. Guide wire having extendable contact sensors for measuring temperature of vessel walls
US6847849B2 (en) 2000-11-15 2005-01-25 Medtronic, Inc. Minimally invasive apparatus for implanting a sacral stimulation lead
US20040087936A1 (en) 2000-11-16 2004-05-06 Barrx, Inc. System and method for treating abnormal tissue in an organ having a layered tissue structure
AT5005U1 (en) 2000-11-21 2002-02-25 Ernst Biegler Ges M B H ELECTRODESY SYSTEM FOR ELECTRICAL PUNCTUAL STIMULATION THERAPY AND HANDLING TOOL THEREFOR
US6633779B1 (en) 2000-11-27 2003-10-14 Science Medicus, Inc. Treatment of asthma and respiratory disease by means of electrical neuro-receptive waveforms
US6681136B2 (en) 2000-12-04 2004-01-20 Science Medicus, Inc. Device and method to modulate blood pressure by electrical waveforms
US7785323B2 (en) 2000-12-04 2010-08-31 Boston Scientific Scimed, Inc. Loop structure including inflatable therapeutic device
US6676657B2 (en) 2000-12-07 2004-01-13 The United States Of America As Represented By The Department Of Health And Human Services Endoluminal radiofrequency cauterization system
US20020087151A1 (en) 2000-12-29 2002-07-04 Afx, Inc. Tissue ablation apparatus with a sliding ablation instrument and method
US20020143373A1 (en) 2001-01-25 2002-10-03 Courtnage Peter A. System and method for therapeutic application of energy
US6735475B1 (en) 2001-01-30 2004-05-11 Advanced Bionics Corporation Fully implantable miniature neurostimulator for stimulation as a therapy for headache and/or facial pain
US6989004B2 (en) 2001-02-28 2006-01-24 Rex Medical, L.P. Apparatus for delivering ablation fluid to treat lesions
US7101384B2 (en) 2001-03-08 2006-09-05 Tru-Light Corporation Light processing of selected body components
US6723053B2 (en) 2001-03-14 2004-04-20 Coopersurgical, Inc. Esophageal balloon catheter device
WO2002074385A2 (en) 2001-03-20 2002-09-26 Bruce R. Gilbert, M.D., Ph.D., P.C. Device for surface stimulation of acupuncture points
US6699243B2 (en) 2001-09-19 2004-03-02 Curon Medical, Inc. Devices, systems and methods for treating tissue regions of the body
US20050283197A1 (en) 2001-04-10 2005-12-22 Daum Douglas R Systems and methods for hypotension
US6666858B2 (en) 2001-04-12 2003-12-23 Scimed Life Systems, Inc. Cryo balloon for atrial ablation
US20040243118A1 (en) 2001-06-01 2004-12-02 Ayers Gregory M. Device and method for positioning a catheter tip for creating a cryogenic lesion
US6620159B2 (en) 2001-06-06 2003-09-16 Scimed Life Systems, Inc. Conductive expandable electrode body and method of manufacturing the same
US7127284B2 (en) 2001-06-11 2006-10-24 Mercator Medsystems, Inc. Electroporation microneedle and methods for its use
US20020198574A1 (en) 2001-06-22 2002-12-26 Ron Gumpert Automatic sobriety training and reconditioning system
EP1271384A1 (en) 2001-06-28 2003-01-02 Boehringer Ingelheim International GmbH System and method for assisting in diagnosis, therapy and/or monitoring of a funtional lung disease
JP4602602B2 (en) 2001-07-19 2010-12-22 オリンパス株式会社 Medical instruments
US20060167498A1 (en) 2001-07-23 2006-07-27 Dilorenzo Daniel J Method, apparatus, and surgical technique for autonomic neuromodulation for the treatment of disease
DE50202789D1 (en) 2001-07-27 2005-05-19 Impella Cardiotech Ag NEUROSTIMULATION UNIT FOR THE IMMOBILIZATION OF THE HEART DURING CARDIOSURGICAL OPERATIONS
US6622047B2 (en) 2001-07-28 2003-09-16 Cyberonics, Inc. Treatment of neuropsychiatric disorders by near-diaphragmatic nerve stimulation
HU224941B1 (en) 2001-08-10 2006-04-28 Bgi Innovacios Kft Phototerapy apparatus
US6994706B2 (en) 2001-08-13 2006-02-07 Minnesota Medical Physics, Llc Apparatus and method for treatment of benign prostatic hyperplasia
US6827718B2 (en) 2001-08-14 2004-12-07 Scimed Life Systems, Inc. Method of and apparatus for positioning and maintaining the position of endoscopic instruments
US7734355B2 (en) 2001-08-31 2010-06-08 Bio Control Medical (B.C.M.) Ltd. Treatment of disorders by unidirectional nerve stimulation
US20050060041A1 (en) 2001-09-04 2005-03-17 Broncus Technologies, Inc. Methods and devices for maintaining surgically created channels in a body organ
WO2003020103A2 (en) 2001-09-04 2003-03-13 Amit Technology Science & Medicine Ltd. Method of and device for therapeutic illumination of internal organs and tissues
US20050060042A1 (en) 2001-09-04 2005-03-17 Broncus Technologies, Inc. Methods and devices for maintaining surgically created channels in a body organ
US7708712B2 (en) 2001-09-04 2010-05-04 Broncus Technologies, Inc. Methods and devices for maintaining patency of surgically created channels in a body organ
US20050137611A1 (en) 2001-09-04 2005-06-23 Broncus Technologies, Inc. Methods and devices for maintaining surgically created channels in a body organ
US6802843B2 (en) 2001-09-13 2004-10-12 Csaba Truckai Electrosurgical working end with resistive gradient electrodes
US6623742B2 (en) 2001-09-17 2003-09-23 Allergan, Inc. Methods for treating fibromyalgia
US7187964B2 (en) 2001-09-27 2007-03-06 Dirar S. Khoury Cardiac catheter imaging system
JP3607231B2 (en) 2001-09-28 2005-01-05 有限会社日本エレクテル High frequency heating balloon catheter
US6635056B2 (en) 2001-10-09 2003-10-21 Cardiac Pacemakers, Inc. RF ablation apparatus and method using amplitude control
US6671533B2 (en) 2001-10-11 2003-12-30 Irvine Biomedical Inc. System and method for mapping and ablating body tissue of the interior region of the heart
US6934583B2 (en) 2001-10-22 2005-08-23 Pacesetter, Inc. Implantable lead and method for stimulating the vagus nerve
US6895267B2 (en) 2001-10-24 2005-05-17 Scimed Life Systems, Inc. Systems and methods for guiding and locating functional elements on medical devices positioned in a body
US6669693B2 (en) 2001-11-13 2003-12-30 Mayo Foundation For Medical Education And Research Tissue ablation device and methods of using
US6692492B2 (en) 2001-11-28 2004-02-17 Cardiac Pacemaker, Inc. Dielectric-coated ablation electrode having a non-coated window with thermal sensors
US7591818B2 (en) 2001-12-04 2009-09-22 Endoscopic Technologies, Inc. Cardiac ablation devices and methods
US6893436B2 (en) 2002-01-03 2005-05-17 Afx, Inc. Ablation instrument having a flexible distal portion
WO2003059336A1 (en) 2002-01-18 2003-07-24 Tatton Technologies, Llc. Methods for treating eye disorders
US7473273B2 (en) 2002-01-22 2009-01-06 Medtronic Vascular, Inc. Stent assembly with therapeutic agent exterior banding
US20080147137A1 (en) 2002-01-23 2008-06-19 Biocontrol Medical Ltd. Inhibition of sympathetic nerves
US20030153905A1 (en) 2002-01-25 2003-08-14 Edwards Stuart Denzil Selective ablation system
US6695761B2 (en) 2002-01-30 2004-02-24 Biomed Solutions, Llc Apparatus for assisting a heart
US6814733B2 (en) * 2002-01-31 2004-11-09 Biosense, Inc. Radio frequency pulmonary vein isolation
AU2003212870A1 (en) 2002-02-01 2003-09-02 The Cleveland Clinic Foundation Methods of affecting hypothalamic-related conditions
AU2003241269A1 (en) 2002-02-01 2003-09-09 The Cleveland Clinic Foundation Neurostimulation for affecting sleep disorders
US7477945B2 (en) 2002-02-01 2009-01-13 The Cleveland Clinic Foundation Delivery device for stimulating the sympathetic nerve chain
US20110306997A9 (en) 2002-02-21 2011-12-15 Roschak Edmund J Devices for creating passages and sensing for blood vessels
US6937896B1 (en) 2002-02-26 2005-08-30 Pacesetter, Inc. Sympathetic nerve stimulator and/or pacemaker
GB0204525D0 (en) 2002-02-27 2002-04-10 Whale Jon Medical therapy apparatus
US20030225443A1 (en) 2002-03-13 2003-12-04 Kanthi Kiran Methods and devices for modulating atrial configuration
US20030187430A1 (en) 2002-03-15 2003-10-02 Vorisek James C. System and method for measuring power at tissue during RF ablation
US7309707B2 (en) 2002-03-20 2007-12-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
US7689276B2 (en) 2002-09-13 2010-03-30 Leptos Biomedical, Inc. Dynamic nerve stimulation for treatment of disorders
US7239912B2 (en) 2002-03-22 2007-07-03 Leptos Biomedical, Inc. Electric modulation of sympathetic nervous system
US6755849B1 (en) 2002-03-28 2004-06-29 Board Of Regents, The University Of Texas System Method for delivering energy to tissue and apparatus
US6978174B2 (en) 2002-04-08 2005-12-20 Ardian, Inc. Methods and devices for renal nerve blocking
US7620451B2 (en) 2005-12-29 2009-11-17 Ardian, Inc. Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach
US20080213331A1 (en) 2002-04-08 2008-09-04 Ardian, Inc. Methods and devices for renal nerve blocking
US8774913B2 (en) 2002-04-08 2014-07-08 Medtronic Ardian Luxembourg S.A.R.L. Methods and apparatus for intravasculary-induced neuromodulation
US7653438B2 (en) 2002-04-08 2010-01-26 Ardian, Inc. Methods and apparatus for renal neuromodulation
US20070129761A1 (en) 2002-04-08 2007-06-07 Ardian, Inc. Methods for treating heart arrhythmia
US8131371B2 (en) 2002-04-08 2012-03-06 Ardian, Inc. Methods and apparatus for monopolar renal neuromodulation
US20070135875A1 (en) 2002-04-08 2007-06-14 Ardian, Inc. Methods and apparatus for thermally-induced renal neuromodulation
US7617005B2 (en) 2002-04-08 2009-11-10 Ardian, Inc. Methods and apparatus for thermally-induced renal neuromodulation
US7853333B2 (en) 2002-04-08 2010-12-14 Ardian, Inc. Methods and apparatus for multi-vessel renal neuromodulation
US8150519B2 (en) 2002-04-08 2012-04-03 Ardian, Inc. Methods and apparatus for bilateral renal neuromodulation
US8150520B2 (en) 2002-04-08 2012-04-03 Ardian, Inc. Methods for catheter-based renal denervation
US7756583B2 (en) 2002-04-08 2010-07-13 Ardian, Inc. Methods and apparatus for intravascularly-induced neuromodulation
US8347891B2 (en) 2002-04-08 2013-01-08 Medtronic Ardian Luxembourg S.A.R.L. Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen
US7162303B2 (en) 2002-04-08 2007-01-09 Ardian, Inc. Renal nerve stimulation method and apparatus for treatment of patients
US8145317B2 (en) 2002-04-08 2012-03-27 Ardian, Inc. Methods for renal neuromodulation
US6953431B2 (en) 2002-04-11 2005-10-11 University Of South Florida Eccentric dilation balloons for use with endoscopes
WO2003088820A2 (en) 2002-04-19 2003-10-30 Broncus Technologies, Inc. Devices for maintaining surgically created openings
US7141041B2 (en) 2003-03-19 2006-11-28 Mercator Medsystems, Inc. Catheters having laterally deployable needles
DE10218894A1 (en) 2002-04-26 2003-11-13 Storz Endoskop Prod Gmbh Device for monitoring medical devices
US7326697B2 (en) 2002-04-29 2008-02-05 Corcept Therapeutics, Inc. Methods for increasing the therapeutic response to electroconvulsive therapy
AU2003222424A1 (en) 2002-05-02 2003-11-17 Medigus Ltd. Entry port for endoscopes and laparoscopes
EP1515775A4 (en) 2002-05-07 2010-03-03 Oncostim Inc Method and device for treating concer with electrical therapy in conjunction with chemotherapeutic agents and radiation therapy
US6921538B2 (en) 2002-05-10 2005-07-26 Allergan, Inc. Therapeutic treatments for neuropsychiatric disorders
AUPS226402A0 (en) 2002-05-13 2002-06-13 Advanced Metal Coatings Pty Limited An ablation catheter
US6898557B2 (en) 2002-05-17 2005-05-24 Hewlett-Packard Development Company, Lp. System and method for remote testing of components
WO2003097095A1 (en) 2002-05-20 2003-11-27 Chemstop Pty Ltd Process for the preparation and activation of substances and a means of producing same
US20040028676A1 (en) 2002-08-06 2004-02-12 Klein Dean A. Swallowing system tissue modifier
US7292890B2 (en) 2002-06-20 2007-11-06 Advanced Bionics Corporation Vagus nerve stimulation via unidirectional propagation of action potentials
US6776991B2 (en) 2002-06-26 2004-08-17 Allergan, Inc. Methods for treating priapism
US6881213B2 (en) 2002-06-28 2005-04-19 Ethicon, Inc. Device and method to expand treatment array
US20040009180A1 (en) 2002-07-11 2004-01-15 Allergan, Inc. Transdermal botulinum toxin compositions
US6866662B2 (en) 2002-07-23 2005-03-15 Biosense Webster, Inc. Ablation catheter having stabilizing array
US6878156B1 (en) 2002-07-26 2005-04-12 Alsius Corporation Portable cooler for heat exchange catheter
US6852110B2 (en) 2002-08-01 2005-02-08 Solarant Medical, Inc. Needle deployment for temperature sensing from an electrode
US7393350B2 (en) 2002-08-06 2008-07-01 Erbe Elektromedizin Gmbh Cryo-surgical apparatus and methods
US6733464B2 (en) 2002-08-23 2004-05-11 Hewlett-Packard Development Company, L.P. Multi-function sensor device and methods for its use
US7328069B2 (en) 2002-09-06 2008-02-05 Medtronic, Inc. Method, system and device for treating disorders of the pelvic floor by electrical stimulation of and the delivery of drugs to the left and right pudendal nerves
US6780183B2 (en) 2002-09-16 2004-08-24 Biosense Webster, Inc. Ablation catheter having shape-changing balloon
WO2004033034A1 (en) 2002-10-04 2004-04-22 Microchips, Inc. Medical device for neural stimulation and controlled drug delivery
US7037319B2 (en) 2002-10-15 2006-05-02 Scimed Life Systems, Inc. Nanotube paper-based medical device
US6755026B2 (en) 2002-10-24 2004-06-29 Tech Medical Devices Inc. Thermoelectric system to directly regulate the temperature of intravenous solutions and bodily fluids
US20040082947A1 (en) 2002-10-25 2004-04-29 The Regents Of The University Of Michigan Ablation catheters
US7066950B2 (en) 2002-10-31 2006-06-27 Cherokee Products, Inc. Vapor therapy treatment device and method for generating therapeutic vapor treatment
US20050222651A1 (en) 2002-10-31 2005-10-06 Cherokee Products, Inc Therapeutic device and method
US7536339B1 (en) 2002-10-31 2009-05-19 Trading Technologies International, Inc. Method and system for quantity entry
US7238357B2 (en) 2002-11-05 2007-07-03 Allergan, Inc. Methods for treating ulcers and gastroesophageal reflux disease
US20040153056A1 (en) 2002-11-11 2004-08-05 Berchtold Holding Gmbh, A German Corporation Probe
US20040106954A1 (en) 2002-11-15 2004-06-03 Whitehurst Todd K. Treatment of congestive heart failure
US7142917B2 (en) 2002-12-04 2006-11-28 Terumo Kabushiki Kaisha Heart treatment equipment and method for preventing fatal arrhythmia
US7986994B2 (en) 2002-12-04 2011-07-26 Medtronic, Inc. Method and apparatus for detecting change in intrathoracic electrical impedance
US7065409B2 (en) 2002-12-13 2006-06-20 Cardiac Pacemakers, Inc. Device communications of an implantable medical device and an external system
NZ540425A (en) 2002-12-20 2009-03-31 Botulinum Toxin Res Ass Inc Pharmaceutical botulinum toxin compositions
US7131445B2 (en) 2002-12-23 2006-11-07 Gyrus Medical Limited Electrosurgical method and apparatus
US7395117B2 (en) 2002-12-23 2008-07-01 Cardiac Pacemakers, Inc. Implantable medical device having long-term wireless capabilities
US7127300B2 (en) 2002-12-23 2006-10-24 Cardiac Pacemakers, Inc. Method and apparatus for enabling data communication between an implantable medical device and a patient management system
US6978182B2 (en) 2002-12-27 2005-12-20 Cardiac Pacemakers, Inc. Advanced patient management system including interrogator/transceiver unit
US7278984B2 (en) 2002-12-31 2007-10-09 Alsius Corporation System and method for controlling rate of heat exchange with patient
US20050059153A1 (en) 2003-01-22 2005-03-17 George Frank R. Electromagnetic activation of gene expression and cell growth
JP4067976B2 (en) 2003-01-24 2008-03-26 有限会社日本エレクテル High frequency heating balloon catheter
US20040147988A1 (en) 2003-01-29 2004-07-29 Stephens Willard M. Method of treatment using one or more of a group of the "THERMA-KLOTH" products
US7613515B2 (en) 2003-02-03 2009-11-03 Enteromedics Inc. High frequency vagal blockage therapy
US7844338B2 (en) 2003-02-03 2010-11-30 Enteromedics Inc. High frequency obesity treatment
US20040172084A1 (en) 2003-02-03 2004-09-02 Knudson Mark B. Method and apparatus for treatment of gastro-esophageal reflux disease (GERD)
DE10305553B4 (en) 2003-02-10 2005-11-03 Lothar Dr.med. Göbel Device for tamponade of body cavities
US20040158237A1 (en) 2003-02-11 2004-08-12 Marwan Abboud Multi-energy ablation station
US6913616B2 (en) 2003-02-14 2005-07-05 Laser Cleanse Laser ionization therapy system and method
AU2004213010A1 (en) 2003-02-18 2004-09-02 Neurosignal Technologies, Inc. Regulation of blood pressure by coded nerve signals
US7837676B2 (en) 2003-02-20 2010-11-23 Recor Medical, Inc. Cardiac ablation devices
US6923808B2 (en) 2003-02-24 2005-08-02 Boston Scientific Scimed, Inc. Probes having helical and loop shaped inflatable therapeutic elements
US7559890B2 (en) 2003-02-26 2009-07-14 Ikona Medical Corporation Endoscopic imaging of an organ system
US8071550B2 (en) 2003-03-03 2011-12-06 Allergan, Inc. Methods for treating uterine disorders
IL154801A0 (en) 2003-03-06 2003-10-31 Karotix Internat Ltd Multi-channel and multi-dimensional system and method
US7551957B2 (en) 2003-03-06 2009-06-23 Bioelectronics Corp. Electromagnetic therapy device and methods
US20060015151A1 (en) 2003-03-14 2006-01-19 Aldrich William N Method of using endoscopic truncal vagoscopy with gastric bypass, gastric banding and other procedures
US7684865B2 (en) 2003-03-14 2010-03-23 Endovx, Inc. Methods and apparatus for treatment of obesity
US7783358B2 (en) 2003-03-14 2010-08-24 Endovx, Inc. Methods and apparatus for treatment of obesity with an ultrasound device movable in two or three axes
US7430449B2 (en) 2003-03-14 2008-09-30 Endovx, Inc. Methods and apparatus for testing disruption of a vagal nerve
US7252677B2 (en) 2003-03-14 2007-08-07 Light Sciences Oncology, Inc. Light generating device to intravascular use
US7394976B2 (en) 2003-03-25 2008-07-01 Arizant Healthcare Inc. Fluid warming cassette and system capable of operation under negative pressure
US7186251B2 (en) 2003-03-27 2007-03-06 Cierra, Inc. Energy based devices and methods for treatment of patent foramen ovale
KR100466866B1 (en) 2003-04-24 2005-01-24 전명기 Electrode for radiofrequency tissue ablation
US7390496B2 (en) 2003-04-25 2008-06-24 Allergan, Inc. Therapeutic treatments for repetitive hand washing
US7396535B2 (en) 2003-04-25 2008-07-08 Ackerman Alan H Therapy for obsessive compulsive head banging
US7101387B2 (en) 2003-04-30 2006-09-05 Scimed Life Systems, Inc. Radio frequency ablation cooling shield
US7221979B2 (en) 2003-04-30 2007-05-22 Medtronic, Inc. Methods and apparatus for the regulation of hormone release
US6838434B2 (en) 2003-05-02 2005-01-04 Allergan, Inc. Methods for treating sinus headache
US20040226556A1 (en) 2003-05-13 2004-11-18 Deem Mark E. Apparatus for treating asthma using neurotoxin
WO2004103459A2 (en) 2003-05-16 2004-12-02 Science Medicus, Inc. Respiratory control by means of neuro-electrical coded signals
US20060111755A1 (en) 2003-05-16 2006-05-25 Stone Robert T Method and system to control respiration by means of neuro-electrical coded signals
US20050261747A1 (en) 2003-05-16 2005-11-24 Schuler Eleanor L Method and system to control respiration by means of neuro-electrical coded signals
US20060287679A1 (en) 2003-05-16 2006-12-21 Stone Robert T Method and system to control respiration by means of confounding neuro-electrical signals
WO2004111074A2 (en) 2003-05-30 2004-12-23 The Cleveland Clinic Foundation In vivo production of a clostridial neurotoxin light chain peptide
US7149574B2 (en) 2003-06-09 2006-12-12 Palo Alto Investors Treatment of conditions through electrical modulation of the autonomic nervous system
US7738952B2 (en) 2003-06-09 2010-06-15 Palo Alto Investors Treatment of conditions through modulation of the autonomic nervous system
US20040253274A1 (en) 2003-06-11 2004-12-16 Allergan, Inc. Use of a clostridial toxin to reduce appetite
EP1648558A4 (en) 2003-06-13 2015-05-27 Biocontrol Medical B C M Ltd Applications of vagal stimulation
US7186220B2 (en) 2003-07-02 2007-03-06 Cardiac Pacemakers, Inc. Implantable devices and methods using frequency-domain analysis of thoracic signal
US8002740B2 (en) 2003-07-18 2011-08-23 Broncus Technologies, Inc. Devices for maintaining patency of surgically created channels in tissue
WO2005006964A2 (en) 2003-07-18 2005-01-27 Broncus Technologies, Inc. Devices for maintaining patency of surgically created channels in tissue
US8308682B2 (en) 2003-07-18 2012-11-13 Broncus Medical Inc. Devices for maintaining patency of surgically created channels in tissue
US6974224B2 (en) 2003-07-30 2005-12-13 Tru-Light Corporation Modularized light processing of body components
US7662101B2 (en) 2003-09-18 2010-02-16 Cardiac Pacemakers, Inc. Therapy control based on cardiopulmonary status
US7610094B2 (en) 2003-09-18 2009-10-27 Cardiac Pacemakers, Inc. Synergistic use of medical devices for detecting medical disorders
US7757690B2 (en) 2003-09-18 2010-07-20 Cardiac Pacemakers, Inc. System and method for moderating a therapy delivered during sleep using physiologic data acquired during non-sleep
US7156843B2 (en) * 2003-09-08 2007-01-02 Medtronic, Inc. Irrigated focal ablation tip
US20050065584A1 (en) 2003-09-09 2005-03-24 Schiff Jonathan D. System and method for cooling internal tissue
DE202004021943U1 (en) 2003-09-12 2013-05-13 Vessix Vascular, Inc. Selectable eccentric remodeling and / or ablation of atherosclerotic material
JP2007505658A (en) 2003-09-15 2007-03-15 アトリウム メディカル コーポレーション Application of therapeutic substances to tissue sites using expandable medical devices
US20050090722A1 (en) 2003-09-17 2005-04-28 Thomas Perez Method and apparatus for providing UV light to blood
US20050255317A1 (en) 2003-09-22 2005-11-17 Advanced Cardiovascular Systems, Inc. Polymeric marker with high radiopacity for use in medical devices
US20050153885A1 (en) 2003-10-08 2005-07-14 Yun Anthony J. Treatment of conditions through modulation of the autonomic nervous system
US7435252B2 (en) 2003-10-15 2008-10-14 Valam Corporation Control of microorganisms in the sino-nasal tract
US20050171396A1 (en) 2003-10-20 2005-08-04 Cyberheart, Inc. Method for non-invasive lung treatment
US7266414B2 (en) 2003-10-24 2007-09-04 Syntach, Ag Methods and devices for creating electrical block at specific sites in cardiac tissue with targeted tissue ablation
US20050096644A1 (en) 2003-10-30 2005-05-05 Hall Jeffrey A. Energy delivery optimization for RF duty cycle for lesion creation
WO2005062823A2 (en) 2003-12-19 2005-07-14 Savacor, Inc. Digital electrode for cardiac rhythm management
JP4391221B2 (en) 2003-12-22 2009-12-24 有限会社日本エレクテル High frequency heating balloon catheter
US7676269B2 (en) 2003-12-29 2010-03-09 Palo Alto Investors Treatment of female fertility conditions through modulation of the autonomic nervous system
US7422555B2 (en) 2003-12-30 2008-09-09 Jacob Zabara Systems and methods for therapeutically treating neuro-psychiatric disorders and other illnesses
US7150745B2 (en) 2004-01-09 2006-12-19 Barrx Medical, Inc. Devices and methods for treatment of luminal tissue
US7371231B2 (en) 2004-02-02 2008-05-13 Boston Scientific Scimed, Inc. System and method for performing ablation using a balloon
US8007495B2 (en) 2004-03-31 2011-08-30 Biosense Webster, Inc. Catheter for circumferential ablation at or near a pulmonary vein
US20050222635A1 (en) 2004-03-31 2005-10-06 Krakovsky Alexander A Potency package two
US20050222628A1 (en) 2004-03-31 2005-10-06 Krakousky Alexander A Implantable device for pain control and other medical treatments
EP2893955A1 (en) 2004-04-12 2015-07-15 Zoll Medical Corporation Automated pediatric defibrillator
KR101193709B1 (en) 2004-04-19 2012-10-23 프로리듬, 인크. Ablation devices with sensor structures
US7410480B2 (en) 2004-04-21 2008-08-12 Acclarent, Inc. Devices and methods for delivering therapeutic substances for the treatment of sinusitis and other disorders
US7377918B2 (en) 2004-04-28 2008-05-27 Gyrus Medical Limited Electrosurgical method and apparatus
US7324850B2 (en) 2004-04-29 2008-01-29 Cardiac Pacemakers, Inc. Method and apparatus for communication between a handheld programmer and an implantable medical device
WO2006007048A2 (en) 2004-05-04 2006-01-19 The Cleveland Clinic Foundation Methods of treating medical conditions by neuromodulation of the sympathetic nervous system
US7706878B2 (en) 2004-05-07 2010-04-27 Zoll Medical Corporation Automated caregiving device with prompting based on caregiver progress
US7899527B2 (en) 2004-05-13 2011-03-01 Palo Alto Investors Treatment of conditions through modulation of the autonomic nervous system during at least one predetermined menstrual cycle phase
WO2006007284A2 (en) 2004-06-21 2006-01-19 Curon Medical, Inc. Systems and methods for treating tissue regions of the body
US8409167B2 (en) 2004-07-19 2013-04-02 Broncus Medical Inc Devices for delivering substances through an extra-anatomic opening created in an airway
CA2591543A1 (en) 2004-07-19 2006-02-09 Broncus Technologies, Inc. Methods and devices for maintaining patency of surgically created channels in a body organ
US8396548B2 (en) 2008-11-14 2013-03-12 Vessix Vascular, Inc. Selective drug delivery in a lumen
WO2006031902A2 (en) 2004-09-10 2006-03-23 The Cleveland Clinic Foundation Methods and systems of achieving hemodynamic control through neuromodulation
US7906124B2 (en) 2004-09-18 2011-03-15 Asthmatx, Inc. Inactivation of smooth muscle tissue
US7553309B2 (en) 2004-10-08 2009-06-30 Covidien Ag Electrosurgical system employing multiple electrodes and method thereof
US7402172B2 (en) 2004-10-13 2008-07-22 Boston Scientific Scimed, Inc. Intraluminal therapeutic patch
JP4792467B2 (en) 2004-10-14 2011-10-12 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ Ablation apparatus and method with ultrasound imaging
US20060089637A1 (en) 2004-10-14 2006-04-27 Werneth Randell L Ablation catheter
US7553307B2 (en) 2004-10-15 2009-06-30 Baxano, Inc. Devices and methods for tissue modification
US8221397B2 (en) 2004-10-15 2012-07-17 Baxano, Inc. Devices and methods for tissue modification
US7524318B2 (en) 2004-10-28 2009-04-28 Boston Scientific Scimed, Inc. Ablation probe with flared electrodes
US7937143B2 (en) 2004-11-02 2011-05-03 Ardian, Inc. Methods and apparatus for inducing controlled renal neuromodulation
US20070083239A1 (en) 2005-09-23 2007-04-12 Denise Demarais Methods and apparatus for inducing, monitoring and controlling renal neuromodulation
US7949407B2 (en) 2004-11-05 2011-05-24 Asthmatx, Inc. Energy delivery devices and methods
US7200445B1 (en) 2005-10-21 2007-04-03 Asthmatx, Inc. Energy delivery devices and methods
WO2006052940A2 (en) 2004-11-05 2006-05-18 Asthmatx, Inc. Medical device with procedure improvement features
US20070093802A1 (en) 2005-10-21 2007-04-26 Danek Christopher J Energy delivery devices and methods
WO2006053308A2 (en) 2004-11-12 2006-05-18 Asthmatx, Inc. Improved energy delivery devices and methods
WO2006053309A2 (en) 2004-11-12 2006-05-18 Asthmatx, Inc. Improved energy delivery devices and methods
MX2007005937A (en) 2004-11-16 2007-09-11 Robert L Barry Device and method for lung treatment.
US8332047B2 (en) 2004-11-18 2012-12-11 Cardiac Pacemakers, Inc. System and method for closed-loop neural stimulation
US20060118127A1 (en) 2004-12-06 2006-06-08 Chinn Douglas O Tissue protective system and method for thermoablative therapies
US20060135953A1 (en) 2004-12-22 2006-06-22 Wlodzimierz Kania Tissue ablation system including guidewire with sensing element
US11207518B2 (en) 2004-12-27 2021-12-28 The Feinstein Institutes For Medical Research Treating inflammatory disorders by stimulation of the cholinergic anti-inflammatory pathway
CN101124012B (en) 2004-12-27 2012-09-05 范因斯坦医学研究院 Device for treating inflammatory disorders by electrical vagus nerve stimulation
US20080021274A1 (en) 2005-01-05 2008-01-24 Avantis Medical Systems, Inc. Endoscopic medical device with locking mechanism and method
US7722538B2 (en) 2005-02-10 2010-05-25 Dirar S. Khoury Conductance-imaging catheter and determination of cavitary volume
US20070060954A1 (en) 2005-02-25 2007-03-15 Tracy Cameron Method of using spinal cord stimulation to treat neurological disorders or conditions
EP3045110B1 (en) 2005-03-28 2019-07-31 Vessix Vascular, Inc. Intraluminal electrical tissue characterization and tuned rf energy for selective treatment of atheroma and other target tissues
US20060241523A1 (en) 2005-04-12 2006-10-26 Prorhythm, Inc. Ultrasound generating method, apparatus and probe
EP2727547B1 (en) 2005-04-21 2020-11-18 Boston Scientific Scimed, Inc. Devices for energy delivery
US8052668B2 (en) 2005-05-13 2011-11-08 Cardiac Pacemakers, Inc. Neurotoxic agents and devices to treat atrial fibrillation
WO2006130873A2 (en) 2005-06-01 2006-12-07 Broncus Technologies, Inc. Methods and devices for maintaining surgically created channels in a body organ
US7621890B2 (en) 2005-06-09 2009-11-24 Endocare, Inc. Heat exchange catheter with multi-lumen tube having a fluid return passageway
CA2612679A1 (en) 2005-06-20 2007-01-04 Richardo D. Roman Ablation catheter
DE102005030861A1 (en) 2005-07-01 2007-01-04 Invendo Medical Gmbh Cooling device for electronic components, preferably an endoscope
US7608275B2 (en) 2005-07-22 2009-10-27 The Foundry, Llc Systems and methods for delivery of a therapeutic agent
US9511210B2 (en) 2006-05-19 2016-12-06 The Foundry, Llc Apparatus for toxin delivery to the nasal cavity
US20070021803A1 (en) 2005-07-22 2007-01-25 The Foundry Inc. Systems and methods for neuromodulation for treatment of pain and other disorders associated with nerve conduction
US8660647B2 (en) 2005-07-28 2014-02-25 Cyberonics, Inc. Stimulating cranial nerve to treat pulmonary disorder
US20070043342A1 (en) 2005-08-16 2007-02-22 Galil Medical Ltd. Cryoprobe with reduced adhesion to frozen tissue, and cryosurgical methods utilizing same
US7628789B2 (en) 2005-08-17 2009-12-08 Pulmonx Corporation Selective lung tissue ablation
EP1933787A1 (en) 2005-08-19 2008-06-25 Werner Francois De Neve Device and method for assisting heat ablation treatment of the heart
US20070055328A1 (en) 2005-09-02 2007-03-08 Mayse Martin L Device and method for esophageal cooling
US9486274B2 (en) 2005-09-07 2016-11-08 Ulthera, Inc. Dissection handpiece and method for reducing the appearance of cellulite
US9037247B2 (en) 2005-11-10 2015-05-19 ElectroCore, LLC Non-invasive treatment of bronchial constriction
US20070106337A1 (en) 2005-11-10 2007-05-10 Electrocore, Inc. Methods And Apparatus For Treating Disorders Through Neurological And/Or Muscular Intervention
US9119953B2 (en) 2005-11-10 2015-09-01 ElectroCore, LLC Non-invasive treatment of a medical condition by vagus nerve stimulation
US8676324B2 (en) 2005-11-10 2014-03-18 ElectroCore, LLC Electrical and magnetic stimulators used to treat migraine/sinus headache, rhinitis, sinusitis, rhinosinusitis, and comorbid disorders
US20110125203A1 (en) 2009-03-20 2011-05-26 ElectroCore, LLC. Magnetic Stimulation Devices and Methods of Therapy
US8868177B2 (en) 2009-03-20 2014-10-21 ElectroCore, LLC Non-invasive treatment of neurodegenerative diseases
US8874205B2 (en) 2009-03-20 2014-10-28 ElectroCore, LLC Device and methods for non-invasive electrical stimulation and their use for vagal nerve stimulation
US8812112B2 (en) 2005-11-10 2014-08-19 ElectroCore, LLC Electrical treatment of bronchial constriction
US9089719B2 (en) 2009-03-20 2015-07-28 ElectroCore, LLC Non-invasive methods and devices for inducing euphoria in a patient and their therapeutic application
US8041428B2 (en) 2006-02-10 2011-10-18 Electrocore Llc Electrical stimulation treatment of hypotension
US9174066B2 (en) 2009-03-20 2015-11-03 ElectroCore, LLC Devices and methods for non-invasive capacitive electrical stimulation and their use for vagus nerve stimulation on the neck of a patient
US8676330B2 (en) 2009-03-20 2014-03-18 ElectroCore, LLC Electrical and magnetic stimulators used to treat migraine/sinus headache and comorbid disorders
US7747324B2 (en) 2005-11-10 2010-06-29 Electrocore Llc Electrical stimulation treatment of bronchial constriction
US20070106338A1 (en) 2005-11-10 2007-05-10 Electrocore, Inc. Direct and Indirect Control of Muscle for the Treatment of Pathologies
US8874227B2 (en) 2009-03-20 2014-10-28 ElectroCore, LLC Devices and methods for non-invasive capacitive electrical stimulation and their use for vagus nerve stimulation on the neck of a patient
WO2007061982A1 (en) 2005-11-22 2007-05-31 Mayo Foundation For Medical Education And Research Detecting and treating nervous system disorders
US7997278B2 (en) 2005-11-23 2011-08-16 Barrx Medical, Inc. Precision ablating method
US8190238B2 (en) 2005-12-09 2012-05-29 Hansen Medical, Inc. Robotic catheter system and methods
US20070149959A1 (en) 2005-12-23 2007-06-28 Sanarus Medical, Inc. Cryoprobe for low pressure systems
JP2009525806A (en) 2006-02-10 2009-07-16 エレクトロコア、インコーポレイテッド Electrical stimulation treatment for hypotension
AU2006337679A1 (en) 2006-02-10 2007-08-16 Electrocore, Inc. Methods and apparatus for treating anaphylaxis using electrical modulation
US20070239256A1 (en) 2006-03-22 2007-10-11 Jan Weber Medical devices having electrical circuits with multilayer regions
US20100174340A1 (en) 2006-04-18 2010-07-08 Electrocore, Inc. Methods and Apparatus for Applying Energy to Patients
US20100057178A1 (en) 2006-04-18 2010-03-04 Electrocore, Inc. Methods and apparatus for spinal cord stimulation using expandable electrode
US8209034B2 (en) 2008-12-18 2012-06-26 Electrocore Llc Methods and apparatus for electrical stimulation treatment using esophageal balloon and electrode
US8401650B2 (en) 2008-04-10 2013-03-19 Electrocore Llc Methods and apparatus for electrical treatment using balloon and electrode
US20100241188A1 (en) 2009-03-20 2010-09-23 Electrocore, Inc. Percutaneous Electrical Treatment Of Tissue
US20070255270A1 (en) 2006-04-27 2007-11-01 Medtronic Vascular, Inc. Intraluminal guidance system using bioelectric impedance
EP2020914B1 (en) 2006-05-10 2017-03-01 Regents of the University of Minnesota Methods and apparatus of three dimensional cardiac electrophysiological imaging
WO2007136566A2 (en) 2006-05-19 2007-11-29 Prorhythm, Inc. Ablation device with optimized input power profile and method of using the same
GB0610637D0 (en) 2006-05-23 2006-07-05 Emcision Ltd Apparatus and method for treating tissue such as tumours
US20080004596A1 (en) 2006-05-25 2008-01-03 Palo Alto Institute Delivery of agents by microneedle catheter
EP2032059A4 (en) 2006-06-05 2009-09-16 Broncus Tech Inc Devices for creating passages and sensing blood vessels
ES2378956T5 (en) 2006-06-28 2019-10-09 Medtronic Ardian Luxembourg Systems for thermally induced renal neuromodulation
US7517320B2 (en) 2006-06-30 2009-04-14 Broncus Technologies, Inc. Airway bypass site selection and treatment planning
EP2067447B1 (en) 2006-06-30 2012-08-15 Bernard Alfons Lucie B. Cambier Steerable catheter device for the chemoembolization and/or embolization of vascular structures, tumours and/or organs
US7425211B2 (en) 2006-08-03 2008-09-16 Arbel Medical Ltd. Cryogenic probe for treating enlarged volume of tissue
US7588549B2 (en) 2006-08-03 2009-09-15 Terumo Cardiovascular Systems Corporation Thermoelectric temperature control for extracorporeal blood circuit
US8177829B2 (en) 2006-08-23 2012-05-15 Boston Scientific Scimed, Inc. Auxiliary balloon catheter
US8103341B2 (en) 2006-08-25 2012-01-24 Cardiac Pacemakers, Inc. System for abating neural stimulation side effects
WO2008049087A2 (en) 2006-10-18 2008-04-24 Minnow Medical, Inc. System for inducing desirable temperature effects on body tissue
ES2560006T3 (en) 2006-10-18 2016-02-17 Vessix Vascular, Inc. Induction of desirable temperature effects on body tissue
WO2008049084A2 (en) 2006-10-18 2008-04-24 Minnow Medical, Inc. Tuned rf energy and electrical tissue characterization for selective treatment of target tissues
US7931647B2 (en) 2006-10-20 2011-04-26 Asthmatx, Inc. Method of delivering energy to a lung airway using markers
EP2091439B1 (en) 2006-11-22 2012-10-24 Broncus Technologies, Inc. Devices for creating passages and sensing for blood vessels
GB0624658D0 (en) 2006-12-11 2007-01-17 Medical Device Innovations Ltd Electrosurgical ablation apparatus and a method of ablating biological tissue
CN100574719C (en) 2006-12-26 2009-12-30 上海导向医疗系统有限公司 Gas throttling cooling type radio frequency ablation electrode
US20080208305A1 (en) 2007-01-17 2008-08-28 The Cleveland Clinic Foundation Apparatus and methods for treating pulmonary conditions
WO2008109760A2 (en) 2007-03-06 2008-09-12 Broncus Technologies, Inc. Blood vessel sensing catheter having working lumen for medical appliances
CN101292897A (en) 2007-04-25 2008-10-29 中国科学院理化技术研究所 Cold and hot probe treatment system
US8641711B2 (en) 2007-05-04 2014-02-04 Covidien Lp Method and apparatus for gastrointestinal tract ablation for treatment of obesity
US8983609B2 (en) 2007-05-30 2015-03-17 The Cleveland Clinic Foundation Apparatus and method for treating pulmonary conditions
EP2170458A1 (en) 2007-06-13 2010-04-07 E- Pacing, Inc. Implantable devices and methods for stimulation of cardiac or other tissues
US20080312543A1 (en) 2007-06-18 2008-12-18 Broncus Technologies, Inc. Measurement of pulmonary hypertension from within the airways
US8784338B2 (en) 2007-06-22 2014-07-22 Covidien Lp Electrical means to normalize ablational energy transmission to a luminal tissue surface of varying size
US8251992B2 (en) 2007-07-06 2012-08-28 Tyco Healthcare Group Lp Method and apparatus for gastrointestinal tract ablation to achieve loss of persistent and/or recurrent excess body weight following a weight-loss operation
WO2009006748A2 (en) 2007-07-09 2009-01-15 Sis-Medical Ag Method and system to detect neointima coverage of a stent
US8235983B2 (en) 2007-07-12 2012-08-07 Asthmatx, Inc. Systems and methods for delivering energy to passageways in a patient
US20090177192A1 (en) 2007-07-13 2009-07-09 Scimed Life Systems, Inc. Method for ablating tissue to facilitate implantation and apparatus and kit for use therewith
JP4967875B2 (en) 2007-07-17 2012-07-04 三菱電機株式会社 Semiconductor light emitting device and manufacturing method thereof
JP5436423B2 (en) 2007-07-24 2014-03-05 アスマティックス,インコーポレイテッド System and method for power control based on impedance detection such as power control for tissue treatment device
US20090043301A1 (en) * 2007-08-09 2009-02-12 Asthmatx, Inc. Monopolar energy delivery devices and methods for controlling current density in tissue
US20090076491A1 (en) 2007-09-19 2009-03-19 Broncus Technologies, Inc. Methods for maintaining the patency of collateral channels in the lungs using cryo-energy
AU2008310656A1 (en) 2007-10-12 2009-04-16 Conmed Corporation Apparatus and methods for the measurement of cardiac output
CN101411645A (en) * 2007-10-19 2009-04-22 上海导向医疗系统有限公司 The uniform radio-frequency ablation electrode of surface temperature
US8906011B2 (en) 2007-11-16 2014-12-09 Kardium Inc. Medical device for use in bodily lumens, for example an atrium
US8323202B2 (en) 2007-11-16 2012-12-04 Pneumrx, Inc. Method and system for measuring pulmonary artery circulation information
US20090192505A1 (en) 2007-12-05 2009-07-30 Reset Medical, Inc. Method for cryospray ablation
US8155744B2 (en) 2007-12-13 2012-04-10 The Cleveland Clinic Foundation Neuromodulatory methods for treating pulmonary disorders
US20090204005A1 (en) 2008-02-07 2009-08-13 Broncus Technologies, Inc. Puncture resistant catheter for sensing vessels and for creating passages in tissue
EP2249900A4 (en) 2008-02-08 2013-11-06 Terumo Corp Device for local intraluminal transport of a biologically and physiologically active agent
US8483831B1 (en) 2008-02-15 2013-07-09 Holaira, Inc. System and method for bronchial dilation
US20090248011A1 (en) 2008-02-28 2009-10-01 Hlavka Edwin J Chronic venous insufficiency treatment
EP2265316B1 (en) 2008-03-06 2016-01-13 Boston Scientific Scimed, Inc. Triggered drug release
US8470337B2 (en) 2008-03-13 2013-06-25 Allergan, Inc. Therapeutic treatments using botulinum neurotoxin
US20090254142A1 (en) 2008-04-08 2009-10-08 Silhouette Medical, Usa Treating Medical Conditions of Hollow Organs
EP2265204B1 (en) 2008-04-10 2017-12-06 ElectroCore LLC Device comprising an enclosure and an interior electrode for delivering energy to a mammal
US8543211B2 (en) 2008-04-10 2013-09-24 ElectroCore, LLC Methods and apparatus for deep brain stimulation
US8682449B2 (en) 2008-04-10 2014-03-25 ElectroCore, LLC Methods and apparatus for transcranial stimulation
EP2662046B1 (en) 2008-05-09 2023-03-15 Nuvaira, Inc. Systems and assemblies for treating a bronchial tree
US8128617B2 (en) 2008-05-27 2012-03-06 Boston Scientific Scimed, Inc. Electrical mapping and cryo ablating with a balloon catheter
US9101382B2 (en) 2009-02-18 2015-08-11 Hotspur Technologies, Inc. Apparatus and methods for treating obstructions within body lumens
US9089700B2 (en) 2008-08-11 2015-07-28 Cibiem, Inc. Systems and methods for treating dyspnea, including via electrical afferent signal blocking
US9211155B2 (en) 2008-08-20 2015-12-15 Prostacare Pty Ltd. Non-thermal ablation system for treating BPH and other growths
EP2328650B1 (en) 2008-08-26 2016-04-06 Cook Medical Technologies LLC Balloon catheters having a plurality of needles for the injection of one or more therapeutic agents
US20110306904A1 (en) 2008-08-26 2011-12-15 Northwestern University Ablation devices and related methods thereof
US8303581B2 (en) 2008-09-02 2012-11-06 Covidien Lp Catheter with remotely extendible instruments
US20100076518A1 (en) 2008-09-18 2010-03-25 Conceptx Medical, Inc. Systems and methods for relieving dyspnea
ES2440751T3 (en) 2008-10-07 2014-01-30 Boston Scientific Scimed, Inc. Medical devices for administration of therapeutic agents to body lumens
CN104068933B (en) 2008-11-11 2017-03-15 施菲姆德控股有限责任公司 The electrode assemblie of little profile
US8734502B2 (en) 2008-12-17 2014-05-27 Cook Medical Technologies Llc Tapered stent and flexible prosthesis
US20100160906A1 (en) 2008-12-23 2010-06-24 Asthmatx, Inc. Expandable energy delivery devices having flexible conductive elements and associated systems and methods
EP2376011B1 (en) 2009-01-09 2019-07-03 ReCor Medical, Inc. Apparatus for treatment of mitral valve insufficiency
US9174045B2 (en) 2009-03-20 2015-11-03 ElectroCore, LLC Non-invasive electrical and magnetic nerve stimulators used to treat overactive bladder and urinary incontinence
US10252074B2 (en) 2009-03-20 2019-04-09 ElectroCore, LLC Nerve stimulation methods for averting imminent onset or episode of a disease
US8914122B2 (en) 2009-03-20 2014-12-16 ElectroCore, LLC Devices and methods for non-invasive capacitive electrical stimulation and their use for vagus nerve stimulation on the neck of a patient
US10286212B2 (en) 2009-03-20 2019-05-14 Electrocore, Inc. Nerve stimulation methods for averting imminent onset or episode of a disease
WO2010110785A1 (en) 2009-03-24 2010-09-30 Electrocore, Inc. Electrical treatment of bronchial constriction
US20100256629A1 (en) 2009-04-06 2010-10-07 Voyage Medical, Inc. Methods and devices for treatment of the ostium
US20100256630A1 (en) 2009-04-07 2010-10-07 Angiodynamics, Inc. Irreversible electroporation (ire) for esophageal disease
EP2243501A1 (en) 2009-04-24 2010-10-27 Eurocor Gmbh Shellac and paclitaxel coated catheter balloons
US8788034B2 (en) 2011-05-09 2014-07-22 Setpoint Medical Corporation Single-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
CN201431510Y (en) * 2009-05-08 2010-03-31 上海理工大学 Gas-cooling and perfusion combined-type radio-frequency ablation probe electrode device for intervertebral disc
US8551096B2 (en) 2009-05-13 2013-10-08 Boston Scientific Scimed, Inc. Directional delivery of energy and bioactives
EP2253337A1 (en) 2009-05-18 2010-11-24 Encapson B.V. Balloon catheter comprising pressure sensitive microcapsules.
US8483832B2 (en) 2009-05-20 2013-07-09 ElectroCore, LLC Systems and methods for selectively applying electrical energy to tissue
EP2440262A2 (en) 2009-06-10 2012-04-18 Boston Scientific Scimed, Inc. Electrochemical therapeutic agent delivery device
JP2012531270A (en) 2009-06-24 2012-12-10 シファメド・ホールディングス・エルエルシー Operable medical delivery device and method of use
AU2010281644A1 (en) 2009-08-05 2012-02-23 Ndi Medical, Llc Systems and methods for maintaining airway patency
US8371303B2 (en) 2009-08-05 2013-02-12 Anesthetech Inc. System and method for imaging endotracheal tube placement and measuring airway occlusion cuff pressure
WO2011021948A1 (en) 2009-08-21 2011-02-24 Auckland Uniservices Limited System and method for mapping gastro-intestinal electrical activity
US8233987B2 (en) 2009-09-10 2012-07-31 Respicardia, Inc. Respiratory rectification
CN107049479B (en) 2009-10-27 2020-10-16 努瓦拉公司 Delivery device with coolable energy emitting assembly
CN102596320B (en) 2009-10-30 2016-09-07 瑞蔻医药有限公司 Method and apparatus by percutaneous ultrasound ripple Renal denervation treatment hypertension
WO2011053772A1 (en) 2009-10-30 2011-05-05 Sound Interventions, Inc. Method and apparatus for non-invasive treatment of hypertension through ultrasound renal denervation
US20110112400A1 (en) 2009-11-06 2011-05-12 Ardian, Inc. High intensity focused ultrasound catheter apparatuses, systems, and methods for renal neuromodulation
US20120302909A1 (en) 2009-11-11 2012-11-29 Mayse Martin L Methods and systems for screening subjects
US8911439B2 (en) 2009-11-11 2014-12-16 Holaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
EP2842510B1 (en) 2009-11-11 2022-08-24 Nuvaira, Inc. Device for treating tissue and controlling stenosis
US20110137284A1 (en) 2009-12-03 2011-06-09 Northwestern University Devices for material delivery, electroporation, and monitoring electrophysiological activity
US20110245756A1 (en) 2009-12-03 2011-10-06 Rishi Arora Devices for material delivery, electroporation, sonoporation, and/or monitoring electrophysiological activity
US20110144630A1 (en) 2009-12-10 2011-06-16 Loeb Marvin P Fiber optic device with controlled reuse
WO2011088399A1 (en) 2010-01-18 2011-07-21 Stanford University Method and apparatus for radioablation of regular targets such as sympathetic nerves
US9993625B2 (en) 2010-01-29 2018-06-12 Mirus Llc Biodegradable protrusions on inflatable device
WO2011119857A2 (en) 2010-03-24 2011-09-29 Shifamed, Llc Intravascular tissue disruption
US10575893B2 (en) 2010-04-06 2020-03-03 Nuvaira, Inc. System and method for pulmonary treatment
EP3482709B1 (en) 2010-04-06 2021-07-07 Nuvaira, Inc. System for pulmonary treatment
CN102933169B (en) 2010-04-14 2016-03-16 波士顿科学西美德公司 Adopt the renal artery denervation art apparatus of spiral forming device
US9237961B2 (en) 2010-04-23 2016-01-19 Medtronic Vascular, Inc. Stent delivery system for detecting wall apposition of the stent during deployment
CA2797130A1 (en) 2010-05-12 2011-11-17 Shifamed Holdings, Llc Low profile electrode assembly
EP2568900B1 (en) 2010-05-14 2017-09-27 Neuraxis, LLC Device for cooling spinal tissue
EP2593029A4 (en) 2010-07-13 2015-03-04 Sandhill Scient Inc Apparatus and method for detecting and measuring condition of esophageal mucosa and indications of gastroesophageal reflux disease
US9295663B2 (en) 2010-07-14 2016-03-29 Abbott Cardiovascular Systems Inc. Drug coated balloon with in-situ formed drug containing microspheres
US20120029512A1 (en) 2010-07-30 2012-02-02 Willard Martin R Balloon with surface electrodes and integral cooling for renal nerve ablation
US9155589B2 (en) 2010-07-30 2015-10-13 Boston Scientific Scimed, Inc. Sequential activation RF electrode set for renal nerve ablation
US9095320B2 (en) 2010-09-27 2015-08-04 CyroMedix, LLC Cryo-induced renal neuromodulation devices and methods
CN202478392U (en) 2010-10-20 2012-10-10 美敦力阿迪安卢森堡有限责任公司 Associated system of catheter device
US9192435B2 (en) * 2010-11-22 2015-11-24 Boston Scientific Scimed, Inc. Renal denervation catheter with cooled RF electrode
US8998893B2 (en) 2010-12-07 2015-04-07 Boaz Avitall Catheter systems for cardiac arrhythmia ablation
US11246653B2 (en) 2010-12-07 2022-02-15 Boaz Avitall Catheter systems for cardiac arrhythmia ablation
EP3132827B1 (en) 2010-12-28 2019-04-03 Cibiem, Inc. Endovascular carotid body ablation catheter for sympathetic rebalancing of patient
US9095262B2 (en) 2011-01-05 2015-08-04 Mehdi Razavi Guided ablation devices, systems, and methods
US20120191080A1 (en) 2011-01-25 2012-07-26 Medtronic, Inc. Method and Apparatus for Regulating the Formation of Ice On A Catheter
US20120191081A1 (en) 2011-01-25 2012-07-26 Medtronic, Inc. Method and Apparatus for Regulating The Formation Of Ice On A Catheter
WO2012103157A1 (en) 2011-01-28 2012-08-02 Medtronc Vascular Inc. Ablation catheter equipped with a shape memory material
US20120203067A1 (en) 2011-02-04 2012-08-09 The Penn State Research Foundation Method and device for determining the location of an endoscope
EP3275390B1 (en) 2011-02-10 2019-06-19 Corvia Medical, Inc. Apparatus to create and maintain an intra-atrial pressure relief opening
US8579800B2 (en) 2011-03-22 2013-11-12 Fabian Emura Systematic chromoendoscopy and chromocolonoscopy as a novel systematic method to examine organs with endoscopic techniques
WO2013106054A2 (en) 2011-04-08 2013-07-18 Vivant Medical, Inc. Flexible microwave catheters for natural or artificial lumens
EP2694150A1 (en) 2011-04-08 2014-02-12 Covidien LP Iontophoresis drug delivery system and method for denervation of the renal sympathetic nerve and iontophoretic drug delivery
WO2012148966A2 (en) 2011-04-25 2012-11-01 Brian Kelly Apparatus and methods related to selective thermal insulation of cryogenic balloons for limited cryogenic ablation of vessel walls
EP2701623B1 (en) 2011-04-25 2016-08-17 Medtronic Ardian Luxembourg S.à.r.l. Apparatus related to constrained deployment of cryogenic balloons for limited cryogenic ablation of vessel walls
US20140316398A1 (en) 2011-04-29 2014-10-23 Brian Kelly Systems and methods related to selective heating of cryogenic balloons for targeted cryogenic neuromodulation
US8909316B2 (en) 2011-05-18 2014-12-09 St. Jude Medical, Cardiology Division, Inc. Apparatus and method of assessing transvascular denervation
US8702619B2 (en) 2011-08-26 2014-04-22 Symap Holding Limited Mapping sympathetic nerve distribution for renal ablation and catheters for same
WO2013052501A1 (en) 2011-10-05 2013-04-11 Innovative Pulmonary Solutions, Inc. Apparatus for injuring nerve tissue
US20130310822A1 (en) 2012-05-18 2013-11-21 Holaira, Inc. Compact delivery pulmonary treatment systems and methods for improving pulmonary function
US9398933B2 (en) 2012-12-27 2016-07-26 Holaira, Inc. Methods for improving drug efficacy including a combination of drug administration and nerve modulation
EP4410338A3 (en) 2013-03-13 2024-10-16 Nuvaira, Inc. Fluid delivery system and method for treatment
WO2014143898A1 (en) 2013-03-15 2014-09-18 Holaira, Inc. Systems, devices, and methods for treating a pulmonary disorder with an agent
WO2015038886A1 (en) 2013-09-12 2015-03-19 Holaira, Inc. Systems, devices, and methods for treating a pulmonary disease with ultrasound energy
WO2015089377A1 (en) 2013-12-12 2015-06-18 Holaira, Inc. Catheter and handle assembly, systems, and methods
EP3468495B1 (en) 2016-06-09 2024-02-28 Nuvaira, Inc. Systems for improved delivery of expandable catheter assemblies into body lumens
EP3551109A4 (en) 2016-12-07 2020-07-22 Nuvaira, Inc. Method and systems for reducing treatment variability and increasing treatment efficacy and durability

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997025917A1 (en) * 1996-01-19 1997-07-24 Ep Technologies, Inc. Multi-function electrode structures for electrically analyzing and heating body tissue
US20090131928A1 (en) * 1998-01-14 2009-05-21 Respiratory Diagnostic, Inc. GERD treatment apparatus and method
WO1999042047A1 (en) * 1998-02-19 1999-08-26 Conway-Stuart Medical, Inc. Method for electrosurgically treating a sphincter
WO2000066017A1 (en) * 1999-05-04 2000-11-09 Curon Medical, Inc. Electrodes for creating lesions in tissue regions at or near a sphincter
US20080262489A1 (en) * 2007-04-23 2008-10-23 Minnow Medical, Llc Thrombus removal

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103860258A (en) * 2012-12-12 2014-06-18 北京中孵友信医药科技股份有限公司 Self-adaptive annular positioning endovascular catheter
CN105555220A (en) * 2013-07-22 2016-05-04 波士顿科学国际有限公司 Medical devices for renal nerve ablation
CN105555220B (en) * 2013-07-22 2019-05-17 波士顿科学国际有限公司 Medical instrument for renal nerve ablation
CN105636538B (en) * 2013-10-18 2019-01-15 波士顿科学国际有限公司 Foley's tube with flexible wire and its correlation technique for using and manufacturing
CN105636538A (en) * 2013-10-18 2016-06-01 波士顿科学国际有限公司 Balloon catheters with flexible conducting wires and related methods of use and manufacture
CN110575244A (en) * 2013-11-19 2019-12-17 伊西康公司 Thoracoscopic method for treating bronchial diseases
CN105744907A (en) * 2013-11-19 2016-07-06 伊西康公司 Thoracoscopic methods for treatment of bronchial disease
CN103735307B (en) * 2014-01-14 2016-06-08 沈诚亮 Bronchus hot forming conduit
CN103735307A (en) * 2014-01-14 2014-04-23 沈诚亮 Bronchial thermoplasty catheter
US11083400B2 (en) 2014-11-20 2021-08-10 Biosense Webster (Israel) Ltd. Catheter with high density electrode spine array
US12089940B2 (en) 2014-11-20 2024-09-17 Biosense Webster (Israel) Ltd. Catheter with high density electrode spine array
US11039772B2 (en) 2015-06-29 2021-06-22 Biosense Webster (Israel) Ltd. Catheter with stacked spine electrode assembly
CN106264715B (en) * 2015-06-29 2020-11-06 韦伯斯特生物官能(以色列)有限公司 Catheter having closed loop array with in-plane linear electrode portions
US10966623B2 (en) 2015-06-29 2021-04-06 Biosense Webster (Israel) Ltd. Catheter having closed loop array with in-plane linear electrode portion
CN106264715A (en) * 2015-06-29 2017-01-04 韦伯斯特生物官能(以色列)有限公司 There is the conduit of closed loop array with plane internal linear electrode part
US11690552B2 (en) 2015-06-29 2023-07-04 Biosense Webster (Israel) Ltd. Catheter with stacked spine electrode assembly
US12097034B2 (en) 2015-06-29 2024-09-24 Biosense Webster (Israel) Ltd. Catheter with stacked spine electrode assembly
US11116436B2 (en) 2015-06-30 2021-09-14 Biosense Webster (Israel) Ltd. Catheter having closed electrode assembly with spines of uniform length
US11723574B2 (en) 2015-06-30 2023-08-15 Biosense Webster (Israel) Ltd. Catheter having closed electrode assembly with spines of uniform length
CN106880400A (en) * 2015-12-16 2017-06-23 上海微创电生理医疗科技有限公司 Electrophysiologicalcatheter catheter and radio frequency ablation system
CN110944581A (en) * 2017-07-28 2020-03-31 美敦力公司 Expandable element for delivery of electric fields
CN110944581B (en) * 2017-07-28 2023-09-12 美敦力公司 Expandable element for delivery of an electric field
US12144629B2 (en) 2023-06-20 2024-11-19 Biosense Webster (Israel) Ltd. Catheter having closed electrode assembly with spines of uniform length

Also Published As

Publication number Publication date
JP6000851B2 (en) 2016-10-05
US9149328B2 (en) 2015-10-06
JP6734082B2 (en) 2020-08-05
US10363091B2 (en) 2019-07-30
US11389233B2 (en) 2022-07-19
KR101820542B1 (en) 2018-01-19
CN106618731B (en) 2020-08-07
EP2498705B1 (en) 2014-10-15
CN106618731A (en) 2017-05-10
CA2780608C (en) 2019-02-26
US20120310233A1 (en) 2012-12-06
CA2780608A1 (en) 2011-05-19
CN102711645B (en) 2016-12-28
KR20120101007A (en) 2012-09-12
EP2842510A1 (en) 2015-03-04
EP2842510B1 (en) 2022-08-24
US20200085495A1 (en) 2020-03-19
US9662171B2 (en) 2017-05-30
EP2498705A1 (en) 2012-09-19
IL219605A0 (en) 2012-07-31
JP2018187407A (en) 2018-11-29
US20220370123A1 (en) 2022-11-24
US20160192981A1 (en) 2016-07-07
US20180042668A1 (en) 2018-02-15
JP2013510676A (en) 2013-03-28
AU2010319477A1 (en) 2012-05-24
WO2011060200A1 (en) 2011-05-19
EP4111995A1 (en) 2023-01-04
JP2016152926A (en) 2016-08-25

Similar Documents

Publication Publication Date Title
CN102711645B (en) For processing tissue and controlling narrow system and device
JP6859393B2 (en) Systems, assemblies, and methods for the treatment of bronchial trees
CN104042322B (en) Delivery apparatus with coolable energy transmitting device

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C53 Correction of patent of invention or patent application
CB02 Change of applicant information

Address after: American Minnesota

Applicant after: Heler Corp.

Address before: Washington State

Applicant before: Innovative Pulmonary Solutions, Inc.

COR Change of bibliographic data

Free format text: CORRECT: APPLICANT; FROM: INNOVATIVE PULMONARY SOLUTIONS, INC. TO: HELER CORP.

C14 Grant of patent or utility model
GR01 Patent grant
CP01 Change in the name or title of a patent holder

Address after: American Minnesota

Patentee after: Nouarra company

Address before: American Minnesota

Patentee before: Heler Corp.

CP01 Change in the name or title of a patent holder